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Summary 
 
 
 
 
 
Copper-Catalysed Conjugate Additions 
 
Conjugate 1,4-additions of carbon nucleophiles to α,β-unsaturated ketones are valuable C-C bond 
forming reactions that furthermore allow introduction of stereogenic centers.(1) Copper-catalysed 
reactions have been successfully employed in a variety of syntheses, for example for (-)-
solavetivone(2) or prostaglandins.(3)  Improvement of enantioselectivity through design of more 
effective ligands is thus highly desirable.  
 The ligands depicted below were synthesised and tested, with excellent enantioselectivities on 
selected substrates. 
 
PPh2
N
O
O
NH
33
PPh2
N
NH
O
R R'
34
Fe
N
R1
O
NH
R2
PPh2
(SFc)-61  
 
 
 
Muscone Synthesis 
 
Musk odorants are a family of molecules possessing a very nice smell, of central importance for the 
fragrance industry. Application of the methodology developed for the copper-catalysed conjugate 
addition to the synthesis of (S)-muscone allowed the obtaining of product 90 in high yield and 
excellent enantiomeric purity. 
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Multicomponent Heck-Allylic substitution Reaction 
 
Synthetic methodology which allows for a rapid increase in molecular complexity is extremely 
valuable in organic chemistry, particularly if it generates more than one new carbon-carbon bond at 
a time, accommodates considerable functionality and is broad in scope. 
Design of a reaction sequence involving a Heck reaction followed by an allylic substitution 
allowed the obtaining of compound 141 depicted below. 
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1.  Introduction 
 
 
The concept of chirality is known in chemistry for more than a century. Louis Pasteur resolved in 
1850 a mixture of tartric acid salts by picking out crystal types on the basis of their differing 
appearance. Pasteur observed that optically active isomers polarised the light and that this must be 
due to an asymmetric grouping of atoms. The ‘asymmetry’ concept was further developed by Van’t 
Hoff and Le Bel and the term ‘chirality’ coined by lord Kelvin in 1904 in his Baltimore Lectures on 
Molecular Dynamics and the Wave Theory of Light in which he stated: ‘I call any geometrical 
figure chiral if its image in a plane mirror cannot be brought to coincide with itself’. The term 
Chiral is derived from the Greek name ‘kheir’ meaning ‘hand’. Indeed, left and right hands are an 
example of chirality (Figure 1). 
 
 
 
Figure 1. Chirality 
 
Chirality plays an important role in biology. Many compounds in living systems are chiral. In 
consequence, the result of interactions between chiral molecules depends on the isomer forms of 
the involved molecules. A well known example, (+)-limonene smells of orange whereas (-)-
limonene has a lemon fragrance (Figure 2). 
 
 
 
(-)-limonene       (+)-limonene 
Figure 2. Limonene enantiomers 
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The possible different interactions of enantiomers with biological systems are especially important 
for the pharmaceutical industry. For example, (S)-ibuprofen reaches therapeutic concentrations in 
blood in 12 minutes versus 30 minutes for the racemic mixture. As well, (S)-Ketoprofen is an 
analgesic whereas (R)-ketoprofen is prescribed for prevention of periodontal disease. More 
dramatic, (R)-thalidomide is a sedative whereas (S)-thalidomide is teratogenic and led to feotal 
malformations when taken by pregnant women. Therefore, stereoselective syntheses affording 
enantiopure molecules are of fundamental importance. In the year 2000, pure enantiomeric drugs 
sold worldwide represented 123 Mrd. US$ and their part is constantly increasing, expected to reach 
170 Mrd. US$ in 2005. 
Possible methods to obtain enantiopure compounds are classical racemate resolution, even though 
only 50 % yield can be reached, or biocatalysis using enzymes, restricted to specific substrates and 
natural occurring reactions. An efficient alternative to these limited methods is the catalytic 
enantioselective synthesis, using chiral catalysts to achieve enantioselective transformations. A 
catalytic reaction is one in which a catalyst is used to accelerate the reaction. Using a chiral 
catalyst, it is possible to selectively accelerate the reaction giving one enantiomere. Research in this 
field was recently awarded with the Nobel price (W.S. Knowles, R. Noyori, K.B. Sharpless, 2001) 
and is the subject of this dissertation. 
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 2. Copper-Catalysed Conjugate Additions 
 
 
2.1  Introduction 
 
Conjugate 1,4-additions of carbon nucleophiles to α,β-unsaturated ketones are valuable C-C bond 
forming reactions that furthermore allow introduction of stereogenic centers.(1) Copper-catalysed 
reactions have been successfully employed in a variety of syntheses, for example for (-)-
solavetivone(2) or prostaglandins.(3)
The most interesting feature of the copper-catalysed conjugate addition to α-β unsaturated ketone is 
the high selectivity for the 1,4-addition. Selectivity for 1,4 or 1,2-additions is related to Hard and 
Soft Acids and Bases theory (HSAB-principle) and Frontier Molecular Orbital Theory (FMO).(4) 
Hard nucleophiles as (MeLi or Grignard reagents) usually are highly polarised, with small ion radii 
(high charge density) and have low lying HOMO. Soft nucleophiles are generally not polarised, 
with low charge density and high lying HOMO with large molecular orbital coefficients at the 
reactive center. Hard nucleophiles are selective for the 1,2-addition on enones whereas soft 
nucleophiles as cuprates give the 1,4-addition product (Scheme 1). 
 
 
O
MeLi (hard)
Me2CuLi (soft)
OH
O
1,2-addition
1,4-addition
 
Scheme 1. 1,4 and 1,2-additions 
 
The Klopman-Salem(5) equation for interaction of a nucleophile N and an electrophile E combines 
the HSAB and FMO principles (Equation 1). 
 
Q: charge density 
ε : dielectric constant 
R : distance (N-E) 
c : coefficient of MO 
β : resonance integral 
E : energy of MO 
 
ΔE = - εRNE
QNQE 2(cNcEβ)2
EHOMO(N) - ELUMO(E)
+
 
         Coulomb term        Frontier Orbital term 
Equation 1. Klopman-Salem equation 
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 Indeed, for a soft nucleophile implying a soft-soft interaction with the enone, the dominant 
interaction is the frontier orbital term because of small ΔE(HOMON / LUMOE) and small charge 
densities reducing the Coulomb term (Equation 1). Examination of the LUMO-coefficients of the 
enones shows the largest coefficient located at the β-position to the carbonyl group, thus implying 
nucleophilic attack at that position according to the FMO theory (Figure 3). 
 
 
O
-0.48+0.62
 
Figure 3. 1,4-addition, LUMO coefficients 
 
With hard nucleophiles, the frontier orbital term is small because of large ΔE(HOMON / LUMOE) 
(Equation 1). The dominant interaction is thus described by the Coulomb term, i.e. electrostatic 
interactions. Examination of the charge density on the enone indicates that the higher charge 
density is located at the carbon of the carbonyl group thus explaining the preferred attack of hard 
nucleophiles at that position (Figure 4). 
 
 
O
+0.29+0.01
 
Figure 4. 1,2-addition, charge densities 
 
 
2.1.1 Grignard and Organolithium Reagents 
 
The asymmetric version of the 1,4-addition of cuprates to enones is of fundamental importance 
since it allows the formation of stereogenic centers. Early attempts employed chiral auxiliaries 
covalently linked either to the enone substrate or to the organocopper reagent. After a 
diastereoselective 1,4-addition, removal of the chiral auxiliary resulted in an overall 
enantioselective reaction.  For example, Helmchen reported the use of a chiral hydroxysulfonamide 
auxiliary for 1,4-additions on α,β-unsaturated esters (Scheme 2).(6) Diastereoselectivities of  99/1 
could be obtained using lithium or Grignard based cuprates. 
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Scheme 2. Diastereoselective conjugate addition 
 
Chiral copper reagents with covalently linked transferable chiral auxiliary were also explored, as 
for example the chiral cuprate 2 formed by reaction of copper with the chiral imine 1 (Scheme 3). 
 
 
N
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Ph
Ph N
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Cu RLi
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1)
2) hydrolysis
1) n-BuLi
2) alkynylcopper
78% ee
1 2  
Scheme 3. Transferable chiral auxiliary 
 
The main disadvantage of chiral auxiliaries is the stoichiometric amounts of expensive chiral 
material that have to be employed for the reaction. Therefore, a version with catalytic amounts of a 
metal and a chiral ligand had to be developed. The pioneering work of Lippard with tropone based  
ligands demonstrated that an enantioselective catalytic 1,4-addition reaction was possible, even 
though with low enantioslectivity.(7) Additives such as HMPA and Ph2(t-Bu)SiCl improved the 
enantioslectivity to 74% ee for addition of  Grignard reagents to cyclohexenone (Scheme 4) thus 
motivating further research in this field. 
 
 
O O
N
NH
Ph
Ph
1) 5 mol% L, CuBr
n-BuLi
2) HMPA, n-BuMgCl
L =
74% ee
 
Scheme 4. Conjugate addition on cyclohexenone 
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Several ligands have been optimized for Grignard additions, with 2-cyclohexenone becoming the 
standard test substrate (Figure 5). 
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Figure 5. Ligands for copper-catalysed conjugate addition on cyclohexenone 
 
 
2.1.2 Organozinc Reagents 
 
In the late eighties, an important development was initiated with the use of organozinc reagents 
reported by Luche and later by Soai using a nickel ephedrine-based catalyst.(8) Indeed, use of 
organozinc reagents is advantageous over Grignard or lithium reagents that can react with the 
carbonyl group before transmetallation with copper occurs. Organozinc reagents are less basic and 
are tolerant to a wide variety of functional groups. The first example of a copper-catalysed 1,4-
addition of an organozinc reagent to enones was reported by Alexakis, using ephedrine-based 
ligand 3 (Scheme 5).(9)
 
 
O O
20 mol% 3,
10 mol% CuI
2eq. Et2Zn
32% ee
N
P
OPh
Me
NMe2
3  
Scheme 5. Conjugate addition using organozinc reagent 
 
Since then, a variety of ligands for copper-catalysed 1,4-addition of organozinc to enones have 
been developed. Detailed studies by Bolm(10) revealed that the reaction is highly sensitive to a large 
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number of factors that govern catalyst activity and enantioselectivity, such as solvent, temperature 
and concentrations. Generally the ligand must be adjusted to each class of substrates. Generally, 
cyclopentenone was found to be a much more demanding substrate than cyclohexenone. Also, 
ligands for acyclic enones or cyclic enones are different. Most of the reported ligands are based on 
phosphorus due to the high affinity of this soft lewis base for copper. Distinction can be made 
between phosphines, phosphonites, phosphite and phosphoramidites ligands. 
 
 
a) Phosphoramidites: 
 
Phosphoramidites monodentate ligands based on (S)-2,2’-binaphtol (BINOL) 4 (Figure 6) or 
α,α,α’,α’-tetraphenyl-2,2’-dimethyl-1,3-dioxolane-4,5-dimethanol (TADDOL) 7 were reported by 
Feringa to have electron donor-acceptor properties between those of arylphosphine and 
arylphosphites.(11) BINOL-based ligands revealed excellent enantioselectivities for both cyclic and 
acyclic substrates. Increased enantioselectivity was observed when sterically demanding 
substituents were introduced at nitrogen. Thus, 98% ee could be achieved for diethylzinc addition 
on cyclohexenone with ligand 5. Nevertheless, conjugate addition on cyclopentenone was found to 
give only moderate enantioselectivities, in contrasts to reactions using C2-symmetric bidentate 
phosphoramidite ligand 6. 
 
 
O
O P N O
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Ph
Ph
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Ph
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O
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R2
Ar Ar
Ar Ar
N
R1
R1
7  
Figure 6. Phosphoramidite ligands 
 
TADDOL-based ligands 7 were also found to be very effective for conjugate addition of 
organozinc reagents on cyclopentenone. Compared to BINOL-based ligands where increased steric 
hindrance on nitrogen enhanced the enantioselectivity, the opposite effect was reported for 
TADDOL-based ligands.(12) 
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b) Phosphites: 
 
The first successful chiral phosphite ligands were reported by our group.(13) Using 
phosphinooxazoline 8 (Figure 7), high enantioselectivities were obtained on cyclohexenone, 
cyclopentenone and acyclic substrates. Introducing bulky substituents at the 3,3’ positions of the 
BINOL backbone further improved the enantioselection for cyclopentenone, reaching 94% ee.(14)
 
 
O
O P
O
N
O
R
R
8
 
Figure 7. 
 
Monodentate phosphites based on TADDOL and BINOL were reported by Alexakis.(15) The 
TADDOL based ligands 9 (Figure 8) were the most successful giving 96% ee for diethylzinc 
addition on cyclohexenone. BINOL based bisphosphite 10 was reported by Chan. It was 
successfully used for the conjugate addition of organozinc to novel substrates, α,β-unsaturated 
lactones.(16)
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Figure 8. 
 
 
c) Phosphonite: 
 
Most phosphonites reported so far displayed only moderate enantioselectivity on test substrates.  A 
TADDOL based ligand reported by Alexakis gave only 54% ee for diethylzinc addition on 
cyclohexenone.(17)  The  BINOL based phosphonite 12 similarly gave 41% ee (Figure 9).(18) 
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Figure 9. 
 
Reetz et al. tested the ferrocene based phosphonite 11, initially developed for rhodium catalysed 
hydrogenation,(19) for copper-catalysed conjugate addition. Impressive enantiomeric excess of 96-
98% were obtained for diethylzinc addition to cyclohexenone and  lactones. 
 
 
d) Phosphines: 
 
The first successful application of phosphines was reported by Imamoto(20) using the chiral 
phosphorus ligand 13 (Figure 10). An ee of 83% ee was obtained for the diethylzinc addition to 
cyclohexenone. Improvement for both cyclic and acyclic enones was achieved by Zhang with 
ligand 14, giving 92% ee for diethylzinc addition on cyclohexenone and for the first time 98% ee 
for chalcones.(21) Also interesting is ligand 15, with 91% ee on cyclohexenone.(22)
 
P P Met-Bu
t-BuMe
PPh2
N
H
O
N N
N PPh2
13 14
15
 
Figure 10. 
 
Recently, Hoveyda reported the use of modular peptide-based phosphines 16 (Figure 11). A 
combinatorial approach to ligand optimisation led to specific combinations of amino-acids for each 
class of substrates. 
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Figure 11. 
 
 
e) Non-phosphorus ligands: 
 
After the report by Noyori of copper-catalysed conjugate additions with achiral copper-
sulfonamide complexes, Sewald developed chiral sulfonamides which induced moderate 
enantioselectivities.(23) Successful examples of chiral sulfonamide ligands 17 (Figure 12) were 
found by Genari using high-throughput screening.(24) An ee of 90% ee could be reached for 
diethylzinc addition to cyclohexenone. Acyclic substrates on the other hand gave much lower 
enantioselectivities. 
 
N
S
NHR3
OH
R2
R1
O O
S
OH
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N N PhPh
PhPh
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17
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19
 
Figure 12. 
 
Because of the high affinity of sulfur for copper, Woodward studied BINOL-derived thiols 18 
which gave 77% ee with acyclic enones.(25). Alexakis reported moderate enantioselectivities for the 
diaminocarben ligand 19.(26) 
 
 
2.1.3 Mechanism 
 
The mechanism of copper-catalysed conjugate addition  is remaining a subject of investigation. 
After that early proposal of single electron transfer has been rejected(27), more plausible 
mechanisms have been proposed over the last decade. Still, no direct evidence supporting the 
postulated catalyst structure has been reported so far. Nevertheless, kinetic studies, NMR 
spectroscopy and theoretical calculations have led to a commonly accepted general mechanism. In 
the reaction of cuprates with enones, the first step is the reversible coordination of copper on the 
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enone, forming the π-complex A (Scheme 6). NMR-spectroscopic studies have demonstrated that 
complex A is a reactive intermediate of the reaction.(28) Kinetic studies have shown that the 
reaction rate depends directly on the concentration of A. Next occurs the oxidative addition to form 
a σ-bound Cu(III) species to form B, even though the formation of the supposed Cu(III) could not 
be demonstrated so far. The accelerating effect of strong σ-donating ligands as sulfur or phosphines 
could be correlated to stabilization of this Cu(III) intermediate(29)After reductive elimination the 
enolate C is formed. The kinetic isotope effects in conjugate addition to cyclohexenone were 
determined by Singleton et al. with the conclusion that the rate-limiting step is the C-C bond 
formation to form the enolate C.(30)
 
 
R' R''
O
R' R''
OCuR
R Li
A R'
R''
OLiCuR
R
B
R' R''
OLiR
C
-RCu
 
Scheme 6. Mechanism for the 1,4-addition of cuprates to enones 
 
The precise nature of the cuprate formed with organolithium is important. In 1952 Gilman reported 
the formation of a reactive cuprate Li(R2Cu)  by addition of one equivalent of organolithium to an 
unreactive and unstable monoorganocopper RCu reagent (Equation 2) (31). 
 
 
CuX + LiR CuR Li(CuR2)LiR-LiX  
Equation 2. Cuprates 
 
Nevertheless, organocuprates display remarkable structural diversity. Depending on the ligands, 
solvents, counter ions or additives, a wide variety of structures has been observed, ranging from 
monomeric to complex aggregates as the neutral dimeric structure 20(32) or the ionic cuprate 21 
reported for t-Bu2CuLi2CN(THF)(pmdeta)2 (pmdeta= pentamethyldiethylentriamine, Figure 13).(33)
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Figure 13. 
 
The reactivity of cuprates was reported to be correlated to the C-Cu-C angle.(34) Using 
B3LYP/631A method for geometry optimization, the energy of the frontier molecular orbitals of 
(CH3)2Cu- was examined for various C-Cu-C angles (Figure 14). Whereas a near to linear geometry 
was found to be suited for SN2 substitution reactions, a bent geometry was ideal for the formation 
of a π-complex with the enone (structure A in Scheme 6). 
 
RR
180° 110-150°
CuCu
HOMO HOMO
σ∗(C-Y) π∗(C-C)
A
 
Figure 14. Angle-reactivity correlation 
 
 
2.1.4 Enantioselectivity 
 
Taking the dimeric cuprate model, recent theoretical calculations have brought some insight in to 
the origin of enantioselectivity observed with chiral catalysts.(35) In this model, copper/olefin 
(soft/soft) and lithium/carbonyl (hard/hard) interactions are the main factors. Stable copper-enone 
π-complexes have been observed using NMR techniques by several research groups.(36) The rate 
determining step was found to be the C-C bond formation to form 26 (Scheme 7) by reductive 
elimination of Cu(III) to Cu(I) from 24. The proposed mechanism is in accordance with kinetic 
data obtained previously by Krauss and Smith who showed that the 1,4-addition of cuprates is first-
order in both cuprate dimer and enone.(37)
 
 
21
  
O
H H
Li
R
R
Cu
Cu
R
Li
R
O
H H
Li R
R CuR
Li
RCu
O
R
H H
Li
Li Cu
R
R
Cu
R
O
R
H H
Li
Li Cu
R
R
Cu
R
O
H H
Li
Li
R
Cu
R
R
Cu
R
O Cu CH2
Li
LiC
Cu
H2C
CHH
H
H
22 23 24
2526  
Scheme 7. Cu(III) intermediate 
 
In distinction to previous assumptions that the enantioselective step may occur by enone face 
discrimination during the coordination of the cuprate on the enone to form 23, as for example in  
model 27 (Figure 15) reported by Tomioka et al., (38) Nakamura proposed that the enantioselection 
occurs during the reductive elimination from Cu(III) to Cu(I), the role of the chiral ligand being to 
selectively accelerate this reductive elimination on one of the diastereoisomeric copper-enolate 24 
intermediates (Scheme 8). 
 
Cu
Me
Li
Li
Me
Cu
Me
Me
N
R
R
P
O
PhPh
N O
R
R
P Ph
Ph
O
Ph
Ph
27  
Figure 15. Face discrimination 
 
Nevertheless, this mechanism is proposed for cuprates, i.e. with organolithium reactants, and it is 
not clear whether or not these results can be transposed to the conjugate addition with organozinc 
reagents. 
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Scheme 8. Enantioselection 
 
 
The only extensive mechanistic studies were published by Noyori dealing with chiral sulfonamide 
ligands, following the reaction by measuring the intensity of the C-O stretching band of the zinc 
enolate in the IR-spectrum.(39) The reaction turned out to proceed with first-order kinetics in both 
Et2Zn and enone as well as in CuCN and sulfonamide. The bidentate catalyst coordinates here both 
the copper and the organozinc reagent, itself coordinated to the carbonyl of the enone (Scheme 9). 
Because Zn is much more electropositive  than Cu, all hard anions are bound to Zn. Noteworthy, 
protic ligand reacts with ZnR2 to form RZnNR’SO2Ar by elimination of hydrocarbon RH 
(Equation 3).(40) Because the reaction proceeds with first-order kinetics in both Et2Zn and enone, 
the turnover rate is limited by the alkyl-transfer step and not by the product releasing step. 
 
 
 
R'NHSO2Ar + ZnR2 RZnNR'SO2Ar + RH
CuX  +  ZnR2 CuR + RZnX
RZnNR'SO2Ar  +  CuR (RZnNR'SO2Ar)(CuR) 
Equation 3. Reaction of protic ligands with diethylzinc 
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Scheme 9. Catalytic cycle 
 
Similarly to Gilmans cuprate, they assumed a mixed-metal cluster CuZnR3. When Et2Zn and CuX 
are mixed in solution, a metathetic anion exchange takes place under the control of the metal redox 
potentials, giving EtZnX and CuEt. The CuEt is reported to interact with Et2Zn to form an active 
mixed-metal cluster compound CuZnEt3. 
 
 
2.2 Synthesis and Applications of New Ligands 
 
2.2.1 Aim of the Work 
 
Various oxazoline-containing ligands have been applied to copper-catalysed conjugate addititon to 
enones. In contrast to its success in allylic alkylations,(41) BOX ligands (bisoxazoline) were not 
effective in copper-catalysed conjugate additions. Following Van Kotens results with thiol 
ligands,(42) Pfaltz et al. reported a thio-oxazoline ligand 28 that showed promising results with 
grignard reagents (Scheme 10).(43) 
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Scheme  10. Conjugate addition with thiol-oxazoline ligand 28. 
 
When using organozinc reagents, the majority of the reported ligands rely on phosphorus 
coordination. BINOL-based phopshoramidites ligands 4 (Figure 6) reported by Feringa showed 
very interesting enantioselectivities.(44) Thus, a BINOL-oxazoline P,N ligand 29 (Figure 16) was 
developed in the group and revealed interesting enantioselectivities upon variation of the R 
substituents at the BINOL moiety.(13) 
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Figure 16. Conjugate additions with ligand 29. 
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2.2.1.1 Schiff-Base Ligands 
 
Amino acid-based Schiff base ligands 30 (Figure 17) were introduced by Inoue for catalysed 1,2-
conjugate additions on aldehydes.(46) Using a combinatorial approach, Hoveyda recently reported a 
modular peptide-based ligand 31 that showed high enantioselectivities on both cyclic and acyclic 
enones.(47)
 
PPh2
N AA1 AA2 NHBu
OH
N AA1 AA2 Me
3130  
Figure 17. Schiff base ligands 
 
Upon variation of the peptidic chain, adaptation of the ligand to each substrate class could be 
achieved (Figure 18). 
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Figure 18. Ligand specificity 
 
In comparison to PHOX ligands that are moderately effective, the very high enantioselectivities 
obtained with ligands 31 called for further investigations since coordination sites of both ligand 
types shows similarities (Figure 19). 
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Figure 19. Ligands superposition 
 
The aim of the present work was thus to investigate the important functionalities of ligand 31 by 
systematic variations of the substituents R and R’. Also, suspecting the amide functionality to play 
a crucial role by presenting a third coordinating group, synthesis of phopshine-oxazolines with an 
amide side-chain was necessary. Finally, modification of the phosphinoaryl part led to synthesis of 
ferrocene ligands. 
 
 
2.2.2 Imine ligands 
 
2.2.2.1  Phosphine-oxazoline amides 
 
The synthesis of phopshine-oxazoline-amide 33 was obtained by coupling diphenylphosphino-
benzoic acid 32 (Scheme 11) with a functionalised amino acid (serine). 
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Scheme  11. Ligand synthesis 
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 The copper(II)-complex was formed using a 1/1 Cu(II)/ligand ratio in dichloromethane. The 
copper(II) source was the commercially available Cu(II)trifluoromethansulfonate. Precipitation 
with pentane led to analytically pure copper complex. Test reactions with the obtained complex on 
cyclohexenone were conducted at room temperature using 5 mol% of catalyst and 1.5 equivalent of 
diethylzinc for 24 hours. The complex was found to be insoluble in toluene, the usual solvent for 
copper-catalysed conjugate additions, thus adjunction of small amounts of polar cosolvents was 
necessary. Enantioselectivities were found to vary depending on the nature and ratio of used 
cosolvent (Table 1). 
 
 
Table 1. Solvent influence on Cu-catalysed diethylzinc addition to cyclohexenonea 
Entry Temp.  (°C) Solvents (ratio) Yield (%)b ee (%)b
1 +25 Tol/CH2Cl2 (8/2) 30 20 (S) 
2 +25 Tol/THF (9.5/0.5) 77 35 (S) 
3 +25 Tol/THF(8/2) 50 50 (S) 
4 +25 THF 33 22 (S) 
a All reactions were carried out under argon using 5 mol% of 33-Cu(OTf)2 for 12 hours.  
b Determined by GC. 
 
Dichloromethane (Entry 1, Table 1) was detrimental both for yields and enantioselectivity, whereas 
THF lowers the yields but increased the ee when a 8/2 toluene/THF mixture was used (Entry 3/2, 
3/4, Table 1). Nevertheless, enantioselectivities obtained were moderate, thus calling for 
optimisation of ligand structure through systematic variations of phosphine-imine ligands 34 
(Scheme 12) to determine the most important functionalities. 
 
 
2.2.2.2 Schiff-base ligands 
 
Schiff base ligands 34 were obtained by coupling suitably functionalized amino acids with 
diphenylphosphinobenzaldehyde in trimethylorthoformate. The substitution on BOC-protected 
amino acids was introduced by amide formation with EDC/HOBT followed by removal of the Boc 
group in acidic solution. 
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Scheme 12. Schiff base ligand synthesis 
 
The obtained imino-phosphine ligands 34 are not air-stable, whereas the copper complex generated 
from these ligands could be handled without special care. Thus, the copper-complexes were formed 
immediately by using a 1/1 Cu(II)OTf2/ligand ratio in dichloromethane. Precipitation with pentane 
led to analytically pure copper complexes. The following ligands were synthesized and tested: 
 
a) Pheylalanine-derived ligands: 
 
BOC-protected phenylalanine amino acids were functionalised according to Scheme 12 and 
coupled with diphenylphosphinobenzaldehyde to give ligand 35 and 36 (Figure 20). Their copper 
complexes were formed and used for diethylzinc addition to cyclohexenone, cyclopentenone and 
non-3-en-2-one. 
 
N
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Figure 20. 
 
Table 2. Ligands enantioselectivity for Cu-catalysed diethylzinc additiona  
Entry Ligand Temp. (°C) Cyclopent. 
% ee (% conv)b
Cyclohex. 
% ee (% conv)b
Nonenone 
% ee (% conv)b
1 35 +25 93.5 R (90) 93.4 R (95) 65 (+) (90) 
2 35 -30 87 R (72) 90 R (90) 60 (+) (90) 
3 36 -30 5 R (50) 57 R (90) 5 (+) (90) 
a All reactions were carried out under argon using 5 mol% of L-Cu(OTf)2 in toluene for 12 hours. b Determined by GC. 
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The catalyst formed with ligand 35 shows acceptable enantioselectivities with each class of 
substrate, giving generally better results at room temperature than at low temperature (Entries 1,2, 
Table 2). In contrast, ligand 36 bearing an ester instead of a bulky amide group showed poor or no 
enantioselection (Entry 3, Table 2) 
 
b) Valine-derived ligands: 
 
The synthesis of the valine-derived ligands is identical to the synthesis of phenylalanine-derived 
ligands described above. 
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Figure 21. 
 
Valine-derived copper complexes were formed and tested for diethylzinc conjugate addition to 
cyclohexenone, cyclopentenone and non-3-en-2-one. 
 
Table 3. Ligands enantioselectivity for Cu-catalysed diethylzinc additiona  
Entry Ligand Temp. (°C) Cyclopent. 
% ee (% conv.)b
Cyclohex. 
% ee (% conv.)b
Nonenone 
% ee (% conv.)b
1 37 +25 95 R (89) 94.5 R (98) 68 (+) (90) 
2 37 -30 90 R (86) 92 R (98) 75 (+) (79) 
3 38 +25 73 R (82) 36 R (98) 63 (+) (85) 
4 38 -30 85.5 R (80) 85.2 R (98) 76.6(+)(84) 
5 39 +25 93 R (85) 97.8 R (98) 68(+)(90) 
6 39 -30 80 R (84) 92.3 R (98) 72 (+)(92) 
7 40 +25 11 R (50) 40.5 R (80) 7 (+) (80) 
8 40 -30 15 R (80) 64 R (80) 10 (+) (80) 
a All reactions were carried out under argon using 5 mol% of L-Cu(OTf)2 in toluene for 12 hours. b Determined by GC. 
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 All catalysts displayed high reactivity and enantioslectivity, apart from the ester ligand 40 (Entries 
7,8, Table 3).  The highest enantioselectivities were obtained with ligands 37 and 39, having a 
bulky amide substituent. Surprisingly, the ees were higher at RT than at -30 °C. An impressive 
97.8% ee could be achieved on cyclohexenone with ligand 39, rivaling the peptidic ligands 
reported by Hoveyda.(47)
 
c) Cyclohexylglycine-derived ligands: 
 
The synthesis of the cyclohexylglycine-derived ligands is identical to the synthesis of 
phenylalanine-derived ligands described above. Noteworthy, cyclohexylglycine is a non-natural 
amino acid. 
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Figure 22. 
 
The corresponding cyclohexylglycine-derived copper complexes were formed and tested for 
conjugate addition of diethylzinc to cyclohexenone, cyclopentenone and non-3-en-2-one in toluene. 
 
 
Table 4. Ligands enantioselectivity for Cu-catalysed diethylzinc additiona 
Entry Ligand Temp. (°C) Cyclopent. 
% ee (% conv.)b
Cyclohex. 
% ee (%conv.)b
Nonenone 
% ee (% conv.)b
1 41 +25 94R (87) 96.4 R (98) 80(+)(80) 
2 41 -30 89R (86) 90 R (98) 82(+) (79) 
3 42 +25 93R (82) 96.6 R (98) 82(+) (85) 
4 42 -30 90R (80) 93 R (98) 83(+) (84) 
a All reactions were carried out under argon using 5 mol% of L-Cu(OTf)2 in toluene for 12 hours. b Determined by GC. 
 
Ligands 41 and 42 displayed almost identical enantioselectivities. Ligand 42 was slightly superior 
to the valine-derived N-tertbutyl amide ligand 37, thus indicating that steric bulk on the amino acid 
moiety is needed. In case of ligand 41, the large cyclohexyl substituent in conjunction with N-
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adamantyl amide substitution is deleterious compared to the valine-derived N-adamantyl amide 
ligand 39. Thus, fine-tuning of the steric balance between the amino acid substituent and the amide 
functionality is required. 
 
d) Valine and isoleucine derive ester ligands: 
 
The synthesis of valine- and isoleucine-derived ester ligands is identical to the synthesis of 
phenylalanine-derived ligands described above. 
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Figure 23. 
 
Their copper complexes were formed and tested for diethyl-zinc conjugate addition on 
cyclohexenone, cyclopentenone and non-3-en-2-one in toluene. 
 
 
Table 5. Ligands enantioselectivity for Cu-catalysed diethylzinc additiona 
Entry Ligand Temp. (°C) Cyclopent. 
% ee (% conv.)b
Cyclohex. 
% ee (% conv.)b
Nonenone 
% ee (% conv.)b
1 43 +25 7 R (32) 13 R (60) 30 (+) (27) 
2 43 -30 5 R (30) 25 R (42) 36 (+)(24) 
3 44 +25 3 R (35) 54 R (50) 8 (+)(20) 
a All reactions were carried out under argon using 5 mol% of L-Cu(OTf)2 in toluene for 12 hours. b Determined by GC. 
 
These ligands were found to form relatively unreactive catalysts and displayed very poor 
enantioselectivities. This might be due to the nature of the amino acid employed and, on the other 
side, to the ester functionality which also gave poor results with others ligands. It appeared that the 
amide is needed, presenting a third coordinating site. 
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 e) Valine-derived ligands with tertiary amide functionality: 
 
To determine if a secondary amine is necessary, analogous ligands with a tertiary amide group 
were synthesised. The synthesis of these valine-derived ester ligands is identical to the synthesis of 
phenylalanine-derived ligands described above. 
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Figure 24. 
 
Their copper complexes were formed and tested for diethyl-zinc conjugate addition on 
cyclohexenone, cyclopentenone. 
 
 
Table 6. Ligands enantioselectivity for Cu-catalysed diethylzinc additiona 
Entry Ligand Temp. (°C) Cyclopent. 
% ee (% conv.)b
Cyclohex. 
% ee (% conv.)b
1 45 +25 40 R (75) 24 R (90) 
2 46 +25 58 R (70) 62 R (90) 
a All reactions were carried out under argon using 5 mol% of L-Cu(OTf)2 in toluene for 12 hours. b Determined by GC. 
 
Both ligands showed low enantioselectivities, confirming that a secondary amide is essential for 
achieving high enantioslectivities. An secondary amide might be necessary to coordinate the 
organozinc reagent after deprotonation as reported for amide ligands with organozinc reagents 
(Figure 25, Equation 3).(48)
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2.2.2.3 Optimisation of the Experimental Conditions 
 
Using the valine-derived ligand 37, solvents, temperature and the amount of Et2Zn were varied to 
determine the optimal conditions. Indeed, copper-catalysed reactions are generally highly sensitive 
to reaction conditions such as solvent, temperature, reagents nature and equivalencies. Concerning 
the temperature, the optimum was found around room temperature, in distinction to most conjugate 
additions reported which were conducted at low temperatures. 
Various solvents were tested on cyclohexenone using two equivalents of diethylzinc and 5 mol% 
catalyst formed from valine-derived ligand 37. Polar or coordinating solvents such as THF were 
found deleterious for enantioselectivity (Figure 26). 
  
 
 
75 
80 
90 
95 
100 
Tol.    Tol/THF9/1 
THF Benzene Hexan
85 
Solvents 
Solvent Influence 
ee
 (%
) 
Figure 26. Solvent influence 
 
Benzene was slightly superior to toluene. Using toluene as solvent, the amount of diethylzinc was 
varied, as depicted in the Figure 27. Only subtle changes in enantioselectivity were observed when 
the amount was increased from 1.0 to 3.0 molar equivalents with respect to the enone. 
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Figure 27. Influence of the Et2Zn/Cyclohexenone ratio 
Et2Zn/Cyclohexenone ratio
 
 
2.2.2.4 Phosphite ligands 
 
For further ligand optimisation, variation of the diphenylphosphine moiety was investigated. The 
synthesis of hydroxy ligand 48 and diphenylphospshite ligand 49 was obtained by coupling the 
functionalised amino acid with salicylaldehyde 47 to form the imine, followed by formation of the 
phopshite with chlorodiphenylphosphine under basic conditions (Scheme 12). Strong 
organolithium bases are incompatible with the imine functionality, thus LDA was the most 
appropriate base. Two equivalents had to be employed since the tert-butyl-amide is also acidic. 
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Scheme 12. 
 
The reaction was also carried out with chlorodicyclohexylphosphine (ligand 50). However, the 
results in the copper-catalysed diethylzinc conjugate addition indicated that copper complexes with 
the phosphite ligand 49 and 50 were unreactive. This might be due to the different electronic 
properties of the phosphite moiety or the larger chelate ring. Using the catalyst derived from the 
phenol ligand 48, no enantioselection could be detected in the 1,4-addition to cyclohexenone or 
cyclopentenone. 
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2.2.2.5 Amides ligands 
ountered with Schiff base ligands is the high sensitivity of the imine 
nctionality to nucleophiles and acids. As a result, chromatographic purification on silica-gel is 
 
The major problem enc
fu
often problematic due to the acidity of the silica. Expecting an higher stability, the amide ligand 51 
was obtained from commercially available diphenylphosphinobenzoic acid 32 and tertbutyl-amide 
valine (Scheme 13). 
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Scheme 13. 
 
plexes were formed with copper(II)(OTf)2 as described above. The reaction of 
yclohexenone with two equivalents of diethylzinc in toluene for 12 hours at room temperature 
Copper com
c
gave moderate enantioselectivity (68% ee, 95% conv.) so that further investigations with that 
ligand type were abandoned. In the mean time, an interesting publication dealing with this type of 
ligand has been published by Breit et al.(49) High enantioselectivities were achieved upon varying 
the copper source  (97% ee for diethylzinc addition to cyclohexenone with CuBr with dipeptide 
ligand 52, Figure 28) 
N
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Figure 28. 
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2.2.3 Ferrocene Ligands 
and its structural elucidation by two separate research groups marked 
e birth of contemporary organometallic chemistry. This revolutionary advance in organometallic 
.2.3.1 Ferrocenes and chirality 
tures of ferrocene-based ligands is the chirality induced by 
ubstitutions at the cyclopentadienyl rings (Figure 29). The planar chirality is obtained by 1,2 
 
The discovery of ferrocene(50) 
th
chemistry was recognised by a Nobel prize in chemistry in 1973.(51) Several of these ferrocene 
complexes form the basis for important industrial processes, as for example the 10 000 tons 
production of herbicides produced per year using a P,P bidentate ferrocene ligand.(51)
 
 
2
 
One of the most interesting fea
s
substitution of one Cp ring as in 53. If the ferrocene is substituted with a chiral side chain, planar 
and central chirality can be combined as in 54. When the ferrocene is 1,1’ substituted, a 
conformation with an axial chirality could be obtained, as in 55. 
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Figure 29. Ferrocenes and chirality 
 
e following interesting characteristics: 
• Adequate rigidity: The backbone of a chiral ligand should not be too flexible so as to 
Moreover, the ferrocene possesses th
provide an appropriate chiral environment. 
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• Easy derivatisation: The cyclopentadienyl ring in ferrocene carries a partial negative charge 
and is susceptible to electrophilic substitution reactions. Ferrocene reacts 3x106 times faster 
• 
• s: the ferrocene moiety could act as a major sterically hindering substituent 
lyst. 
ample, ferrocene amine is a stronger base than aniline, and ferrocene 
• 
• 
ether with the 
obtained following the retrosynthetical Scheme depicted 
 
than benzene. 
Chirality. 
Steric propertie
on the cata
• Electronic properties: The partial negative charge of the Cp ring gives the ferrocene a donor 
quality. For ex
carboxylic acid is a weaker acid than benzoic acid. 
Stability: Ferrocene is thermally stable and tolerant to oxygen and moisture. 
Inexpensive and readily available. 
Thus, ligands presenting the central chirality on the amino acid side chain tog
planar chirality on the ferrocene were 
below (Scheme 14). 
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Scheme 14. 
 
 phosphino ferrocenyl-aldehyde 60 prepared from ferrocenyl-aldehyde 56, with 
nctionalized amino acids afforded the ligand 61 (Scheme 14). Noteworthy, introduction of the 
Coupling the
fu
diphenylphosphino group on the ferrocene aldehyde 56 was done in a non-stereoselective manner, 
thus forming a racemic mixture of phosphino-aldehyde 60. Coupling with natural L-amino acids 
thus afforded diastereoisomeric pairs 61 that could be separated by simple silica-gel 
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chromatography. Having two stereogenic centers in the molecule, both diastereoisomers must be 
synthesised and tested since a match/mismatch relation could be observed between the two 
stereocenters if they both influence the stereoselectivity. The synthesis of the racemic phosphino-
ferrocenyl-aldehyde 60 followed Kagans procedure for aldehyde ortholithiation.(52) Starting from 
commercial ferrocene, monolithiation with n-butyllithium followed by quenching with 
dimethylformamide afforded the ferrocene aldehyde 56 in 90% yield (Scheme 15).(53) The obtained 
ferrocenecarboxaldehyde was quantitatively converted to the dimethyl acetal 57 by heating in neat 
trimethyl orthoformate in presence of acid catalyst. Transacetalization of the crude acetal 57 with 
commercially available racemic 1,2,4-butanetriol afforded the acetal 58 and a minor amount of 
dioxolane at room temperature. 
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Scheme 15. 
 
 the free hydroxyl group as its methyl ether was then performed using sodium hydride 
nd iodomethane in quantitative yield. Ortholithiation with t-BuLi in diethyl ether followed by 
Protection of
a
quenching with chlorodiphenylphosphine afforded the racemic phosphino-acetal 59. The auxiliary 
group was removed under acidic condition to afford the ortho-substituted aldehyde 60. The 
phosphino-aldehyde 60 was air stable. Coupling with the functionalised amino acid gave a 
diastereoisomeric pair 61 that could be separated by silica-gel chromatography. No oxidation 
occurred during this purification process, nevertheless prolonged stay on silica-gel results in partial 
imine bond cleavage. It was possible to crystallize the (S, RFc)  tert-butyl-amide valine  ligand 62, 
thus confirming its absolute stereochemistry. 
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Figure 30. X-ray structure of (S, RFc)-62 
 
The tert-butyl-amide valine ligands 62 (Figure 31) were tested for copper-catalysed conjugate 
addition of diethylzinc to cyclohexenone with various copper salts and copper/ligand ratios (Table 
7). 
 
Table 7. Ligands enantioselectivity for Cu-catalysed diethylzinc addition on cyclohexenonea  
Entry Ligand Temp. (°C) Copper salt Copper/ligand ratio Conv.(%)b ee (%)b
1 (S, RFc) 0 Cu(II)OTf2 1/1 95 10 (S) 
2 (S, SFc) 0 Cu(II)OTf2 1/1 95 70 (R) 
3 (S, RFc) +25 Cu(II)OTf2 1/1 95 11 (S) 
4 (S, SFc) +25 Cu(II)OTf2 1/1 95 75 (R) 
5 (S, RFc) 0 Cu(I)OTf 1/1 50 3 (S) 
6 (S, SFc) 0 Cu(I)OTf 1/1 95 84 (R) 
7 (S, RFc) +25 Cu(I)OTf 1/1 96 12 (S) 
8 (S, SFc) +25 Cu(I)OTf 1/1 95 86.5(R)
9 (S, RFc) 0 Cu(I)OTf 1/2 94 11 (S) 
10 (S, SFc) 0 Cu(I)OTf 1/2 85 93 (R) 
11 (S, RFc) +25 Cu(I)OTf 1/2 95 12 (S) 
12 (S, SFc) +25 Cu(I)OTf 1/2 95 95 (R) 
13 (S, SFc) 0 Cu(I)PF6 1/2 25 85 (R) 
a All reactions were carried out under argon using 3 mol% of catalyst 62 in toluene for 12 hours. b Determined by GC. 
 
Reactions at room temperatures gave always better yields and enantioselectivities than at 0 °C. 
Preformed catalysts with Cu(II) salt (Entries 1-4, Table 7) gave lower enantioselectivities than 
when formed in situ with Cu(I) salt (Entries 5-8, Table 7). Using Cu(I), a metal/ligand ratio of 1/2 
was clearly giving superior catalysts than with a 1/1 ratio (Entries 9-12/5-8). Most interesting, each 
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diastereoisomeric ligand pair showed pronounced difference in enantioselectivity, thus indicating 
that the ferrocenyl moiety plays an important role in the reaction. A clear match/mismatch situation 
is observed (Entries 11/12, Table 7). 
Several ferrocene-based imine ligands were synthesized by coupling suitably functionalised amino 
acids with racemic phosphino ferrocenylaldehyde 60 (Figure 31). 
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Figure 31. 
 
The diethylpropylamine necessary for the formation of 63 was obtained in three steps following a 
literature procedure starting from commercially available triethylacarbinol 65 via a Ritter reaction 
with chloroacetonitrile. Acidic work-up afforded the chloroacetamide 66 that was converted to the 
amine by cleavage of the chloroacetamide group with thiourea, thus avoiding use of HCN (scheme 
16).(54)
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Scheme 16. 
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The copper complexes were formed in situ and tested for diethylzinc conjugate addition to 
cyclohexenone and cyclopentenone in toluene. The mismatched (S, RFc) ligands (Table 7) were not 
investigated in most case. 
 
 
Table 8. Ligands enantioselectivity for Cu-catalysed diethylzinc additiona  
Entry Ligand Temp. (°C) Cyclopent. 
% ee (% conv.)b
Cyclohex. 
% ee (%conv.)b
1 (S, SFc)-62 +25 94 R (32) 95.5 R (95) 
2 (S, SFc)-63 +25 93 R (30) 96.5 R (90) 
3 (S, SFc)-64 +25 88 R (35) 97 R (95) 
a All reactions were carried out under argon using 3 mol% of L-Cu(OTf) in toluene for 12 hours. b Determined by GC. 
 
All ligands showed slighltly increased enantioselectivity compared to their non-ferrocene 
analogues. However, if compared with the large influence of the ferrocenyl moiety in case of the 
mismatched ligand, the limited influence of the ferrocenyl moiety is surprising. This might be due 
to small amounts of uncomplexed copper(I) or presence of trace amount of diatereoisomeric 
complex because of difficulty to totaly separate the diastereoisomeric pairs by silica-gel 
chromatography. 
 
 
2.2.3.2 Ferrocene-amide ligands 
 
Although the imine group on Schiff-base ferrocene ligands 61 is more stable than on the simple 
amino acids ligands 34, substitution by an amide group would simplify the purification processes 
and the overall stability in solution. Moreover, the amide function can act as a directing group for 
orthometalation, avoiding long reaction sequences to introduce substituents. Thus, a synthesis 
following the retrosynthetic scheme 17 was considered using tertbutyl-amide valine. 
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Scheme 17. 
 
Starting from commercially available ferrocene, monolithiation with n-BuLi(53) followed by 
reaction with carbon dioxyde afforded the ferrocene carboxylic acid 67 in 65% yield (Scheme 18). 
The ferrocene amide 68 was obtained by coupling with N-tert-butylvalinamide with EDC. 
Ortholithiation with various organolithium reagents showed sec-BuLi in THF at -78°C to be the 
most effective base. Quenching with chlorodiphenylphosphine gave the (S, SFc)-
phosphinoferrocene 69 with more than 90% diastereoisomeric excess. 
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Scheme 18. 
 
The high d.e. obtained was not ideal since only one diatereoisomere could thus be formed and 
tested. 
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Table 9. Ligands enantioselectivity for Cu-catalysed diethylzinc addition on cyclohexenonea 
Entry Ligand Temp. (°C) Copper salt Copper/ligand ratio Conv. (%)b ee (%)b
1 (S, SFc)-69 0 Cu(I)OTf 1/2 65 0 
2 (S, SFc)-69 +25 Cu(I)OTf 1/2 90 7 (S) 
a All reactions were carried out under argon using 3 mol% of catalyst in toluene for 12 hours. b Determined by GC. 
 
 
Test for diethylzinc addition to cyclohexenone gave very low enantioselectivity (Entries 1,2 Table 
9), confirming the mismatched configuration. A possible solution to obtain the other 
diatereoisomer was the two-step ortholithiation with introduction of an easily cleavable blocking 
substituent during the first step such as TMS, that forces a second ortholitiation to occur on the 
opposite face (Scheme 19). 
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Scheme 19. 
 
Unfortunately, introduction of TMS to form 71 (Scheme 19) was low yielding, probably because of 
the steric bulk of the TMSCl reagent hindering the approach to the ferrocene. 
An enantioselective pathway was thus necessary to obtain the other diastereoisomere (Scheme 20). 
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Scheme 20. 
 
The ferrocene carboxylic acid 67 was formed as described above. EDC coupling with 
diisopropylamine afforded the ferrocene amide 72. The diisopropylamide moiety acts in the next 
step as ortholithiating group, reported by Snieckus et al. to be enantioselective in the presence of 
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enantiomerically pure sparteine. Reaction with n-BuLi and (-)-sparteine followed by quenching 
with chlordiphenylphosphine afforded the ferrocene 73 in 90% yield and 97% ee.(55) 
Surprisingly, the hydrolysis of the amide did not occur under a variety of strongly basic or acidic 
conditions, and no procedure has been described by Snieckus. 
 
 
2.2.3.3 Axially chiral ligands 
 
An interesting variation is the formation of axially chiral ferrocenes. To achieve an axial chirality 
on a ferrocene, one must block the possible rotation of the two cyclopentadienyl moieties (Figure 
32). 
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Figure 32.                                
 
A bulky substituent such as TMS is thus required to induce steric repulsions upon rotation.  The 
formed ferrocene would thus act as a bridge inducing distortions in the coordination sphere of the 
copper complex. Here again, because of presence of an additional stereogenic unit on the amino 
acid side-chain, a diatereoisomeric match/mismatch pair situation could appear and therefore the 
synthesis of both diatereoisomers is needed. A convenient approach to simultaneous synthesis of 
the diastereoisomeric pair is depicted below (Scheme 21). 
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Scheme 21. 
 
Starting from commercially available ferrocene, a bis-lithiation(56) with two equivalents of n-BuLi 
afforded the 1,1’-dilithioferrocene intermediate that is brominated in the presence of 
tetrabromoethane to give 75. The bromo substituent acted as an ortholithiating group upon reaction 
with one equivalent of LDA at -78 °C in THF.(57) Quenching with TMSCl afforded the racemic 
TMS substituted dibromo ferrocene 76. Reaction with one equivalent of n-BuLi at -78 °C followed 
by quenching with chlordiphenylphosphine allows the substitution of the bromo for the 
diphenylphosphine moiety exclusively at the less hindered cyclopentadienyl ring to give 77. A 
second lithiation with n-BuLi followed by quenching with DMF finally gave the desired aldehyde 
78 in 30% overall yield. Enantiomeres were separated on chiral preparative HPLC because the 
formed diastereoisomeric ligand pairs upon coupling with the functionalised amino acids 79, could 
not be separated by silica-gel chromatography. 
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Figure 33. 
 
The valine derived ligands 79 and 80 (Figure 33) were synthesised and the catalyst formed in situ 
with a 2/1 ligand /metal ratio. Catalysts were tested for diethylzinc conjugate addition to 
cyclohexenone in toluene for 12 hours. 
 
 
Table 10. Ligands enantioselectivity for Cu-catalysed diethylzinc addition to cyclohexenonea  
Entry Ligand Temp. (°C) Copper salt Conv. (%)b ee (%)b
1 (S,SFc)-79 -30 Cu(I)OTf 95 80(R) 
2 (S,RFc)-79 -30 Cu(I)OTf 89 10(R) 
3 (S,SFc)-79 +25 Cu(I)OTf 94 78(R) 
4 (S,RFc)-79 +25 Cu(I)OTf 80 5 (R) 
5 (S,SFc)-80 -30 Cu(I)OTf 80 81(R) 
6 (S,RFc)-80 -30 Cu(I)OTf 95 15(R) 
7 (S,SFc)-80 +25 Cu(I)OTf 95 80 (R) 
8 (S,RFc)-80 +25 Cu(I)OTf 90 23(R) 
9 81 +25 Cu(I)OTf 92 58 (R) 
a All reactions were carried out under argon using 3 mol% of catalyst in toluene for 12 hours. b Determined by GC. 
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As previously, a match/mismatch relation was observed between diastereoisomeric pairs (Entries 
1/2 and 5/6 Table 10). The obtained enantioselectivities were generally lower than those with 
planar chiral ligands 61. Noteworthy, the enantioselectivity at low temperatures (-30 °C) is better 
than that at room temperature. This might be due to a temperature dependent conformational 
change by rotation of the cyclopentadienyl rings, thus loosing the ligands rigidity. The ligand 81 
without TMS on the ferrocene has also been synthesized by skipping the TMS introduction step 
(Figure 34). Catalysis with 81 has demonstrated the expected effect of TMS since its 
enantioselectivity is situated between that of the two diastereoisomers having the TMS group 
(Entry 9, Table 10). 
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Figure 34. 
 
 
2.3     Discussion 
 
Among the ferrocenyl derived ligands, the planar chiral ligands 61 showed the best 
enantioselectivities. An important match/mismatch effect could be observed, indicating as expected 
that the chirality on the ferrocene has a strong influence on the overall enantioselectivity. It is 
therefore expected that this type of ligands could find applications in numerous catalysed reactions, 
and present an interesting starting point for further investigations.  
Exchange of the lower cyclopentadienyl ring for a pentamethylcyclopentadiene would be of 
interest since Cp* has different electronic and steric properties.  Unfortunately, substitutions at the 
upper cyclopentadiene ring of CpFeCp* derivatives such as 83 are more difficult than on  Cp2Fe 
ferrocenes. Thus, a similar pathway to that depicted in Scheme 14 for ferrocene is impossible. An 
ortholithiating group that favors further substitutions is thus necessary.(58) This can be obtained by  
functionnalisation of a free cyclopentadiene with the desired ortholithiating group followed by 
formation of the ferrocene with Cp*. Diphenylphosphine oxide has been reported to act as 
ortholithiation directing group(58) and was thus chosen for the synthesis. Formation of the 
cyclopentadienyl-diphenylphosphite 82 was achieved by reaction of sodium cyclopentadienyl with 
chlorodiphenylphosphine oxide. Further reaction with sodium forms the functionalised 
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cyclopentadienyl anion that was reacted with Cp*Fe(acac) to form the desired ferrocene 83. The 
introduced phosphine oxide could then be exploited as ortholithiating group. Unfortunately, 
bromination with tertrabromoethane was unsuccessful, as well as with other brominating agents 
(Scheme 22). 
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Scheme 22. 
 
A different synthesis starting with bromocyclopentadienyl could be an alternative (Scheme 23). 
The bromine, that was indeed reported as a possible ortholithiating group and used as such for the 
synthesis of axial chiral ferrocenes 79, could be used for introduction of a diphenylphosphino 
group. Subsequent lithiation and quenching with DMF would produce the desired 
phosphinoaldehyde 85. 
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Scheme 23. 
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3. Muscone Synthesis 
 
 
3.1 Introduction 
 
Fragrances have an ancient history in most civilizations. Employed for spiritual or therapeutic 
purposes, they were extracted from plants or animals for ages. Chemistry in the second half of the 
19th century opened the way to synthetically synthesised fragrances such as vanillin 86 or coumarin 
87 (Figure 35). 
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Figure 35. Fragrances 
 
Synthesis of fragrances gained in interest with the development of the fragrance industry and 
demand for molecules with new odor characteristics obtained initially by modifications of existing 
molecules, as for example ethyl-vanillin 88 that has better olfactive characteristics than its natural 
counterpart 86 (Figure 35). Also, avoiding fastidious isolation from plants allowed drastic 
reduction in cost and improvement in quality. For example, to obtain 1kg of jasmine fragrance, 
extraction of eight million jasmine flowers is necessary. As well, 100g strawberry flavor would be 
extracted from 1000kg strawberries.(62) Musk odorants were extracted since antiquity from the male 
musk deer Moschus moschiferus, today an endangered specie on the WWF list of protected 
animals. 
 
 
Figure 36. Moschus Moschiferus 
 
Musk odorants are a family of molecules possessing a ‘very nice, warm, sweet, animal and 
powerful’(63) smell, of central importance for perfume constitution thus forming its bottom note 
being long-lasting, tenacious and substantive. The musks synthesis story began at the end of the 
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nineteenth century with the serendipitous discovery of 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene 
89 (Figure 37) by Albert Bauer whilst he was experimenting with the synthesis of  TNT-derived 
explosives by Friedel-Crafts reaction of tert-butyl-halides on trinitrotoluene.(64)
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Figure 37. 
 
The formed product 89 posses a characteristic musky odor, and was a commercial success under 
the name of ‘Bauer Musk’.  Soon after, Ruzicka identified the macrocyclic ketone (R)-(-)-muscone 
(3-methylcyclopentadecan-1-one) 90 as the natural main odorous principle of musk pod.(65) 
Nevertheless, synthetic difficulties and comparatively high price did not allow him to supersede the 
nitro-musks 91 (Figure 38), even though their photochemical reactivity caused discoloration and 
skin sensitisation. These problems led to the developpement of new molecules, polycyclic 
compounds (92, 93, 94, Figure 38), that are still today the most used musk odorants. 
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Figure 38. Development of musk fragrances. 
 
However, use of nitro or polycyclic musks began recently to decline due to their toxicity and low 
biodegradability.(66) Today the importance of macrocyclic musks is increasing again because of 
their interesting biodegradability properties.(67) Their main handicap remains the relatively high 
price compared to nitro or polycyclic musks, due to the complexity of synthesis of the macrocyclic 
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large ring (14-17 membered rings). Indeed, high dilution (<1nM) is generally required to avoid 
dimerization or polymerization. Recent macrocyclisation strategies initially developed for the 
synthesis of antibiotic macrolides(68) have been exploited in the last 20 years to overcome these 
difficulties. Focusing on the synthesis of racemic muscone, some pioneering syntheses deserve 
particular attention.  Key steps are generally macrocyclisation or ring expansion. 
 
 
3.1.1 macrocyclisation 
 
As mentioned above, the main problem generally occurring when attempting a macrocyclisation 
reaction is the competitive dimerisation or polymerisation. High dilutions are a possible solution 
but are not practical on industrial scale. Alternative solutions that circumvent that problem were 
brought by surface reaction on metal as the acyloin condensation reaction of α,ω-diesters on 
sodium metal (Scheme 24). Concentration of around 1M could be employed.(69)
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Scheme  24. Acyloin condensation 
 
The intramolecular reaction of 1,15 pentadecadionate 95 provided 96 which was dehydrated over 
alumina to the α,β-unsaturated ketone 97. The enone 97 could be then converted to racemic 
muscone 90. 
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 3.1.2 Ring enlargement 
 
Ring enlargement became an interesting option for muscone synthesis when cyclododecanone 98 
came to the market as one of the downstream products of the butadiene oligomerisation. Interesting 
but low yielding sequential ring expansions chemistry(70) followed by five step dehydratation 
sequence(71) has first been applied (Scheme 25) but more interesting and practical was the 
Firmenich ring expansion process (Scheme 26). 
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Scheme  25. Sequential ring expansion 
 
The synthesis involves two key steps: a Lewis-acid mediated intramolecular ene reaction (99)          
and the β-cleavage of the potassium alkoxide derived from 100 to the macrocyclic muscone.(72)
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Scheme 26. 
 
Nevertheless, synthesis of enantiomerically pure (R)-muscone remained challenging. The reason 
why enantioselective synthesis is necessary is that enantiomers have generally different biological 
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properties due to interactions with peptide-built biological receptors made of chiral (L)-amino acids 
(Figure 39). 
 
 
Figure 39. Interaction with receptor 
 
A well known example, (+)-limonene smells of orange whereas (-)-limonene has a lemon fragrance 
(Figure 40). 
 
 
                                                        (-)-limonene         (+)-limonene 
Figure 40. 
 
In the case of muscone, the (-)-(R)-muscone was described as ‘very nice, rich and powerful’ with 
an odor threshold of 61 ppb whereas the musk note of its (+)-(S)-enantiomer was found to be ‘poor, 
and less strong’ with an odor threshold of 233 ppb.(73) Despite these characteristics, only very few 
enantioselective syntheses have been achieved, and generally suffer from excessive length, low 
chemical and optical yield or scarcity of starting material. Nevertheless, some interesting syntheses 
have been achieved, such as Oppolzer’s synthesis (Scheme 27).(74)
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Starting with 14-pentadecynal 101, hydroboration followed by transmetallation with diethyl zinc in 
presence of 1% (+)-DAIB (3-exo-(dimethylamino)-isoborneol) allowed the ring closing with good 
substrate concentration (0.05M). The synthesis is then completed by a stereoselective Simmons-
Smith cyclopropanation followed by an oxidation and reduction step. Also remarkable, the ring 
closing olefin metathesis using Grubbs catalyst 102,(75)  inspired from the strategy employed by 
Fürstner in the synthesis of (+)-12-methyl-13-tridecanolide.(76) The source of chirality was found in 
(+)-citronellal (Scheme 28) 
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Scheme 28. 
 
Unfortunately, the direct cyclisation of 103 with 5 mol% catalyst failed due to the inertness of 
ruthenium alkylidene 102 toward RCM of terminally substituted olefins,(77) implying five further 
steps to remove the olefinic gem-dimethyl substitution with diene 103. Also notable, Sakai’s 
stereocontrolled synthesis via diastereoselective conjugate addition to a cyclic α,β-unsaturated ester 
of (R,R)-cyclohexane-1,2-diol 104 accompanied by spontaneous Dieckmann condensation (Scheme 
29).(78)
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Scheme 29.  
 
The high diastereoselectivity in dimethyl cuprate conjugate addititon to diester 104 was found to be 
due to face selectivity. The two ester groups, which are positioned close to each other, 
subsequently undergo Dieckmann cyclisation. Nevertheless, the intramolecular 
transesterification(79) had to be carried under high dilution conditions to give 104 in modest yield 
(57%). 
(R)-Muscone of high optical purity could be obtained by non-catalytic conjugate addition of 
dimethyl cuprates with chiral ligands derived from camphor.(80) More desired catalytic synthesis 
through copper-catalysed 1,4-additions were found to be only moderately  enantioselective 
(Scheme 30).(81) Nevertheless, the reaction attracted our attention due to its potential to lead to (R)-
muscone  in an atom economical manner. 
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Scheme 30. Copper-catalysed muscone synthesis 
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3.2  Synthesis 
 
3.2.1 Palladium-Catalysed Macrocyclisation. 
 
 
Palladium-catalysed macrocyclisation was recently reported from our laboratory.(82) Phosphine-
oxazoline ligands 106 were found to be very effective for palladium-catalysed homo and cross-
coupling of alkynes (Scheme 31), affording excellent yields, high turnover numbers and high 
regiocontrol. The obtained enynes are valuable precursors to a variety of functionalised 
compounds, and in particular the muscone macrocycle. 
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Scheme 31. Palladium-catalysed coupling of alkynes 
 
The presumed mechanism(83) involves the formation of an palladium(II)-alkynyl complex 107 
followed by coordination of a second alkyne and carbometalation leading to 108 (Scheme 32). The 
high regioselectivity for the internal insertion on the coordinated alkyne is related to steric and 
electronic effects in formation of the most stable Pd-C bond. 
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Scheme  32. Mechanism 
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In particular, 3-methylen-cyclopentadec-1-yne 109 was considered for the synthesis of (R)-
muscone 90 (Scheme 33). 
 
O
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Scheme 33. 
 
Using a dilute solution of 5 mol% of ligand 106 and 2.5 mol% of Pd(OAc)2 (0.25mM), a solution 
of hexadeca-1,15-diyne 111 (0.11M) was slowly added via a syringe pump  over 24h in order to 
favor the cyclisation over the competing intermolecular reaction (Scheme 34). 
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Scheme 34. 
 
The enyne product 109 was obtained in 70% yield.(84) The possibility to reach higher yields by 
testing solvents of different viscosity was explored. The viscosity could have a direct influence on 
the ratio between intra- and intermolecular reaction through reduced molecular agitation thus 
hindering an approach of neighboring molecules. 
 
 
Table 11. Solvents influence 
Solvent Viscosity (mPa.s) Dielectric constant (ε) Yield %a (Time h)
Hexane 0.31 1.88 70 % (48 h) 
Toluene 0.59 2.38 70 % (96 h) 
Cyclohexane 1.0 2.24 85% (12 h) 
1,4-dioxane 1.2 2.25 0% (12 h) 
a Determined by GC. 
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The reaction was tested in hexane, dioxane and cyclohexane, a solvent with similar solvating 
properties to toluene but higher viscosity constant (Table 11). The reaction was performed using 4 
mol% of Pd(OAc)2 and 2 equivalents of ligand 106 in 2l of solvent (0.2mM). The hexadeca-1,15-
diyne in solution in 25ml of solvent (0.36M) was added together with 5% of tridecane as internal 
standard by syringe pump over 8 hours. The reaction was followed by taking samples every hour 
and monitoring conversion by G.C. Results indicated that whereas the reaction was slow in toluene, 
cyclohexane as solvent increased the conversion and reaction speed, reaching 85% conversion in 
12 hours. Having the macrocycle 109 in hands, several strategies to obtain the muscone macrocycle 
were possible (Scheme 35). 
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Scheme 35. Possible pathways 
 
Two different pathways were considered for converting 109 to muscone. Pathway A (Scheme 35) 
takes the 3-methylcyclopentadecenone 112 as intermediate for a copper-hydride catalytic 
enantioslective 1,4-addition. Pathway B goes through cyclopentadecenone 113 for an copper-
catalysed 1,4-addition of dimethylzinc. 
 
 
3.2.2 Copper-Hydride Conjugate Addition 
 
A straightforward possible route to 3-methylcyclo-pentadecenone 112 involves hydroxylation of 
enyne 109 to give intermediate 114 that could undergo rearrangement to enone 112 (Scheme 36) 
 
 
 
60 
O109
HO
Hydroxylation rearrangement
114 112  
Scheme  36. 
 
Hydroxylation by electrophilic adition of acids to obtain 114 was explored. The reaction was 
expected to ocur chemo- and regioselectively on the double bond in a Markovnikov manner. 
Indeed, alkenes are more reactive than alkynes toward electrophilic addition. This can be explained 
by the different stabilities of the cations being formed in the rate-determining step of addition, i.e.. 
substituted carbonium ions vs. substituted vinyl cations.(85) Surprisingly, the olefinic moiety of the 
enyne 109 did not react with the employed acids (Table 12). 
 
 
Table 12. Reactivity of enyne 109 toward electrophilic addition of acids 
Entry Solvent Acid Temp. (°C) Time (h) Conv. (%)b
1 Hexane 4eq. HOTf -78 12 0 
2 Hexane 4eq. HOTf 0 12 0 
3 CH2Cl2 4eq. HOTf 23 12 0 
4 i-propanol 4 eq. HOTf Reflux 12 0 
5 CH2Cl2 4eq. TFA 23 12 0 
6 Hexane 5eq. H2SO4 23 24 0 
7 CH2Cl2 5eq. H2SO4 23 24 0 
8 CH2Cl2 6 eq. AcOH 23 24 0 
9 i-propanol 4 eq. AcOH Reflux 12 0 
b Determined by GC. 
 
Indeed, enynes were found to react differently from isolated olefins. Because of the polarization of 
the conjugated enyne system, the attack of electrophiles is hindered and takes place 
regioselectively at C-1 of the carbon-carbon triple bond thus forming a vinyl cation near the C-C 
double bond so as to be stabilised by the rest of the system (Scheme 37).(86)
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Scheme 37. Reactivity of enyne systems toward electrophiles 
 
Only the reaction conducted in presence of acetic acid and trifluoromethanesulfonic acid in 
dichloromethane gave the enone 115 in high yields (70-80% yield, Scheme 38). The reaction, 
referred to as the Rupe rearrangement,(87) is an acid-catalysed reaction occurring by electrophilic 
addition on C-1 of the alkyne 109 to form stabilized vinylcation. Nucleophilic attack of water on 
the vinyl-cation forms the enol (tautomeric form of the ketone 115) with concomitant isomerisation 
of the exocyclic double-bond to the more stable endocyclic double-bond.(88)
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Scheme 38. Reaction with acetic acid and trifluoromethanesulfonic acid 
 
Catalysed hydroxylation with HgSO4 gave the 2-methylenecyclopentadecanone 116 (Scheme 39) 
that is not suited for muscone synthesis. Oxymercuration of enynes is chemoselective for the 
acetylenic moiety and regioselective favoring hydration next to the double bond, here also 
presumably because of stabilization of the intermediate vinyl cation. 
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Scheme 39. Reaction with mercuric salts 
 
Epoxydation of conjugate enynes was reported to be chemoselective for the alkene.(89) mCPBA  
was reacted with the enyne 109 to give the 117 in 70% yield (Scheme 41). The epoxyde was 
subsequently opened regioselectivly on the less hindered side by LiBEt3H (‘super hydride’), giving 
the desired carbinol 114. Interestingly, LiBEt3H exhibited the opposite regioselectivity to DIBAL 
or LiBH4, that were reported to form the less substituted alcohol, presumably because of 
aluminium coordination on the epoxide favoring an SN1-type pathway (Scheme 40).(90) 
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Scheme 40. Aluminium coordination on epoxide 
 
The alcohol rearrangement occurred with 20% MoO2(acac)2 in dichlormethane at room 
temperature for 12 hours (Scheme 41).(91)
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Scheme 41.  
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The expected 3-methylcyclopentadecenone 112 was obtained in 30% yield, accompanied by enyne 
118, probably resulting from dehydration of the carbinol 114 to the internal alkene. Noteworthy, a 
Meyer-Schuster rearrangement could also be possible for the isomerisation of carbinols to 
enone.(92)
Because of the low yield observed for the formation of 3-methylcyclopentadecenone 112, synthesis 
through a more direct pathway, a chemoselective oxidative hydroboration was studied (Scheme 
42). 
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Scheme 42. 
 
Different borane reagents were reported to exhibit very different selectivities toward double and 
triple bonds.(93) Thus is it possible to achieve preferential hydroboration of the triple bond 
selectively in presence of the double bond. Disiamyl borane or 9-BBN were reported to be 
unselective whereas dibromoborane is highly selective for the acetylenic bond and generally 
regioselective in an anti-Markovnikov manner. Applied to the enyne 109, the ketone 119 was 
obtained in 60 % total yield. Macrocyclic enones were previously reported to be flexible enough to 
form isomers.(94) Here also an isomeric mixture of cis/trans α,β-unsaturated and β,γ-unsaturated 
ketones was obtained, with the trans isomer being predominant for α,β-unsaturated ketones 112 
and 120 (Scheme 42 and 43). Isomerisation presumably occurs while quenching with NaOH(aq.). 
Separation of the 112 isomeres from the mixture was possible by silica-gel chromatography using 
hexane/Et2O 100/1 eluant. Separation of the trans-112 from the cis-112 isomere could be realised, 
but 8-10% of contaminant cis-isomere was observed. 
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Scheme  43.  Cis/trans ratios 
 
Photochemical(95) or acid-catalysed isomerisation of β,γ to α,β-unsaturated ketones has been 
abundantly documented and showed to proceed through an enol intermediate (Scheme 44).(96) 
 
 
O OH O
 
Scheme  44. Isomerisation 
 
The trans-3-methylcyclopentadecenone 112 was isolated by silica-gel chromatography and 
subjected to copper-catalysed hydride conjugates addition with (S)-BINAP as ligand and 
polymethylhydrosiloxane (PMHS) as a safe and inexpensive hydride source (Scheme 45).(97)
 
O O
5 mol% Cu(OTf)
10 mol%. (S)-BINAP
PMHS
(R)-90112  
          60% ee, 55 % yield 
Scheme 45.  
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The obtained enantioselectivity was low with 60% ee. In addition, the reaction was sluggish giving 
only 55% yield of (R)-muscone 90. An alternative synthesis was thus needed and, therefore, the 
path b in Scheme 35 was investigated. 
 
 
3.2.3 Copper-Catalysed Dimethylzinc Addition 
 
Pathway b illustrate the use of cyclopentadecenone 113 as substrate for a copper-catalysed 1,4-
addition of dimethylzinc (Scheme 46). 
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       Tol.
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121
 
Scheme 46. 
 
The above described pathway between intermediates 109 and 113 has been investigated by 
Lücking.(82) The selective oxydation of the enyne double bond in 109 was achieved in 57 % yield 
by ozonolysis.(99) The treatment of the obtained ynone 121 with aqueous solution of chrome(II)-
sulfate  in DMF(100) gave the desired trans-enone 113 in 84% yield. The trans conformation was 
confirmed by 1H-NMR analysis. The chemical shift in CDCl3 of the β-ethylenic hydrogen is at 6.78 
ppm for the trans conformation and 6.20 ppm for the cis. The cis-cyclopentadecenone 124 
(Scheme 47) was synthesised following Regitz’s procedure(101) in order to examine its reactivity 
also. 
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Scheme  47. Synthesis of  the cis-isomere  
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Claisen condensation with formic acid ethyl ester gives the α-methylene ketone 122. The formyl 
group is acting as α-hydrogen activating group for the reaction with p-toluensulfonazide to form 
the α-diazo ketone 123. The silver-oxyde catalysed N2-cleavage gives the cis-cyclopentadecenone 
124 with high selectivity by a hydride migration on an intermediate carbenoide 
cyclopentadecanone. 
The last and crucial step of the synthesis of 90 in Scheme 46 involved an enantioselective copper-
catylsed 1,4-addition of dimethylzinc. Oxazoline-phosphite ligands(13) 29 (Figure 16) were reported 
to give moderate enantioselectivities (67% ee, 34% yield).(84) Also, a new generation of ligands 
developed for copper-catalysed 1,4-additions were tested (Figure 41). The major problem 
encountered was the low reactivity of the substrate, requiring high reaction temperatures. This in 
turn lowered the yields due to 1,4-addition of the formed zinc-enolate to the starting enone. 
Maximal temperature to avoid this side reaction was generally observed to be around 20 °C. At 
lower temperatures, complexes containing the valine-based P-N ligands 37 and 39 were found to be 
the most reactive and enantioslective (Table 13). 
 
PPh2
N
O
N
R
H
L=
 
37 R = t-Bu 
  39 R = 1-Adamantyl 
Figure 41. 
 
Table 13. Temperature influence on Cu-catalysed dimethylzinc addition to 113 and 124a  
Entry Substrate Temp.(°C) Conv.(%)b Yield (%)b ee  (%)c
1 113 -30 10 10 40 (R) 
2 113 +25 60 55 58 (R) 
3 113 +50 100 20 50 (R) 
4 124 0 60 60 58 (S) 
5 124 +25 70 65 50 (S) 
a All reactions were carried out under argon using 5 mol% of 37-Cu(OTf)2 in toluene for 24 hours.b Determined by GC 
using tridecane as internal standard. c  Determined by GC (M.N. Hydrodex β-3P) 
 
Complexes were formed using a 1/1 Cu(II)/ligand ratio in dichloromethane. Precipitation with 
pentane led to analytically pure copper complexes. The ligand 37 was synthesised in one step by 
coupling diphenylphosphine-benzaldehyde 125 with suitably functionalised amino acid 126 in 
trimethyl orthoformate and used without further purification (Scheme 48). 
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Scheme 48. 
 
Employing 5 mol% catalyst and 1.5 equivalent of dimethylzinc at -30 °C, the yield obtained was of 
10% after 24 hours (Entry 1, Table 13). No trace of dimer could be detected by gas 
chromatographic analysis. As the reaction temperature was elevated to 25 °C, the yield increased to 
55% (Entry 2, Table 13) whereas at 50 °C the yield dropped to 30% due to oligomerisation (Entry 
3, Table 13). The optimal temperature with respect to enantioselectivity appeared to be 
approximatively 25 °C (58% ee, Entry 2, Table 13). The cis-cyclopentadecenone 124 appeared to 
be more reactive than the trans. The enantioselectivity slightly increased to 58% ee of the opposite 
enantiomer (Entry 4, Table 13). 
A novel approach was necessary to shorten the synthesis and overcome the lack of reactivity and 
enantioselectivity. Theoretical calculations supported the hypothesis that the s-cis and s-trans 
conformations of the macrocycle (Figure 42) coexists in solution and could be responsible for the 
moderate enantioselection observed. 
 
O
O
 
s-trans 113                         s-cis 113 
Figure 42. 
 
The use of cyclopentadeca-2,14-dienone 128 (Scheme 49) provided an elegant solution to the 
problem. An increase in reactivity and enantioselectivity was observed by lowering the LUMO and 
creating a more rigid macrocycle. DFT-calculations conducted on possible conformations of 128 
favors the s-trans conformation. Starting with commercially available cyclopentadecanone 127, 
α,β-dehydrogenation with IBX (1-hydroxy-1,2-benziodoxol-3(1H)-1-oxide) following a procedure 
recently reported by Nicolaou(104) yielded the cyclopentadeca-2,14-dienone 128 in 50% to 65% 
yield. 
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Scheme 49. 
 
While the starting ketone 127 was fully consumed, 113 was obtained as a side product, which 
could be separated by silica-gel chromatography and reused. Yields were found to be dependant on 
the reaction temperature, substrate concentration and solvents. It is noteworthy that IBX can be 
regenerated with Oxone®.(105) The dienone 128 was subjected to enantioselective catalytic copper-
catalysed conjugate addition of dimethylzinc. 
 
 
Table 14. Temperature influence on Cu-catalysed dimethylzinc addition to 128a  
Entry Ligand Temp. (°C) Conv.(%)b Yieldb ee (%)c
1 37 +25 99 85 70 (S) 
2 37 -30 98 97 95 (S) 
3 39 -30 98 98 98 (S) 
a All reactions were carried out under argon using 5 mol% of 37/39-Cu(OTf)2 in toluene for 48 hours. bDetermined by 
GC using tridecane as internal standard c Determined by GC (M.N. Hydrodex β-3P) and HPLC of 129 on Daicel AS. 
 
The reaction occurred with 5 mol% catalyst and 2 equivalents of dimethylzinc. No trace of 3,14-
dimethyl-cyclopentadecanone (resulting from a second dimethylzinc addition) could be detected by 
gas chromatography. Indeed, the first conjugate addition led to a stable zinc(3-methyl-
cyclopentadeca-1,14-dienolate) that did not react further with nucleophiles such as dimethylzinc. 
Nevertheless, it can react at 25 °C with initial dienone (Entry 1, Table 14). A temperature of -30 °C 
was found optimal for both yield and enantioselectivity with 98% yield and 98% ee (S) (Entry 3, 
Table 14). The enantiomeric excess was found to be constant over the whole reaction time (Figure 
43). 
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Figure 43. Conversion and ee vs time 
 
Interestingly, the product had the same (S) configuration than that obtained with cis-
cyclopentadecenone 124 and opposite to that obtained from trans-cyclopentadecenone 113.  (S)-
Muscone was obtained quantitatively after hydrogenation over Pd/C. 
 
 
3.3              Discussion 
 
A very efficient route to obtain 98% ee muscone has been established. To the best of our 
knowledge, this is the first example of nearly enantiopure muscone synthesis obtained by a copper-
catalysed reaction. Moreover, these results demonstrate that simple amino acid-based ligands are 
highly efficient for conjugate additions on cyclic disubstituted enones. It can be postulated that the 
low enantioselection reported in synthesis of muscone by copper-catalysed conjugate additions on 
enones 113 or 124 could to be due to their facile s-cis/s-trans transconformation due to a more 
flexible conformation compared to the dienone. 
 
 
 
 
 
 
 
70 
3.4 Kinetic Resolution of Enones 
 
The resolution of racemic mixtures is an important process due to the ease of preparing racemic 
products and the number of transformations that can be exploited to react one enantiomer in 
preference to the other.(60) The major limitation of this technique is that the maximum theoretical 
yield of obtained enantiopure compound cannot be higher than 50%. In some cases, the unreacted 
enantiomer can be racemised and resubmitted to resolution in order to increase the yield (dynamic 
kinetic resolution). If that is possible, theoretically 100% of the racemic mixture can be converted 
to one enantiomer. This can be obtained by enzymatic reaction or in tandem with a chemical 
racemisation to provide enantiopure products. For example, Sih has reported the dynamic kinetic 
resolution of ethyl ester with the protease Streptomyces griseus in alkaline solution with 92% yield 
and 85% ee (Scheme 50).(60)
 
 
N
CO2Et
O
N
CO2Et
OStreptomyces griseus
92% yield
85% ee
pH 9.7
 
Scheme 50. 
 
The first reported example of dynamic kinetic resolution by purely chemical means was reported 
by Noyori in 1989 with a Ru-BINAP hydrogenation catalyst on β-ketoester which readily 
isomerises via an enol intermediate.(60) The reduction with Ru-BINAP catalyst gave one of the four 
diastereomers in high de and ee (Scheme 51). 
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Scheme 51. 
 
Despite the numerous kinetic resolutions or dynamic kinetic resolutions reported, no example of 
such a reaction on enone substrates by hydrogenation of the C-C double bond has been reported. 
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In connection with the synthesis of muscone, a possible kinetic resolution of intermediate 129 
(Scheme 49) was investigated to increase the enantiomerical purity of the remaining enone. Thus, 
iridium-catalysed hydrogenation of racemic enone 130 was expected to produce a mixture of 
optically active ketone 131 and untouched non-racemic enone 132 (Scheme 52). 
 
O
R * ( )n
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Scheme 52. 
 
The following substrates were synthesized: 
 
O
*
O O
Ph
O
* * *
129 133 134 135  
Figure 44. 
 
The substrates 133-135 were obtained by a tandem Michael addition-aldol condensation of β-keto 
esters to conjugate enones followed by saponification and decarboxylation following the procedure 
reported by Koo et al. (Scheme 53).(60)
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Scheme  53. 
 
The following ligands synthesised previously in our laboratory and described in the dissertations of 
I. Escher, J. Blankenstein,K. Zhang, N. Zimmerman and R. Hilgraf were tested for the kinetic 
resolution of 133 at room temperature in dichloromethane under one bar of hydrogen. The 
observed selectivity factors S are listed under the employed ligand formulas in Figure 45. 
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Figure 45. Selectivities (S) on substrate 133 
 
The reaction conditions were optimized for 5-methylcyclohexenone 133 with the iridium complex 
formed from ligand ZMN707 under 25 bars of hydrogen. Solvents were found to have an important 
influence on the selectivities, with aprotic apolar solvents giving the best results (Figure 46). 
 
 
  
Figure 46. Solvent influence 
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Using toluene as solvent, the most effective ligands on six-membered cyclic enones were found to 
be the ligands described by N. Zimmermann (zmn707) and K. Zhang (X68) (Figure 47). 
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Figure 47. 
 
The selectivities were found to be correlated with the steric bulk present on the cyclohexenones 
(Table 15). 
 
 
Table 15. Ligands selectivity (S) for Ir-catalysed hydrogenationa 
Entry Ligand Enone 133 (S) Enone 134 (S) Enone 135 (S) 
1 X68 2.9 3.3 4.5 
2 ZMN707 2.4 1.7 2.3 
a All reactions were carried out under argon using 3 mol% of L-Ir in toluene for 1 hours under 25 bars hydrogen 
pressure at room temperature. 
 
Ligand X68 gave the best results, showing a remarkable selectivity factor of 4.5 for enone 135. 
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 4. Multicomponent Heck-Allylic Substitution Reaction 
 
 
4.1 Introduction 
 
Synthetic methodology which allows for a rapid increase in molecular complexity is extremely 
valuable in organic chemistry, particularly if it generates more than one new carbon-carbon bond at 
a time, accommodates considerable functionality and is broad in scope. 
Multicomponent reactions (MCRs) are one pot reactions involving three or more reactants that 
react in a domino-cascade fashion to produce a single product. The obvious challenge with the 
optimization of such reactions lies in the control of the numerous possible side-reactions leading to 
unwanted products. Since the discovery of the multicomponent Ugi and Passerini reactions, MCRs 
have attracted much attention due to their synthetic efficiency. Indeed, high structural complexity 
can be achieved in a one pot reaction, without demanding purifications. Thus, the process has been 
extensively studied for synthesis of libraries of high value for drug development. 
 
 
4.1.1 Heck Reaction 
 
The palladium-catalysed alkenylation or arylation of alkenes, known as the Heck reaction, was 
discovered in the late sixties by Heck and Mizoroki(106) It is a nice reaction tolerating a wide variety 
of functional groups such as cyano, ether, ester or carboxyl groups. Additionally, it is insensitive to 
water, some reactions being performed efficiently in aqueous solutions.(107) Although this new 
method proved to be very efficient for C-C bond formation, it did not receive initially the broad 
attention that its potential would call for. The major drawback was the use of stoichiometric 
amounts of palladium salts and toxic organomercurials (Scheme 53).(108) 
 
 
R-Hg-X  +  PdX2 R-Pd-X
R'
R
R'
-HgX2
 
Scheme 53. Transmetalation with organomercurials 
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It was subsequently observed that a catalytic amount of palladium could be used in presence of 
stoichiometric amount of copper(II) salts or thallium salts.(109) The solution to avoid toxic 
organometallics turned out to be the use of aryl or vinyl halides or triflates (Scheme 54).(110) 
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Scheme 54. Heck reaction with halides and triflates 
 
Although details of the Heck reaction are still under investigation, the commonly accepted 
mechanism follows a four-step catalytic cycle (Scheme 55).(111)
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Scheme 55. Catalytic cycle 
 
The catalytically active complex is assumed to be a 14-electron palladium(0) specie generated in 
situ. The first step is assumed to be a oxydative addition, generating a σ-organopalladium(II) 
complex. In the next step, after elimination of one ligand (when halides are used), the complex 
coordinates the alkene molecule, which syn-inserts into the σ-organopalladium bond via a four-
center transition state.(112) After internal rotation, a β or β’-hydride syn-elimination occurs, and 
finally, regeneration of the active complex is achieved after reductive elimination. Kinetic 
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investigations(113) indicated that the oxidative addition may be the rate determining step. However, 
recent kinetic studies conducted with p-bromobenzaldehyde and butyl acrylate show a contrario 
that the resting state of the catalyst within the catalytic cycle is the intermediate derived from 
oxydative additions.(113). 
 
 
4.1.1.1 Neutral versus cationic pathways 
 
Next to the original aryl or vinyl halides used for the Heck reaction, Cacchi and Stille(114) 
introduced aryl and vinyl triflates.  Whereas the oxydative addition with halides gives a strong Pd-
X bond, the Pd-OTf bond with triflates is very labile. Thus, with aryl or vinyl halides as substrates, 
the dissociation of one ligand is necessary so that the coordination of the olefin can take place 
(Scheme 56). 
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Scheme 56. Neutral and cationic pathways 
 
Although pentacoordinated intermediates were also postulated, calculations conducted by Thorn 
and Hoffmann(115) showed that the energy barrier for the generation of the reactive intermediate in 
a pentacoordinated complex is higher than that of a tetracoordinated. With aryl or vinyl triflates, 
the situation is much different because of the free vacant coordination site resulting from the ion-
pair structure of the Pd-OTf complex. The vacant coordination site generated with triflates allowed 
the use of bidentate chelating ligands, improving the enantioselection (cationic pathway). Indeed, 
the low enantioselectivity generally observed with halides is presumably due to the decomplexation 
of one ligand end (neutral pathway).(116) However, in some case dissociation of monophosphine 
ligand in preference to triflate was also reported,(147a) as well as dissociation of halides with 1,10-
phenanthroline ligands.(117) 
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 4.1.1.2 Regioselectivity 
 
With strongly coordinating anions, the regioselectivity correlates with the steric hindrance, since 
the C-C bond is usually formed at the less substituted terminus of the olefin (path B, Scheme 56). 
With labile anions (path A, Scheme 56), electronic factors predominate and the (C-C)-bond is 
generally formed on the olefin terminus having the less partial charge (Figure 48).(118) 
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Figure 48. Regioselectivity 
 
 
4.1.2 Palladium-Hydride Complexes 
 
The β-hydride elimination occurs in a syn manner. Dissociation from the olefin gives a 
palladium(II)-hydride complex, that is subsequently reduced to Palladium(0) by reductive 
elimination of HX, presumably by deprotonation of the palladium-hydride complex by the 
stoichiometric amount of base necessary for the reaction (Scheme 57). 
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Scheme 57. β-Hydride elimination 
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 In some cases when palladium-hydride stays coordinated to the olefin, migration of the newly 
formed alkene double bond is observed.(119) It is postulated that migration proceeds through a series 
of β-hydride elimination-readdition steps (Scheme 58) 
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Scheme 58.  Palladium-hydride migration 
 
Suppression of isomerisation was observed under specific conditions, e.g. by addition of Ag(I) or 
Tl(I) salts(118) or use of triflates. Silver and thallium salts being postulated to sequester halides 
anions from the complex, these observations indicate that the cationic pathway could be related 
with the suppression of isomerisation. It can be postulated that two factors govern the isomerisation 
ability of a complex: The stability of the olefin-palladium(II) complex and the stability against 
reductive elimination of the palladium(II)-hydride resulting from the β-hydride elimination. Indeed, 
it was proposed that the isomerisation efficiency is related to the dissociation-association ability of 
the olefin from the palladium(II)-hydride complex,(118) slow dissociation from the olefin promoting 
isomerisation. In this context, distinction must be made between electron rich complexes resulting 
from a neutral pathway and electron poor complexes resulting from cationic pathway (Scheme 56). 
Electron rich palladium, as bromopalladium(II)-hydride, coordinates best with electron deficient 
olefins, due to better overlap of the metal d orbital with the π* orbital of the olefin (π-
backdonation).(118) The amount of π-backbonding depends strongly on how electron-rich the metal 
center is and whether or not there are electron-withdrawing groups on the akene to make it a better 
acceptor ligand. Thus, electron deficient palladium complexes, as cationic palladium-hydride with 
triflate counteranion, show less π-backdonation on alkenes, thus forming unstable palladium-alkene 
complexes.(118,120) Moreover, the nature of the ligand has a predominant influence on the outcome 
of the dissociation-insertion equilibrium. 
 
 
4.1.2.1 Stability of palladium hydride 
 
Even after dissociation of the olefin from the palladium hydride complex, recoordination can occur, 
allowing palladium-hydride migration if there is no reductive elimination in the meantime. Thus, 
relative stabilities of neutral versus cationic palladium-hydride complexes must be examined. A 
theoretical study on reductive eliminations on group 10 metals(121) concluded that the higher the 
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electron density on the metal, the slower the reductive elimination rates. Unfortunately, 
experimental data(122) describing the reductive elimination of HX from halo(hydrido)palladium 
complexes is scarce, presumably due to the unstability of such complexes. Indeed, palladium-
hydrides are known to be hydride as well as proton donors, and were reported to be unstable 
toward acids or bases (Equation 4.).(123) 
 
 
L2PdHCl + HCl L2PdCl2 +H2
L2PdHCl + Et3N         L2Pd + EtN3H+ + Cl- 
Equation 4. 
 
Moreover, dismutations were also reported (equation 5).(123) 
 
 
2HPd(dppe)+             Pd(dppe)2+  +   Pd(dppe)  +  H2 
Equation 5. 
 
Comparative studies in the group 10 transition metals showed that palladium is more hydridic than 
platinium and nickel. Also, the palladium-hydride acidity is stronger compared to platinium-
hydride but equal to nickel-hydride.(123) For the 18 electron cationic complex HPd(PNP)2+, the pKa 
was found to be between 18 and 22.(123) Nevertheless, the detailed mechanism of the reductive 
elimination remains obscure. According to the principle of microscopic reversibility, oxydative 
addition and reductive elimination must follow the same route but in different directions, so that 
reductive elimination could be deduced from the opposite reaction, the oxydative addition. 
Oxydative additions were intensively studied, and three main mechanisms were postulated.(124,125) 
 
- synchronous oxidative addition: 
LnM   +  HCl                LnM(H)(Cl)  
 
- Electrophilic oxidative addition: 
LnM             LnMH+                LnM(H)(Cl)
H+ Cl-
 
 
- Nucleophilic addition: 
LnM             LnMCl -                LnM(H)(Cl)
Cl- H+
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Even though there is no experimental data concluding on the mechanism for the reductive 
elimination, if the reductive elimination would be an inverse electrophilic oxidative addition, the 
direct formation of cationic palladium-hydrides with triflates would favor the reductive elimination 
of the hydride from the complex. 
 
 
4.1.3 Allylic Substitution Reaction 
 
Since the first description of stoichiometric palladium-catalysed allylic substitution by Tsuji in 
1965 (Scheme 59),(126) the reaction has become one of the most versatile C-C bond-forming 
reaction. Extensive investigations have defined substrate and nucleophile tolerance, regioselectivity 
and stereoselectivity.(127) 
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Pd(0)
X
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+X-  
Scheme 59. Allylic substitution 
 
The most commonly used leaving group is the acetate, but halides, sulfones, ethers, epoxides, 
carbonates, carbamates, phosphates could be also employed. Depending on the nature of the 
leaving group, the reaction can proceed through a neutral complex if the leaving group acts as 
strongly coordinating anion on palladium or a more reactive cationic complex with labile 
conteranions. A wide variety of nucleophiles were described such as stabilised carbanions, amines, 
hydrides and organometallic reagents. Various nitrogen-containing compounds such as primary and 
secondary amines, sodium azide, protected hydroxylamines, phtalimides, 2-pyridone, sulfonamides 
and di-tert–butyl iminodicarboxylate have been employed as nucleophiles. 
Enantioselective allylic alkylation has been investigated using chiral ligands.(128) Hayashi et al. 
reported interesting examples of allylic alkylation with allylic acetates and diketonate anions, using 
ferrocene-based diphosphines. It is commonly accepted that Pd° species involved in the catalytic 
cycle are stabilised by phosphines, thus numerous diphosphine ligands were reported at that time. 
Bisoxazoline ligands introduced by Pfaltz et al. inspired new generations of N-N and P-N based 
ligands that proved to give very high enantioselectivities.(150) 
The generally accepted mechanism of palladium-catalysed reaction is composed of two steps.(129) 
First Pd0 reacts with the allylic substrate to provide an (η3-allyl)palladium(II) complex. This 
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complex can isomerise in various ways and this can have important consequences on the course of 
the reaction.(130) The second step involves nucleophilic attack on the allylic complex termini and 
regenerates Pd0. With ‘hard’ nucleophiles the second step occurs through coordination of the 
nucleophile to the palladium-allyl complex followed by reductive elimination. With ‘soft’ 
nucleophiles (stabilised carbanions or amines) the reaction occurs through nucleophilic attack at 
one of the two allylic termini of the complex. In general, with amine nucleophiles, the allyl system 
is attacked at the less substituted carbon.(131) Nevertheless, it depends on the polarisation of the π-
allyl system. With π-acceptors ligands that induce a higher positive charge on the π-allyl-metal 
complex that might be located on the more substituted allylic terminus where a stabilisation by 
hyperconjugation is possible, thus rendering this terminus more reactive toward nucleophilic 
attack.(132) 
Even though the reaction rate with amine nucleophiles is lower than the rates observed with 
stabilized carbon nucleophiles, very good yields can be obtained after prolonged reaction times. 
Usually, the double bond stereochemistry is lost during the reaction (Scheme 60). 
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Scheme 60. Isomerisation 
 
This is due to the π-σ-π palladium isomerisation resulting in a syn-anti interconversion favoring the 
less hindered syn isomer (Scheme 61). 
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Scheme 61. Syn-anti interconversion 
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The arylpalladium complexes involved in these substitution reactions have been thoroughly 
investigated. They are often relatively easy to crystallize and since palladium(II) is diamagnetic, 
the complexes can be analysed by NMR techniques(131)
 
 
4.1.4 Multicomponent Reaction 
 
The palladium-catalysed reaction of vinyl halides with conjugate dienes in presence of amine 
nucleophiles was first reported by Heck and Larock.(135) The reaction involves the initial formation 
of a σ-palladium complex A (Scheme 62) by oxydative addition of an aryl or vinyl halide to a 
Pd(0) specie. Reaction of the formed σ-palladium complex with conjugated dienes in a Heck-
reaction manner is believed to form a π-allylic palladium intermediate B (Scheme 62).(135) The π-
allylic palladium complex could then undergo β-hydride elimination to substituted diene (path a) or 
reaction of nucleophiles to form allylated products (path b and c, Scheme 62). 
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Scheme 62. 
 
Phosphines as ligands were reported to be beneficial or detrimental to the yields depending on the 
nature of the nucleophile or the olefin, but no general prediction could be made.(135, 136) Secondary 
amine nucleophiles as morpholine or piperidine gave good results, with a predominant substitution 
at the less substituted end of the π-allylic palladium complexes (path c, Scheme 62). It was 
generally observed that nitrogen nucleophiles are very sensitive to the steric hindrance present on 
the π-allylic palladium intermediate.(137) Also, primary amines showed enhanced tendencies to 
attack the internal π-allylic terminus (path b, Scheme 62).(138) Strongly basic amines as 
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diethylamine gave mainly elimination to diene (path a, Scheme 62). In general, path a is in 
competition with the desired allyic substitution (b and c). Also, the formation of regioisomers due 
to the possible addition of vinyl palladium on both ends of the alkenes (Figure 48), or E/Z mixtures 
due to nucleophilic substitution on syn-anti π-allyl palladium complexe (Scheme 61) cannot be 
totally suppressed. 
Intramolecular versions were reported(139) giving access to heterocycles or polycyclic compounds 
(Scheme 63). Noteworthy, if the ligand L is chiral, it is possible to create a stereogenic center if the 
reaction follows path b in Scheme 62. 
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Scheme 63. 
 
The reaction conditions are generally critical to the success or failure of the reaction. Polar solvents 
and temperatures of 80-120 °C are required, especially with electron rich substrates such as 
anilines. Other factors critical to the success of the process are the nature and stoichiometry of the base 
employed and the presence of a chloride source. Of these, the nature of the base is often the most 
important. Acetate, carbonate and bicarbonate have proven to be the most successful. The nature of the 
base has a strong influence on the reaction rate and selectivity. Sodium and potassium salts have proven 
to be the most generally useful bases. The addition of LiCl or Bu4NCl to the reaction often has a 
profound effect on the yield and rate of reaction. Usually one equivalent of the chloride reagent per 
aryl or vinylic halide or triflate is employed, although catalytic amounts are sometimes effective. The 
addition of more chloride reagent usually slow down the reaction substantially and usually affords little 
improvement in yields. The effect of n-Bu4NCl seems to have little to do with solubility or phase transfer 
effects, since LiCl is in general equally effective and gives often more reproducible results. 
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Indirect observations indicated that the reaction could be feasible not only with 1,3-dienes as substrates 
(Scheme 63) but also with simple olefins (Scheme 64). 
 
 
X R
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Nu, base  
Scheme 64. Reaction with olefins 
 
Indeed, loss of conformation in the Heck reaction was reported(140) and proposed to be due to the 
formation of a π-allylic palladium complexe by palladium-hydride isomerisation which readily 
converts anti complexes to the more stable syn isomer before elimination of the hydridopalladium 
to produce a diene (Scheme 65). 
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Scheme 65. Observed loss of stereochemistry during Heck reaction 
 
Moreover, Larock reported the formation and isolation of π-allyl palladium complexes by reaction 
of vinylic mercurials with olefins in presence of Pd(II) salts.(141) The mechanism commonly 
accepted involves isomerisation via a palladium-hydride complex in the key step (step A, Scheme 
66). 
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Scheme 66. Mechanism 
 
The isomerisation via a palladium-hydride complex does not proceed by complete separation of the 
palladium-hydride complex from the alkene, as jugged from the exclusive formation of the trans 
product from 1,4-cyclohexadiene (Scheme 67).(141,142) 
 
 
5 mol% Pd°,
 C6H5I
diethylmalonate
C6H5 CH(CO2C2H5)2
 
Scheme 67. Reaction with 1,4-cyclohexadiene. 
 
The other steps of the cycle are similar to the already described steps consisting of an allylic 
substitution and a Heck reaction. As for reaction with diene substrates, the reaction conditions play 
a predominant role and are fairly similar to these described above, with special emphasis on the 
need to use only mild bases.(143,144) Strong bases such as KOtBu, NaH, NaOH, BuLi, NEt3, n-
BuNH2 give consistently lower yields. Also, secondary amines were found to give better results 
than primary.(143)
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Allylic substitutions with amine nucleophiles were generally found to be highly sensitive to steric 
hindrance. The amine generally attacks at the least substituted or least hindered end of the π-allyl 
palladium complex.(137,140,143) Also, unhindered monosubstituted terminal alkenes react well. 
As precedently, phosphines as ligands were reported to be beneficial or detrimental to the yield 
depending on the nature of the nucleophile or the olefin, with no possible prediction. 
Addition of Cholride under the form of Bu4NCl or LiCl was reported to be beneficial(145) in 
particular when not only simple olefins are used as substrates but also non conjugated dienes 
(Scheme 68). 
 
 
PhI +
5%Pd(dba)2 Ph
NuNu  
Scheme 68. Reaction with non-conjugate dienes 
 
With these substrates, formation of a π-allyl palladium complex is obtained after migration of the 
palladium-hydride by successive addition-elimination steps. Larock reported that palladium can 
reversibly migrate up and down on even very long carbon chains,(142) as for example on tetradeca-
1,13-diene with 10 carbons between the double bonds. With vinyl halides as substrates, the 
migration has a tendency to occur toward the less substituted end of the molecule (Scheme 
69).(145,146)
 
Pd Pd
Pd
+
56% 23%  
Scheme  69.  Migration toward the less substituted end 
 
Noteworthy, vinyl or phenyl triflates were reported to be fairly unreactive.(142,147) Thus, most of 
reported similar reactions were obtained with halides.(136) That could explain the lack of reported 
enantioselective tandem-reactions, since halides favor the unselective ‘neutral pathway’ (Scheme 
56). 
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4.2 Synthesis of Allylic Amines 
 
4.2.1 Optimisation 
 
Cyclohex-1-en-1-yl triflate(149) 138 (Scheme 70) prepared form cyclohexanone with pehyl-
methanesulfonamide triflate, and 1-hexene were chosen as reactants. 
 
 
O OTf
Tf2NPh
138  
Scheme 70. 
 
Triflates rather than halides were chosen because of the high enantioselectivities generally 
reported in enantioselective Heck reactions.(149) The alkenyl triflate 138 is expected to lead to a 
cationic palladium complex with retention of the chelate coordination of the chiral bidentate 
ligand allowing efficient transfer of the chiral information from the catalyst to the substrate 
(Scheme 71). 
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Scheme 71. 
 
The chosen ligand was the tert-butyl-substituted (phosphinoaryl)-oxazoline 106 because of the 
excellent reactivity and enantioselectivities reported in the allylic substitution reactions as well 
as enantioselective Heck reactions.(150) We have chosen morpholine as nucleophile and base 
because of its relatively low basicity. Strong bases were reported to favor the Heck reaction 
product 140 over the domino product 139 (Scheme 72).(151)
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Scheme 72. 
 
Commercially available and air stable Pd2(dba)3 was used as source of Palladium(0) for the 
reaction. The catalyst was preformed by stirring the Pd2(dba)3 with two equivalents of ligand 106 in 
degassed DMA, then substrates were added and the reaction mixture kept at 80°c for 72 hours. 
Adjustment of reaction conditions (catalyst loading, solvents, temperature) were found to be 
necessary to achieve high conversions (Scheme 73) 
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Scheme 73. Multicomponent reaction 
 
Under such conditions, a mixture of products was obtained. On one side, the desired products 
resulting from the tandem reaction (141 and 142 in a 2.5/1 ratio) and on the other side the 
competing Heck reaction products (143 and 144 in a 1/2 ratio). The tandem products derived 
only from the non-branched Heck reaction product intermediates, presumably because of lower 
steric hindrance. 
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 4.2.1.1.Influence of palladium loading on conversion 
 
 
 
 
 
 
 
 
a Pd mol% reported to the alkenyl triflate substrate, 5eq. of morpholine, 5 eq. of 1-hexene, 80°c, 72h, DMF 
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Figure 49. Influence of palladium loading on conversion 
 
Palladium loading of at least 5 mol% was found to be necessary (Figure 49).  The listed 
conversions correspond to the formation of products 141, 142 plus 143, 144. Noteworthy, the non-
catalytic reaction conducted with a stoichiometric amount of catalyst, without base, followed by 
one pot addition of nucleophile after 24 hours gave only the Heck reaction products 143 and 144. 
 
 
4.2.1.2 Influence of solvents on conversion and (143,144)/(141,142) ratio 
 
Influence of solvents on conversionaInfluence of solvents on (143,144)/(141,142) ratioa
0 
4
8 40
60
80
100 20
        
a 5 mol% Pd reported to alkenyl triflate substrate,2eq. L, 5eq. of morpholine, 5 eq. of 1-hexene, 80°c, 72h 
Figure 50. 
 
12
16
CH2Cl2 MeOH DMF DMA 
0
20
CH2Cl2 MeOH DMF DMA
C
on
v.
 (%
) 
2/
1 
ra
tio
 
Solvent Solvent 
 
91
The conversion and (143,144)/(141,142) ratio are dramatically affected by the solvent (Figure 50). 
Polar aprotic solvents are best suited, presumably because they solvate the best the intermediate 
cationic complex. Use of DMA proved to be superior to DMF, due to competing formation of 145 
from transamidation of DMF with morpholine (Figure 51). 
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Figure 51. Product from reaction between morpholine and DMF 
 
Furthermore, the amount of morpholine was varied in DMA as solvent (Figure 52). 
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a 5 mol% Pd reported to alkenyl triflate substrate,2eq. Ligand, 5 eq. of 1-hexene, 80°c, 72h, DMA 
Figure 52. 
 
Surprisingly high morpholine amounts were necessary, with 5 equivalents being optimal. This high 
amount of morpholine could explain the low yields generally observed since presence of base 
favors the Heck reaction products 143, 144 by competitive hydride elimination from the palladium-
hydride complex before isomerisation. Improvement in yields could go through lowering the 
amount of nucleophile. The concentration of morpholine was lowered by sequential additions over 
the whole reaction time or continuous addition by means of a syringe pump. In both case yields 
were not improved but the conversion was complete, giving mainly the diene product resulting 
from the Heck reaction. From these experiments, it appears that equilibrium in nucleophile 
concentration must be reached. High morpholine concentration increases the solution basicity thus 
directing the reaction toward the Heck reaction, whereas a too low nucleophile concentration 
lowers the probability of reaction of the formed π-allyl intermediate with the nucleophile. A 
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reaction involving intramolecular nucleophilic substitution proved to be more effective for that 
kind of reaction (Scheme 74).(152) 
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Scheme 74. Intramolecular tandem reaction 
 
Nucleophiles more basic than morpholine depicted below (Figure 53) were also tested, but the 
yields detected by GC-MS were extremely low. 
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Figure 53. 
 
 
The palladium source was also varied in order to determine its influence.  In every case 
conversions were complete but Pd(PPh3)4 was found to give the same range of (143,144)/(141,142) 
ratios as Pd2(dba)3 whereas palladium(II) as Pd(OAc)2 gave somewhat lower ratios. Pd2(dba)3 is 
thus best suited for the reaction. Complexes of Pd2(dba)3 with various ligands were examined. 
Phopshine ligands (Entries 1-3, Table 15) such as BINAP or P(n-Bu)3 gave similar results as ligand 
106, with equivalent conversions and slightly better (143,144)/(141,142) ratios. Noteworthy, 
BINAP complexes are more reactive in toluene and give better (143,144)/(141,142) ratios. Amine 
ligands (Entries 4,5, Table 15) gave unreactive complexes and low selectivity for the desired 
products 141,142. 
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 Table 15. Ligands and solvents influence on the multicomponent reactiona 
Entry Solvent Ligand (143,144)/(141,142) ratiob Conv. (%)b
1 DMF 3eq. BINAP 1.86 50 
2 Toluene 3eq. BINAP 1.50 100 
3 DMF 3eq. P(n-Bu)3 2.33 100 
4 THF 2eq.diaminonaphtalene 9 5 
5 Toluene 2eq.diaminonaphtalene 9 5 
6 DMF 3eq. P(OMe)3 1 20 
7 Toluene 3eq. P(OMe)3 4 10 
8 DMF 3eq. P(OPh)3 1 15 
9 Toluene 3eq. P(OPh)3 1 10 
a All reactions were carried out under argon. bDetermined by GC  
 
Most interesting, phosphite ligands (Entries 6-9, Table 15) are the most selective in favor of the 
desired tandem products 141 and 142 but form less reactive complexes. 
The low yield generally obtained is possibly related to the high proportion of unreactive branched 
Heck reaction product 144. Indeed, no tandem reaction product 146 or 147 (Figure 54) resulting 
from the branched intermediate was observed. 
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Figure 54. 
 
 
4.2.1.3 Enantioselective version 
 
Although the yield remained moderate using the optimised conditions for the reaction, use of chiral 
tert-butyl substituted (phosphinoaryl)-oxazoline 106 was expected to give chiral allyl-amine 
products.  Indeed, we obtained 86% ee in DMF (Entry1, Table 16) whereas use of DMA as solvent 
lowered the ee to 72% ee but improved slightly the yield (Entry 2, Table 16). Use of additives such 
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as LiCl or Bu4NCl acting as chloride source were detrimental for enantioselection (Entry 3 and 4, 
Table 16). 
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Scheme 75. 
 
 
Table 16. Solvent and additives influence a 
Entry Solvent Additive Pd 
mol% 
Eq. 
hexene
Eq. 
morpholine
T 
(°C) 
Time 
(d) 
Yield 
(%)b
ee 141 
(%)b
1 DMF - 5 5 5 80 5 15 86 
2 DMA - 5 5 5 100 4 25 72 
3 DMF 2eq. LiCl 5 5 5 100 4 12 72 
4 DMF 2eq.TBAC 5 5 5 100 3 10 66 
a All reactions were carried out under argon using 5 mol% of 106-Pd2(dba)3. bDetermined by GC  
 
 
4.2.2 Substrates 
 
4.2.2.1 Halides 
 
The reaction has been tested on other substrates. Halides were examined for the possible different 
reactivity due to the stronger coordination ability of halides compared to triflates (Scheme 76). 
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Scheme 76.  
Use of vinyl halides gives better yields but no enantioselectivity (Table 17). This might be due, as 
previously, to partial dissociation of the bidentate ligand caused by strongly coordinating counter-
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ions such as bromide (neutral pathway). This restricts the use of vinyl halides to monodentates 
ligands in order to achieve enantioselection. 
 
 
Table 17. Reaction with β-bromostyrenea
Entry Solvent Additive Pd 
mol% 
Eq. 
hexene
Eq. 
morpholine
T 
(°C)
Time 
(d) 
Yield 
(%)b
ee 155 (%)b
1 DMF  5 5 5 110 5 25 4 
2c DMF  5 5 5 110 4 4 - 
3 DMF 3eq.Ag3PO4 5 5 5 110 4 30 3 
4 DMF 7eq.Ag3PO4 5 5 5 110 4 29 4 
5 DMF 10eq.TBAC 5 5 5 100 4 15 8 
a All reactions were carried out under argon using 5 mol% of 106-Pd2(dba)3. bDetermined by GC. c no ligand added 
 
 
4.2.2.2 Vinyl ethers 
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The electronic properties of the substrate proved to have a direct influence on the reaction. Indeed, 
electron poor substrates such as styrene were unreactive. The reaction was thus tested with electron 
rich substrates as enolethers (Scheme 77). Electron deficient palladium complexes such as cationic 
palladium-hydride with triflate as counteranion coordinate more strongly with electron rich 
alkenes. Indeed, obtained results were in most case superior to previous reactions with 1-hexene or 
styrene using 5% palladium complex in DMA or DMF and five equivalents of morpholine as 
nucleophile at 80 °C for two days. Yields in the range of 40-50% were obtained with enolethers 
(Table 18), with little influence of the steric hindrance of the substrate. Enantioselectivity were 
high with 93% ee (Entry 2, Table 18) in the case of butylvinyl ether and generally in the range of 
80-90% ee. 
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Table 18. Reaction with vinyl ethersa 
Entry Solvent Pd 
mol% 
Substrate Eq. Nucleoph. T (°C) Time 
(d) 
Yield 
(%)b
ee 148 
(%)b
1 DMF 5 O i-pr 5. morpholine 95 2 45 90 
2 DMF 5 O 5. morpholine 80 2 40 93 
3 DMF 5 O  5. morpholine 80 2 50 84 
4 DMA 5 O  3. morpholine 80 2 50 88 
5 DMA 5 O  5.bis(methoxy)-
ethylamine 
80 2 50 - 
a All reactions were carried out under argon using 5 mol% of 106-Pd2(dba)3. bDetermined by GC. 
 
 
The obtained product 148 was unexpected. Presumably, it resulted from an intramolecular 
rearrangement depicted in Scheme 78. After syn-insertion of palladium on the vinylether, β-hydride 
elimination and subsequent isomerisation via palladium-hydride complex, the π-allyl complex was 
formed and underwent an intramolecular nucleophilic attack at the allylic terminus of the complex 
by the neighbouring ethers oxygen. This led to an oxonium intermediate that was suited for a 
nucleophilic attack by nucleophiles to form the product. 
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Scheme 78. 
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Another possible pathway involving rearrangement of the π-allyl intermediate through a cyclic 
oxonium is depicted in Scheme 79 below: 
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4.2.2.3 Acyclic triflates 
 
Use of acyclic alkenyl triflates was experimented in order to expand the reaction’s scope (Scheme 
80). This type of substrate could additionally offer the advantage of low steric hindrance, thus 
enhancing the reaction yields that are often sensitive to steric hindrance. 
 
 
R1
OTf
R2
+
Pd2(dba)3 R1
N
O
R2
morpholine
 
Scheme 80. 
 
Substrates were obtained by addition of triflic acid on alkynes (Scheme 81).(153) 
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OTf
HOTf
Pentane
149  
Scheme 81. 
 
The reaction above works well with simple alkynes but gives low yields (<10% yield) with the 
substrates depicted in Figure 55. 
 
 
 
Figure 55. 
 
The catalyst was optimised using 1-hexene and pentenyl triflate 150. The nucleophilic attack 
generally occurred at the less hindered end of the π-allyl complex, thus forming achiral compound 
151 (Scheme 82). 
 
 
OTf
+
Pd2(dba)3
 morpholine N
O
150
151 151'
+
 
Scheme 82. 
 
Phosphite ligands appeared to give very good 151’/151 ratios and conversions (Entries 7-9, Table 
19). THF as solvent was found to be best suited for 151’/151 ratio with phosphite ligand (Entry 9, 
Table 19). TADDOL-based ligands (Entries 10-12, Table 19) were reactive but the 151’/151 ratios 
were lower than with phosphites. Phosphine or amine ligands such as phosphino-oxazolines (entry 
1, Table 4.5), bisoxazolines (Entry 2, Table 19), 1,10-phenantroline (entry 3, Table 19) or 
diphenylphosphine-propane (Entry 4, Table 19) did not gave satisfactory 151’/151 ratios. 
Noteworthy, dppf gave significantly better 151’/151 selectivity than other diposphines (Entry 5, 
Table 19). 
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Table 19. Ligand and solvent influence on reaction with acyclic triflatesa 
Entry Solvent Ligand 151’/151  ratio Conv. (%)b
1 DMF PHOX 106 1 100 
2 THF BISOX 106 2 50 
3 THF 153 1.5 100 
4 THF dppp 1.50 100 
5 THF dppf 0.67 100 
6 THF 154 0 0 
7 DMF P(OMe)3 0.07 90 
8 Toluene P(OMe)3 0.11 90 
9 THF P(OMe)3 0.10 95 
10 THF HR477 0.25 90 
11 THF HR678 0.66 90 
12 THF HR461 1 90 
13 THF 152 0.3 85 
a All reactions were carried out under argon. bDetermined by GC 
 
 
Steric hindrance on the ligand seems also to play an important role since the small trimethyl 
phosphite ligands (Entries 7-9, Table 19) gives better selectivities than more bulky phosphite 
ligands (Entries 10-13, Table 19). 
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Figure 56. 
 
 
The success of the palladium-hydride isomerisation can be correlated to its coordination on the 
alkene. The amount of 1-hexene was lowered from 5 equivalents to one equivalent. Slight decrease 
in selectivity was observed, indicating that excess alkene is required. 
 
 
4.3 Discussion 
 
Study of the reaction has highlighted its limitations but shows promise that enantioselective 
synthesis is feasible by multicomponent reactions. Observations indicate several reasons for the 
low yields obtained with cyclohexenyl triflates, the main being presumably their high 
regioselectivity toward the internal olefin terminus during the Heck reaction step with tested 
substrates. Use of acrylates could therefore improve the yields. Also, the reaction seems to be 
highly sensitive to steric hindrance, probably due to difficulty of nucleophilic attack on sterically 
hindered π-allyl intermediates, a feature also found in allylic substitutions.  This problem could be 
overcome by intramolecular nucleophilic substitution where the nucleophile stays in proximity of 
the reactants. Electron rich substrates as enolethers show better reactivity, thus indicating that 
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electronic factors play a predominant role. This is also supported by the huge reactivity difference 
in relation to the electronic properties of the ligand. Reactions conducted with vinyl halides are 
generally higher yielding than with vinyl triflates. This could have several reasons: 
• Relative unstability of the cationic palladium-hydride intermediate with triflates 
compared to the neutral complex (with strongly coordinating halides). 
• Faster dissociation of the alkene from a cationic palladium-hydride because of low 
π-backbonding from metal to the alkene. 
• Regioselectivity of the addition on olefins directed toward the external terminus. 
 
Surprisingly, electron poor ligands such as phosphites (strong metal to ligand π-backbonding, poor 
σ-donor) are superior to more electron rich phopshine ligands (weaker π-backbonding, stronger σ-
donation) or amines (no π-backbonding, good σ-donor).(152) This might be due to formation of more 
reactive π-allyl palladium complexes through increasing the electrophilicity of the complex. 
Noteworthy, attack of the nucleophile on the more hindered allylic terminus could be facilitated 
because of induced positive charge located at the more substituted allylic terminus. 
 
 
4.3.1 Enantioselectivity 
 
The enantiomeric excesses obtained by reacting cyclohexenyl triflate with 1-hexene 
demonstrated that formation of stereogenic centers is possible by a multicomponant Heck-
allylic substitution reaction. Enantioselection could result from the Heck-reaction step, the 
allylic substitution step or a combination of both. When integrating a enantioselective Heck-
reaction step in the tandem Heck-allylic substitution, the mechanism leading to 
enantioselectivity is examined in the case of insertion on the ‘less hindered end’ of the alkene 
(Scheme 83). The olefin insertion step can occur on both sides of the alkene thus forming 
intermediates 1 and 1’. The β-elimination step can then lead to E and/or Z alkene (2E, 2Z and 
2’E, 2’Z), generally in favor of the E isomer (plain arrows). Each of these isomers can form syn 
π-allyl complexes by isomerisation via a palladium-hydride complex (3,3’) that subsequently 
can undergo nucleophilic substitution. 
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Scheme 83. 
 
 
Depending on the selectivity of the nucleophilic attack at one allylic terminus, one isomer or an 
isomer mixture (4/5) can be obtained. Most important, enantiomeric excess of the obtained 
products (4 and 5) is clearly not only depending on the face discrimination during the alkene 
coordination step giving 1 or 1’(the ‘Heck-reaction’ step). Indeed, even though the face 
coordination would occur selectively giving only 1, an unselective β-elimination step that would 
not only produce the E alkene (2E) but also the Z (2Z) would lead to formation diastereoisomeric 
π-allyl complexes 3 and 3’, and subsequently to a racemic mixture of products 4/4’ and/or 5/5’. 
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5. Experimental section 
 
 
5.1  General Experimental Points 
 
1H-NMR: spectra were recorded on a Varian Gemini 300 (300 MHz) spectrometer as well as on 
Bruker Avance 400, 500, and 600 MHz NMR spectrometers equipped with BBO broadband (500 
MHz) and BBI inverse (600 MHz) probe heads. When necessary, the signals were assigned by 
APT, DEPT, COSY, HMQC, HMBC, and NOESY measurements. References: 
1H NMR: TMS δ = 0 ppm or CHC13 = 7.26 ppm 
13C NMR: TMS  δ = 0 ppm or CHC13 = 77.0 ppm 
31P NMR: (PhO)3P=O (58% solution in CDC13) = -18.0 ppm 
IR: spectra were recorded on a Perkin Elmer 1600 séries FTIR spectrometer. Spectra of liquids 
were measured neat as thin films between two sodium chloride plates, those of solids as t KBr 
disks. 
El and FAB:  mass spectra were carried out at the Department of Chemistry at the University of 
Basel on mass spectrometers VG70-250 (EI) and Finnigan MAT 1312 (FAB). The ions were 
generated by electron ionization (El, 70 eV) or bombardment with fast xenon atoms (FAB), using 
of 3-nitrobenzyl alcohol (3-NBA) as matrix and sometimes potassium chloride as additive in the 
latter case. The data are given in mass units per charge (m/z). 
ESI: mass  spectra  were  measured with a Finnigan MAT LCQ octapole mass spectrometer. 
Elemental analyses: Department of chemistry at the University of Basel, Leco CHN-900 (C-, H-, 
N-detection) and Leco RO-478 analysers. The data are indicated in mass percents. 
G.C.:  Carlo  Erba HRGC  Mega2  Series  MFC  800 chromatographs. Achiral separations were 
mostly performed on the column Restek rtx-1701, 0.25 μm, 30 m, 60 kPa He or H2, chiral 
separations on several β- or γ-CD modified capillary columns. 
HPLC: Shimadzu Systems with a SCL-10A System Controller, CTO-10AC column oven, LC10-
AD pump System, DGU-14A degasser, and a SPD-M10A Diode Array Detector or a UV-vis 
detector (220 nm and 254 nm). Chiral columns Chiracel OD-I I, OB-H, OJ and Chiralpak AD and 
AS from Daicel Chemical Industries Ltd. were used (250mm x 4.6 mm) at a flow of 0.5 ml.min-1 
hexan/isopropanol mixtures at temperatures between 20 °C and 40 °C. 
Optical rotations were measured in a Perkin Elmer Polarimeter 341, sodium lamp, 1 dm cuvette 
lengths, c in g/100 ml. 
TLC: Macherey-Nagel Polygram plates SIL GAJV254, 0.2 mm silica with fluorescence indicator. 
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Column chromatographic separations were performed on silica 60 (particle size 40-63 μm, 230-400 
mesh) purchased al Merck, or Uetikon Chemie, accelerated by pressurised air or nitrogen (flash 
chromatography). 
High-pressure hydrogenations (up to 50 bars) were carried out in 60 ml autoclaves of Premex AG, 
Lengnau, Switzerland. Hydrogen gas used in all experiments was purchased at Carbagas Switzerland at 
quality 45 (99.995%). 
Reactions with air- or moisture-sensitive compounds were performed under an argon atmosphere using 
standard Schlenk techniques, or in a nitrogen atmosphere in a M. Braun glove box (H20 <1 ppm, O2 <2 
ppm). Glassware was oven-dried and then flame-dried under vacuum prior to use. 
 
 
5.2 Purification of Chemicals 
 
Diethyl ether, tetrahydrofuran, and toluene were dried over sodium/benzophenone, pentane over 
sodium-potassium alloy/benzophenone, dichloromethane over CaH2 and freshly distilled under a stream 
of nitrogen prior to use. Other solvents were purchased dry at Fluka or Aldrich in septum sealed bottles 
and kept in an inert atmosphere over molecular sieves. When needed, solvents were degassed prior 
to use by three freeze-pump-thaw cycles. Diethylamine, diisopropylamine, and triethylamine were 
dried over CaF2 and distilled under argon. Phosphorus trichloride was refluxed overnight under argon 
to remove hydrogen chloride and subsequently distilled under argon. 
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 5.3 Abbreviations 
 
arom.           aromatic 
BINAP        2,2´-bis(diphenylphosphino)-1,1´-binaphthyl 
BOC            tert-butoxacarbonyl 
B.p.              boiling point 
calc.             calculated 
cat.               catalyst 
CD               circular dichroisms 
CI-MS         chemical ionisation 
DABCO      1,4-diazabicyclo[2,2,2]octane 
dba              dibenzylideneacetone 
DBU            1,8-diazabicyclo[5,4,0]undec-7-ene 
DMA           dimethylacetamide 
DMF           dimethylformamide 
DMSO        dimethylsulfoxide 
ee                enantiomeric excess 
EI-MS         electron impact 
eq                equivalent 
FAB-MS   fast atom bombardment 
GC      gas chromatoraphy 
HPLC  high pressure liquid chromatography 
IR   infrared spectrum 
L   ligand 
M metal 
M.p. melting point 
MS mass spectrometry 
Nu nucleophile 
R organic substituent 
Rf retention factor 
rt room temperature 
S solvent 
TBME  tert-butyl methyl ether 
Tf  trifluoromethanesulfonyl 
Tf2NPh  1,1,1- trifluoro-N-phenyl-N-[(trifluoromethyl)sulfonyl]-methanesuldonimide 
THF   tetrahydrofuran 
TLC tin layer chromatography 
TMEDA N,N,N´,N´-tetramethylethanediamine 
TON turnover number 
tR retention time 
triflate trifluoromethanesulfonate 
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5.4 Synthesis of Phosphino-Oxazoline ligands 
 
5.4.1 Synthesis of tert-butyl (S)-1-(tert-butylcarbamoyl)-2-hydroxyethylcarbamate 
 
BOCHN O
OHHO
BOCHN
O
NH
HO
 
 
General Procedure. Tert-butylamine (1 ml, 9.7 mmol) and Boc-Ser-OH (2 g, 9.7 mmol) were 
suspended in dichloromethane (100ml) and cooled to O °C. Triethylamine (10.7 mmol, 1.48 ml) 
was added and the reaction mixture stirred for 15 minutes. EDC.HCl (3.7 g, 19.4 mmol) was added 
and the mixture stirred for a further 10 min. HOBt (1.3 g, 9.7mmol) was added and the reaction 
was stirred overnight, warming to room temperature. Water (70 ml) was added and the layers were 
separated. The organic layer was washed with 1M aq.HCl (50ml), saturated aq. NaHCO3 (50ml) 
and dried (Na2SO4). After filtration and removal of the solvent under reduced pressure, NMR 
analysis showed the amide with >93 % purity which was used in the next step without further 
purification. 
 
C12H24N2O4     (260.33) 
1H-NMR (400 MHz, CDCl3)  δ 1.37 (s, 9H), 1.42 (s, 9H), 4.0 (m, 1H), 4.3 (m,1H), 4.5 (m, 
1H) 
13C-NMR (100 MHz, CDCl3) δ 26 (CH3), 28 (CH3), 54 (C), 59 (CH2), 61 (CH),  80 (C), 157 
(C), 167 (C) 
 
 
5.4.2 Synthesis of (S)-N-tert-butyl-2-amino-3-hydroxypropanamide 
 
BOCHN
O
NH
HO
H2N
O
NH
HO
 
 
General Procedure. The crude amide (0.87 g, 3.3 mmol) was dissolved in anhydrous 
dichloromethane (80 ml) and trifluoroacetic acid (1.5 ml, 20 mmol) was added slowly over 5 
minutes. The mixture was stirred for 8 hours at room temperature and then cooled to 0 °C. 
Saturated Na2CO3 (aq.) was added slowly (caution- gas evolved) until pH>10. The layers were 
separated and the aqueous layer was extracted with dichloromethane (3 x 30 ml). The combined 
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organic layers were dried (Na2SO4) and the solvent removed under vacuum. The product was be 
purified by column chromatography (SiO2). Yield 90 %. 
 
C7H16N2O2     (160.21) 
1H-NMR (400 MHz, CDCl3)          δ = 1.39 (s, 9H), 3.63 (m, 1H), 4.1 (m, 1H), 4.4 (m,1H), 6.35 (s,    
1H), 7.51 (s, 1H) 
13C-NMR (100 MHz, CDCl3)    δ = 29 (CH3), 52 (CH), 55 (C), 63 (CH2), 168 (C) 
Rf      0.3 (EtOac/Hexane 5/5) 
 
 
5.4.3 Synthesis of N-((S)-1-(tert-butylcarbamoyl)-2-hydroxyethyl)-2-(diphenylphosphino)-
benzamide 
 
PPh2
O
OH
PPh2
O
N
H O
N
HO
 
 
Coupling following the general procedure (5.4.1) with (diphenylphosphino)benzoic acid (1.9 g, 6.2 
mmol) and tert-butylserine-amide (1 g, 6.2 mmol ) in 70 ml of degassed dichloromethane for 8 
hours. Solvents for extraction were also degassed. Yield 93 %. 
 
C26H29N2O3P     (448.49) 
1H-NMR (400 MHz, CDCl3)  δ 1.31 (s, 9H), 4.38 (dd, 1H), 4.43 (dd, 1H), 4.55 (m, 1H), 6.22 
(s, 1H),  7.0-7.99 (m, 14H) 
31P-NMR (162 MHz, CDCl3)   δ -7.4 
 
 
5.4.4 Synthesis of (S)-N-tert-butyl-4,5-dihydro-2-(2-(diphenylphosphino)-phenyl)oxazole-4-
carboxamide 33 
 
PPh2
O
N
H O
N
HO
PPh2
N
O
O
N
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The amidoalcohol (1.5 g, 3.3 mmol) and the Burgess-Reagent (0.86 g, 3.6 mmol) were placed 
under argon in an ampoule equipped with a magnetic stirring bar and a Young® valve, dissolved 
with 10 ml of degassed tetrahydrofuran. The ampoule was sealed under argon and the mixture 
stirred at 70 °C for 3h. The crude reaction mixture was directly purified by chromatography on 
silica-gel (SiO2) using degassed solvents (EtOAc/Hexane 5/5). 70 % yield. 
 
C26H27N2O2P    (430.48) 
1H-NMR (400 MHz, CDCl3)   δ 1.36 (s, 9H), 4.49 (m, 2H), 4.68 (t, 1H, J = 8Hz), 7.0 (m, 
1H), 7.2-7.35 (m, 12H), 7.9 (m, 1H) 
13C-NMR (100 MHz, CDCl3)   δ 29 (CH3), 51.2 (C), 70.5 (CH2), 70.6 (CH), 128-139 (CH), 
164.5 (C), 171 (C) 
31P-NMR (162 MHz, CDCl3)  δ -12.5 
Ir (KBr) 3303, 3052, 2966, 1675, 1521, 1476, 1433, 1363, 1226, 1092, 
1050, 962, 849, 743, 695, 509 
Rf      0.4 (hexan/ethyl acetate 6/4) 
(α)D20      -4.9 (c = 4.1, CHCl3) 
 
 
5.4.5      Copper-complex formation 
 
+ Cu(OTf)2 (L*)(Cu)IIOTf
PPh2
N
O
O
N
 
 
Synthesis following the general procedure (5.5.1.4) with oxazoline ligand 33 (0.5 g, 1.16 
mmol) and copper (II)trifluormethanesulfonate (0.42 g, 1.16 mmol) 
 
C27H27CuF3N2O5PS       (643,09) 
ESI-MS                          493.1 (L+Cu, 100),  494.2 (31), 495.1 (49), 496.2 (10) 
 
 
5.5  Synthesis of Imine ligands 
 
5.5.1   N-adamantylphenylalanine-amide ligand 
 
5.5.1.1   tert-butyl (S)-1-(adamantylcarbamoyl)-2-phenylethylcarbamate 
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 N
H
H
N
O
O
ONH
OH
O
O
O
 
 
Synthesis following the general procedure (5.4.1) with Boc-Phenylalanine (1 g, 3.7 mmol) and 1-
Aminoadamantyl (0.7 g, 2.7 mmol) in 70 ml of dichloromethane for 12 hours. Yield 95 % 
 
C24H34N2O3     (398.54) 
1H-NMR (400 MHz, CDCl3)   δ = 1.43 (s, 9H), 1.63 (m, 6H), 1.81 (m, 6H), 2.0 (m, 3H), 2.9 
(m, 1H), 3.1 (m, 1H), 4.1 (m, 1H), 5.1 (m, 1H), 5.48 (m, 1H), 
7.2-7.33 (m, 5H) 
13C-NMR (100 MHz, CDCl3)   δ = 28.7 (CH), 29.7 (CH3), 36.6, 39.6, 41.7, 52.3 (C), 52.5(C), 
80.3 , 127-129 (CH),137.5 (C),  155.7 (C), 170.0 (C) 
 
 
5.5.1.2  Synthesis of  (S)-2-amino-N-adamantyl-3-phenylpropanamide 
 
N
H
H
N
O
O
O H2N
H
N
O
 
 
Synthesis following the general procedure (5.4.2) with Boc-N-adamantylphenylalanine-amide (1 g, 
2.5 mmol) in 50 ml of dichloromethane for 10 hours. Yield 94 %. 
 
C19H26N2O      (298.42) 
1H-NMR (400 MHz, CDCl3)  δ = 1.63 (m, 6H), 1.95 (m, 6H), 2.1 (m, 3H), 2.7 (dd, 
1H, J = 8.2, 4.1Hz, CH2), 3.2 (dd, 1H, J = 0.42), 3.45 
(q, 1H, J = 4.3Hz, CH2), 7.2-7.33 (m, 5H) 
13C-NMR (100 MHz, CDCl3)   δ = 29.8, 36.8, 41.5, 41.9, 51.5, 57.3(CH), 127-129 
(CH),137.5 (C), 173.5 (C) 
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5.5.1.3  Synthesis of (S)-2-(2-(diphenylphosphino)benzylideneamino)-N-adamantyl-3-
phenylpropanamide 35 
 
PPh2
H
O
N
H
N
O
PPh2
 
 
General procedure. N-adamantylphenylalanine-amide (1 g, 3.3 mmol) and diphenylphosphino 
benzaldehyde (0.95 g, 3.3 mmol) were dissolved in degassed trimethylorthoformate (15 ml) and 
stirred overnight. If HCl salt of the amine is used, 1.1 eq. of triethylamine is added. After 12 to 14 
hours, the color turns from yellow to colourless. The solution was stripped to dryness under 
vaccum to give a white powder. NMR analysis showed the amine with >98 % purity wich was used 
in the next step without further purification (decomposition over silica-gel chromatography). Yield 
95 % 
 
C38H39N2OP    (570.7) 
1H-NMR (400 MHz, CDCl3)   δ 1.55 (m, 6H), 2.08 (m, 3H), 2.15 (m, 6H), 2.3 (dd, 1H), 3.25 
(dd, 1H), 3.7 (dt, 1H), 6.55-7.4 (m, 19H), 7.72 (d, 1H, J = 
3.3Hz) 
31P-NMR (162 MHz, CDCl3)   δ = -13.3 
 
 
5.5.1.4 Copper-complex formation 
 
N
H
N
O
PPh2
+ Cu(OTf)2 (L*)(Cu)IIOTf
 
 
General procedure. The phosphino-imine ligand 35 (1g, 1.75 mmol) was placed together with one 
equivalent of copper (II)-trifluormethanesulfonate (0.63 g, 1.75 mmol) under argon atmosphere in a 
50 ml flask equipped with a stirring bar. Degassed dichloromethane (10 ml) was added and the 
reaction mixture stirred at room temperature for 2h. A dark green solution was obtained. This green 
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solution was stripped to dryness and redissolved in dichloromethane, filtered and the complex 
precipitated with hexane to generate a green solid. The solid was characterized using ESI-MS 
 
C39H39CuF3N2O4PS    783.32 
ESI-MS     1203.3 (45, 2L+Cu), 782.3 (50, L+Cu+Otf), 633.1 (100, L+Cu) 
 
 
5.5.2  Methylphenylalanine-ester ligand 
 
5.5.2.1  Synthesis of (S)-methyl 2-amino-3-phenylpropanoate 
 
H2N
O
O
 
 
Synthesis following the general procedure (5.4.1, 5.4.2) with Boc-Phenylalanine (1g, 3.6 mmol) in 
methanol. Yield 89%. 
C10H13NO2     (179.22) 
1H-NMR (400 MHz, CDCl3)  δ 2.99 (m, 1H), 3.26 (m, 1H), 3.61 (s, 3H), 3.9 (t, 1H), 7.0-8.1 
(m, 5H) 
 
 
5.5.2.2    Synthesis of (S)-methyl 2-(2-(diphenylphosphino)benzylideneamino)-3-phenylpropanoate 
36 
P
N
O
O
 
 
Synthesis following the general procedure (5.5.1.3) with methylphenylalanine-ester (1 g, 5.5 
mmol) and diphenylphosphino benzaldehyde (1.6 g, 5.5 mmol). 98 % yield. 
 
C29H26NO2P     (451.5) 
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1H-NMR (400 MHz, CDCl3)  δ 2.9 (m, 1H), 3.25 (m, 1H), 3.6 (s, 3H), 4.1 (t, 1H, J = 7.3 
Hz), 6.8-8.0 (m, 14H), 8.7 (d, 1H) 
 
 
5.5.2.3  Copper-complex formation 
 
(L*)(Cu)IIOTf
P
N
O
O
+ Cu(OTf)2
 
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 1.1 
mmol) and copper (II)-trifluormethanesulfonate (0.4 g, 1.1 mmol) 
 
C30H26CuF3NO5PS   (664.11) 
ESI-MS            965.1 (43, 2L+Cu), 663.2 (50, L+Cu+OTf), 514.3 (100, 
L+Cu) 
 
 
5.5.3 tert-butylvaline-amide ligand 
 
5.5.3.1  tert-butyl (S)-1-(tert-butylcarbamoyl)-2-methylpropylcarbamate 
 
N
H O
H
N
O
O
 
 
Synthesis following the general procedure (5.4.1) with Boc-Valine (2.1 g, 9.7 mmol) and tert-
butylamine (1 ml, 9.7 mmol) in dichloromethane for 12 hours. Yield 94 %. 
 
C14H28N2O3     (272.38) 
1H-NMR (400 MHz, CDCl3)  δ = 0.9 (dd, 6H), 1.32 (s, 9H), 1.41 (s, 9H), 2.05 (m, 1H), 3.7 
(m, 1H) 
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 5.5.3.2  (S)-N-tert-butyl-2-amino-3-methylbutanamide 
 
H2N
H
N
O  
 
Synthesis following the general procedure (5.4.2) with Boc-tert-butylvaline-amide (1g, 3.6 mmol) 
in 50 ml of dichloromethane for 10 hours. Yield 96 % 
 
C9H20N2O     (172.27) 
1H-NMR (400 MHz, CDCl3)  δ = 0.8-0.95 (dd, 6H, J = 7.5, 61.0 Hz), 1.34 (s, 9H), 2.25 (m, 
1H), 3.0 (d, 1H, 4.2 Hz) 
13C-NMR (100 MHz, CDCl3)  δ = 17, 20, 29, 31, 51 (C), 61, 174 (C) 
 
 
5.5.3.3 Synthesis of (S)-2-(2-(diphenylphosphino)benzylideneamino)-N-tert-butyl-3-
methylbutanamide 37 
 
PPh2
N
O
H
N
 
 
Synthesis following the general procedure (5.5.1.3) with tert-butylvaline amide (1 g, 5.8 mmol) 
and diphenylphosphino benzaldehyde (1.68 g, 5.8 mmol). Yield 98 %. 
 
C28H33N2OP     (444.55) 
1H-NMR (400 MHz, CDCl3)  δ = 0.38-0.59 (dd, 6H, J = 6.8, 83.6), 1.39 (s, 9H), 2.10 (m, 
1H), 3.44 (d, 1H, J = 1.5 Hz), 6.90-7.77 (m, 14H), 8.43 (d, 1H, 
J = 3.6 Hz) 
13C-NMR (100 MHz, CDCl3)  δ = 16.9, 19.7, 29.4, 32.8, 51.5 (C), 81.7, 128.7-135.1, 161.8 
(C) 
31P-NMR (162 MHz, CDCl3)   δ = -12 
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5.5.3.4 Copper-complex formation 
PPh2
N
O
H
N
(L*)(Cu)IIOTf+ Cu(OTf)2
 
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 1.12 
mmol) and copper (II)-trifluormethanesulfonate (0.4 g, 1.12 mmol) 
 
C29H33CuF3N2O4PS  (657.16) 
ESI-MS   (MeOH)  950.9 (45, 2L+Cu), 656.1 (55, L+Cu+OTf), 507.3 (100, 
L+Cu) 
 
 
5.5.4 Aniline-valine-amide 
 
5.5.4.1  Synthesis of (S)-2-amino-N-benzyl-3-methylbutanamide 
 
H2N
H
N
O  
 
Synthesis following the general procedure (5.4.1, 5.4.2) with Boc-valine (1 g, 4.6 mmol) and 
benzylamine (0.5 ml, 4.6 mmol). Yield 89%. 
 
C12H18N2O     (206.28) 
1H-NMR (400 MHz, CDCl3)   δ 0.9 (d, 3H, J = 11.2Hz), 1.0 (d, 3H, J = 11.2 Hz), 2.1(m, 
1H), 3.52 (d, 1H, J = 4.2Hz), 4.5 (m, 2H), 6.7-7.2 (m, 19H) 
 
 
5.5.4.2  Synthesis of (S)-2-(2-(diphenylphosphino)benzylideneamino)-N-benzyl-3-
methylbutanamide 38 
 
PPh2
N
O
H
N
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 Synthesis following the general procedure (5.5.1.3) with benzylaminevaline-amide (1 g, 4.8 mmol) 
and diphenylphosphino benzaldehyde (1.4 g, 4.8 mmol). 98% yield. 
 
C31H31N2OP     (478.56) 
1H-NMR (400 MHz, CDCl3)   δ 0.5 (d, 3H, J = 13.1Hz), 0.7 (d, 3H, J = 13.1 Hz), 2.3 (m, 
1H), 3.62 (d, 1H, J = 4.3Hz), 4.3 (dd, 1H), 4.5 (dd, 1H), 6.65-
7.4 (m, 19H), 8.4 (d, 1H, J = 4.2 Hz) 
 
 
5.5.4.3 Copper-complex formation 
 
PPh2
N
O
H
N (L*)(Cu)IIOTf+ Cu(OTf)2
 
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 1.0 mmol) 
and copper (II)-trifluormethanesulfonate (0.37 g, 1.0 mmol) 
 
C32H31CuF3N2O4PS  (691.18) 
ESI-MS    1019.4  (30, 2L+Cu), 690.3 (55, L+Cu+OTf), 541.3 (100, 
L+Cu) 
 
 
5.5.5 N-adamantylvaline ligand 
 
5.5.5.1  Synthesis of  tert-butyl (S)-1-(adamantylcarbamoyl)-2-methylpropylcarbamate 
 
N
H
H
N
O
O
O
 
 
Synthesis following the general procedure (5.4.1) with Boc-Valine (1 g, 4.6 mmol) and 1-
aminoadamantyl (0.86 g, 4.6 mmol) in dichloromethane for 10 hours. Yield 93 %. 
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 C20H34N2O3     (350.5) 
1H-NMR (400 MHz, CDCl3)  δ = 0.92 (dd, 6H, J = 7.7, 15.4 Hz), 1.43 (s, 9H), 1.66 (m, 
6H), 1.97 (m, 6H), 2.06 (m, 3H), 3.68 (t, 1H, J = 0.86 Hz), 
5.05 (m, 1H), 5.48 (m, 1H) 
13C-NMR (100 MHz, CDCl3)   δ = 19.6, 28.7, 29.8, 31.5 (C), 36.7 (CH), 41.9 (CH), 52.5(C), 
60.9, 156.2 (C), 170.7 (C) 
 
 
5.5.5.2   Synthesis of  (S)-2-amino-N-adamantyl-3-methylbutanamide 
 
H2N
H
N
O
 
 
Synthesis following the general procedure (5.4.2) with Boc-N- adamantylvaline-amide (1g, 2.8 
mmol) in 50 ml of dichloromethane for 12 hours. Yield 94 % 
 
C15H26N2O     (250.38) 
1H-NMR (400 MHz, CDCl3)  δ = 0.53-0.69 (dd, 6H, J = 7.1,53.5 Hz), 1.4 (m, 6H), 1.72 (m, 
6H), 1.78 (m, 3H), 1.91 (m, 1H), 2.79 (d, 1H, J = 7.1 Hz) 
13C-NMR (100 MHz, CDCl3)   δ = 16.4 (CH3), 20.1 (CH3), 29.8 (CH), 31.3 (CH), 36.8 , 
42.0, 51.5 (C), 60.9 (CH), 173.7 (C) 
 
 
5.5.5.3   Synthesis of (S)-2-(2-(diphenylphosphino)benzylideneamino)-N-adamantyl-3-
methylbutanamide 39 
N
H
N
O
PPh2
 
 
Synthesis following the general procedure (5.5.1.3) with N-adamantylvaline-amide (1 g, 3.9 mmol) 
and diphenylphosphino benzaldehyde (1.16 g, 3.9 mmol). 98 % yield 
 
 
118 
C34H39N2OP     (522.66) 
1H-NMR (400 MHz, CDCl3)  δ = 0.39 (d, 3H, J = 9.2Hz), 0.6 (d, 3H, J = 9.2Hz), 1.65 (m, 
6H), 2.05 (m, 10H), 3.45 (d, 1H), 6.9-7.8 (m, 10H), 8.44 (d, 
1H) 
13C-NMR (100 MHz, CDCl3)  δ = 16.7 (CH3), 19.6 (CH3), 29.9 (CH), 36.8, 42.2, 51.7 (C), 
80.5 (CH), 128.0-136.1, 161.5 (C) 
31P-NMR (162 MHz, CDCl3)   δ = -14.06 
 
 
5.5.5.4 Copper-complex formation 
 
(L*)(Cu)IIOTf+ Cu(OTf)2
N
H
N
O
PPh2
 
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 0.95 
mmol) and copper (II)-trifluormethanesulfonate (0.35 g, 0.95 mmol) 
 
C35H39CuF3N2O4PS   (735.28) 
ESI-MS    1107.3 (43, 2L+Cu), 734.2 (51, L+Cu+OTf), 585.3 (L+Cu) 
 
 
5.5.6 Methylvaline-ester ligand 
 
5.5.6.1   tert-butyl (S)-1-(methoxycarbonyl)-2-methylpropylcarbamate  
 
N
H O
O
O
O
 
 
Synthesis following the general procedure (5.4.1) with Boc-Valine (1g, 4.6 mmol) in methanol for 
10 hours. Yield 89 % 
 
C11H21NO4      (231.29) 
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1H-NMR (400 MHz, CDCl3)  δ 0.85 (d, 3H , J = 6.8 Hz), 0.93 (d, 3H , J = 6.8 Hz), 
1.41 (s, 9H), 2.1 (m, 1H), 3.7 (s, 3H), 5.0 (d, 1H, J = 
8.3 Hz) 
 
 
5.5.6.2  Synthesis of (S)-methyl 2-amino-3-methylbutanoate 
 
H2N
O
O
 
 
Synthesis following the general procedure (5.4.2) with Boc-methylvaline-amide (1g, 4.3 mmol) in 
50 ml of dichloromethane for 12 hours. Yield 94 % 
 
C6H13NO2     (131.17) 
1H-NMR (400 MHz, CDCl3)  δ 0.9 (d, 3H , J = 7.0 Hz), 1.1 (d, 3H , J = 7.0 Hz), 2.3 
(m, 1H), 3.55 (s, 3H), 4.2 (d, 1H, J = 8.0 Hz) 
 
 
5.5.6.3  Synthesis of  (S)-methyl 2-(2-(diphenylphosphino)benzylideneamino)-3-methylbutanoate 
40 
N
O
O
PPh2  
 
Synthesis following the general procedure (5.5.1.3) with methylvaline-ester (1 g, 7.6 mmol) and 
diphenylphosphino benzaldehyde (1.16 g, 3.9 mmol). 98 % yield 
 
C25H26NO2P     (403.45) 
1H-NMR (400 MHz, CDCl3)  δ 0.86 (d, 3H , J = 7.1 Hz), 1.12 (d, 3H , J = 7.1 Hz), 
2.5 (m, 1H), 3.7 (s, 3H), 4.6 (d, 1H, J = 8.0 Hz), 8.1 
(s, 1H), 7.04-7.6 (m, 14H) 
 
 
 
 
 
120 
5.5.6.4  Copper-complex formation 
 
(L*)(Cu)IIOTf+ Cu(OTf)2N
O
O
PPh2  
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 1.24 
mmol) and copper (II)-trifluormethanesulfonate (0.45 g, 1.24 mmol) 
 
C26H26CuF3NO5PS  (616.07) 
ESI-MS   869.4 (37, 2L+Cu), 615.3 (48, L+Cu+OTf), 466.3 (100, L+Cu) 
 
 
5.5.7   N-adamantlycyclohexylglycine-amide ligand 
 
5.5.7.1  Synthesis of  tert-butyl (S)-(adamantylcarbamoyl)(cyclohexyl)methylcarbamate 
 
N
H
H
N
O
O
O
 
 
Synthesis following the general procedure (5.4.1) with Boc-cyclohexylglycine (1g, 3.88 mmol) and 
1-aminoadamantyl (0.73 g, 3.9 mmol). 92 % yield 
 
C23H38N2O3     (390.56) 
1H-NMR (400 MHz, CDCl3)   δ 0.9-1.2 (m, 6H), 1.43 (s, 9H), 1,66 (m, 6H), 1,71 (m, 4H), 
1.9 (m, 6H), 2.07 (m, 3H), 3.67 (t, 1H, J =  8.2Hz), 5.06 (d, 
1H,  J =  8.3Hz), 5.44 (s, 1H) 
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5.5.7.2  Synthesis of (S)-2-amino-2-cyclohexyl-N-adamantylacetamide 
 
H2N
H
N
O
 
Synthesis following the general procedure (5.4.2) with Boc-N-adamantylcyclohexylglycine-amide 
(1g, 2.5 mmol) in 50 ml of dichloromethane for 11 hours. Yield 93 % 
 
C18H30N2O     (290.44) 
1H-NMR (400 MHz, CDCl3)  δ 0.95-1.27 (m, 6H), 1,67 (m, 10H), 2.0 (m, 6H), 2.07 (m, 
4H), 3.82 (d, 1H, J =  3.5Hz) 
 
 
5.5.7.3 Synthesis of (S)-2-(2-(diphenylphosphino)benzylideneamino)-2-cyclohexyl-N-
adamantylacetamide 41 
N
H
N
O
PPh2
 
 
Synthesis following the general procedure (5.5.1.3) with N- adamantylcyclohexylglycine-amide (1 
g, 7.6 mmol) and diphenylphosphino benzaldehyde (1.16 g, 3.9 mmol). 98 % yield 
 
C37H43N2OP     (562.72) 
1H-NMR (400 MHz, CDCl3)  δ 0.90-1.35 (m, 6H), 1,7 (m, 10H), 2.1 (m, 10H), 3.42 (d, 
1H), 6.8-7.8 (m, 14H), 8.3 (s, 1H) 
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5.5.7.4  Copper-complexe formation 
 
(L*)(Cu)IIOTf+ Cu(OTf)2N
H
N
O
PPh2
 
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 0.88 
mmol) and copper (II)trifluormethanesulfonate (0.32 g, 0.88 mmol) 
 
C38H43CuF3N2O4PS (775.34) 
ESI-MS 1187.3 (43, 2L+Cu), 774.3 (52, L+Cu+OTf), 625.4 (100, 
L+Cu) 
 
 
5.5.8 tert-butlycyclohexylglycine-amide ligand 
 
5.5.8.1  Synthesis of (S)-N-tert-butyl-2-amino-2-cyclohexylacetamide 
 
H2N
H
N
O  
 
Synthesis following the general procedure (5.4.1, 5.4.2) with Boc-cyclohexylglycine (1g, 3.2 
mmol) and tert-butylamine (0.33 ml , 3.9 mmol) Yield 89%. 
 
C12H24N2O     (212.33) 
1H-NMR (400 MHz, CDCl3)  δ = 0.95-1.32 (m, 5H), 1.35 (s, 9H), 1.50-1.92 (m, 5H), 3.06 
(d, 1H, J = 4.2 Hz), 5.05 (s, 1H) 
13C-NMR (100 MHz, CDCl3)  δ = 27, 27.2, 29 (CH3), 31, 41.5 (CH), 51 (C), 61 (CH), 173.5 
(C) 
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5.5.8.2 Synthesis of (S)-2-(2-(diphenylphosphino)benzylideneamino)-N-tert-butyl-2-
cyclohexylacetamide 42 
N
H
N
O
PPh2  
 
Synthesis following the general procedure (5.5.1.3) with tert-butylcyclohexylglycine-amide (1 g, 
4.7 mmol) and diphenylphosphino benzaldehyde (1.36 g, 4.7 mmol).97 % yield 
 
C31H37N2OP    (484.61) 
1H-NMR (400 MHz, CDCl3)  δ = 1.1-1.4 (m, 5H), 1.4 (s, 9H), 1.45-1.85 (m, 5H), 3.87 (d, 
1H, J = 4.2 Hz), 8.05 (s, 1H), 7.1-7.6 (m, 14H) 
 
 
5.5.8.3 Copper-complex formation 
 
(L*)(Cu)IiOTf+ Cu(OTf)2N
H
N
O
PPh2  
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 1.0 mmol) 
and copper (II)-trifluormethanesulfonate (0.37 g, 1.0 mmol) 
 
C32H37CuF3N2O4PS  (697.23) 
ESI-MS   1031.2 (45, 2L+Cu), 696.3 (55, L+Cu+OTf), 547.3 (100, L+Cu) 
 
 
5.5.9 Methylisoleucine-ester 
 
5.5.9.1 Synthesis of (2S,3S)-methyl 2-amino-3-methylpentanoate 
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H2N
O
O
 
 
Synthesis following the general procedure (5.4.1, 5.4.2) with Boc-isoleucine (1g, 4.3 mmol) Yield 
90%. 
 
C7H15NO2     (145.2) 
1H-NMR (400 MHz, CDCl3) δ 0.95 (t, 3H, J = 6.9Hz), 1.1 (d, 3H, J = 7.0Hz ), 1.41 (m, 
1H), 1.51 (m, 1H), 2.19 (m, 1H), 3.8 (s, 3H), 4.1 (m, 1H) 
 
 
5.5.9.2   Synthesis of (2S,3S)-methyl 2-(2-(diphenylphosphino)benzylideneamino)-3-
methylpentanoate 44 
P
N
O
O
 
 
Synthesis following the general procedure (5.5.1.3) with methylisoleucine-ester (1 g, 6.8 mmol) 
and diphenylphosphino benzaldehyde (2.0 g, 6.8 mmol). 97 % yield 
 
C26H28NO2P     (417.48) 
1H-NMR (400 MHz, CDCl3)  δ 0.72 (t, 3H, J = 7.1Hz), 0.8 (d, 3H, J = 7.0Hz), 1.2-1.4 (m, 
2H), 1.97 (m, 1H), 3.65 (s, 3H), 3.67 (d, 1H), 6.8-8.1 (m, 
14H), 8.9 (d, 1H) 
13C-NMR (100 MHz, CDCl3)  δ 11.3 (CH3), 16.0 (CH3), 22.7, 25.2, 34.5, 38.3 (CH) 52.1 
(CH3), 79.6 (CH), 128-140 (CH), 162.2 (CH), 172.6 (C) 
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5.5.9.3 Copper-complex synthesis 
 
 
(L*)(Cu)IIOTf+ Cu(OTf)2
PPh2
N
O
O
 
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 1.2 mmol) 
and copper (II)trifluormethanesulfonate (0.43 g, 1.2 mmol) 
 
C27H28CuF3NO5PS  (630.09) 
ESI-MS    897.2 (40, 2L+Cu), 629.2 (56, L+Cu+OTf), 480.1 (100, L+Cu) 
 
 
5.5.10 Dicyclohexylvaline-amide 
 
5.5.10.1 Synthesis of  (S)-2-amino-N,N-dicyclohexyl-3-methylbutanamide 
 
H2N
N
O  
 
Synthesis following the general procedure (5.4.1, 5.4.2) with Boc-valine (1g, 4.6 mmol) and 
dicyclohexylamine (0.83g, 4.6 mmol). Yield 92%. 
 
C17H32N2O     (280.45) 
1H-NMR (400 MHz, CDCl3)  δ 0.75 (d,3H), 0.85 (d, 3H), 1.0-1.8 (m, H), 2.5 (m, 1H), 3.6 
(m, 1H), 3.68 (dt, 2H) 
13C-NMR (100 MHz, CDCl3)  δ 21.0 (CH3), 25.5, 26.0, 27.2, 31.3, 32.0 (CH), 53.2 (CH), 
56.0 (CH), 175.3 (C) 
EI-MS 280 (1), 237 (2), 209 (7), 180 (3.5), 166 (3) ,138 (4), 128 (3), 
98 (4), 72 (100), 55 (24), 41 (10) 
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5.5.10.2 Synthesis of (S)-2-(2-(diphenylphosphino)benzylideneamino)-N,N-dicyclohexyl-3-
methylbutanamide 45 
 
 
PPh2
N
O
N
 
 
Synthesis following the general procedure (5.5.1.3) with dicyclohexylvaline-amide (1 g, 3.5 mmol) 
and diphenylphosphino benzaldehyde (1.0 g, 3.5 mmol). 98 % yield. 
 
C36H45N2OP     (552.73) 
1H-NMR (400 MHz, CDCl3)  δ 0.6 (d,3H), 0.75 (d, 3H), 0.9-1.6 (m, H), 2.1 (m, 1H), 4.0 
(m, 1H), 3.68 (dt, 2H) 
13C-NMR (100 MHz, CDCl3)  δ 21.2 (CH3), 25.9, 26.3, 27.3, 31.5, 32.0 (CH), 53.2 (CH), 
79.0 (CH), 125-135 (CH), 162 (CH), 173.3(C) 
31P-NMR (162 MHz, CDCl3)   δ -16.7 
 
 
5.5.10.3   Copper-complex synthesis 
 
PPh2
N
O
N (L*)(Cu)IIOTf+ Cu(OTf)2
 
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 0.9 mmol) 
and copper (II)-trifluormethanesulfonate (0.32 g, 0.9 mmol) 
 
C37H45CuF3N2O4PS  (765.34) 
ESI-MS   1167.5 (45, 2L+Cu), 764.2 (55, L+Cu+OTf), 615.3 (100, L+Cu) 
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5.5.11 Diethylvaline-amide ligand 
 
5.5.11.1   Synthesis of (S)-2-amino-N,N-diethyl-3-methylbutanamide 
 
 
H2N
O
N
 
 
Synthesis following the general procedure (5.4.1, 5.4.2) with Boc-valanine (1g, 4.9 mmol) and 
diethylamine (0.52 ml, 4.9 mmol). Yield 89%. 
 
C9H20N2O     (172.27) 
1H-NMR (400 MHz, CDCl3)  δ 0.86 (dd, 6H, J = 3.6 Hz), 1.03 (t, 3H, J = 7.2Hz), 1,12 (t, 
3H, J = 7.2Hz), 1.75 (m, 1H), 3.12 (m, 2H), 3.24 (d, 1H, J = 
6.6Hz), 3.31 (m, 1H), 3.51 (m, 1H) 
13C-NMR (100 MHz, CDCl3)  δ 12 (CH3), 14 (CH3), 17 (CH3), 21 (CH3), 33 (CH) , 41 
(CH2), 42 (CH2), 57 (CH), 174 (C) 
 
 
5.5.11.2   Synthesis of (S)-2-(2-(diphenylphosphino)benzylideneamino)-N,N-diethyl-3-
methylbutanamide 46 
 
PPh2
N
O
N
 
 
Synthesis following the general procedure (5.5.1.3) with diethylvaline-amide (1 g, 5.8 mmol) and 
diphenylphosphino benzaldehyde (1.68 g, 5.8 mmol). 98 % yield. 
 
C28H33N2OP     (444.55) 
1H-NMR (400 MHz, CDCl3)   δ 0.63 (d, 3H, J = 7.6Hz), 0.87 (d, 3H, J = 7.6Hz), 0.98 (t, 
3H, J = 6.3 Hz), 1.03 (t, 3H, J = 6.3 Hz), 2.3 (m, 1H), 2.9-3.3 
(m, 4H), 3.7 (d, 1H, J = 10Hz), 6.8-8.1 (m, 14H), 8.92 (d, 1H, 
J = 7.5Hz) 
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13C-NMR (100 MHz, CDCl3)   δ 13 (CH3), 15 (CH3), 20 (CH3), 21 (CH3), 32 (CH), 40 
(CH2), 41 (CH2), 80 (CH), 126-134 (CH), 161 (CH), 172 (C) 
31P-NMR (162 MHz, CDCl3)   δ -17.0 
 
 
5.5.11.3  Copper complex synthesis 
 
PPh2
N
O
N
(L*)(Cu)IIOTf+ Cu(OTf)2
 
 
Synthesis following the general procedure (5.5.1.4) with phosphino-imine ligand (0.5 g, 1.1 mmol) 
and copper (II)-trifluormethanesulfonate (0.40 g, 1.1 mmol) 
 
C29H33CuF3N2O4PS  (657.16) 
ESI-MS   951.4 (44, 2L+Cu), 656.2 (57, L+Cu+OTf), 507.2 (100, L+Cu) 
 
 
5.5.12 tert-butylvaline-amide 
 
5.5.12.1  Synthesis of (S)-2-(2-hydroxybenzylideneamino)-N-tert-butyl-3-methylbutanamide 
48 
OH
N
O
H
N
 
 
Synthesis following the general procedure (5.5.1.3) with tert-butylvaline-amide (1 g, 5.8 mmol) 
and salicylaldehyde (0.72 g, 5.8 mmol). 97 % yield. 
 
C16H24N2O2     (276.37) 
1H-NMR (400 MHz, CDCl3)   δ 0.88 (d, 3H, J = 0.72Hz), 0.96 (d, 3H, J = 7.2Hz), 1.33 (s, 
9H), 2.42 (m, 1H), 3.57 (d, 1H, J = 6.0Hz), 6.7-7.3 (m, 4H, 
Ar), 8.19 (s, 1H) 
13C-NMR (100 MHz, CDCl3)  δ 18 (CH3), 20 (CH3), 29 (CH3), 32 (CH), 52 (C), 80 (CH), 
117-135 (CH, Ar), 161 (C), 168 (CH), 171 (C) 
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EI-MS 276 (47), 261 (1.5), 234 (1), 219 (4), 193 (1.5), 176 (100), 
162 (47), 142 (29), 121 (10), 107 (23), 77 (22), 58 (24), 41 
(23) 
IR (KBr) 3329, 3212, 3053, 2931, 2872, 2790, 2364, 1673, 1535, 1570, 
1523, 1391, 1360, 1224, 1153, 1046, 929, 762, 734, 569 
5.5.12.2  Copper-complexe synthesis 
 
OH
N
O
H
N
(L*)(Cu)IIOTf+ Cu(OTf)2
 
 
Synthesis following the general procedure (5.5.1.4) with benzylacohol ligand (0.5 g, 1.8 mmol) and 
copper (II)-trifluormethanesulfonate (0.65 g, 1.8  mmol) 
 
C17H24CuF3N2O5S  (488.99) 
ESI-MS   338.1 (100, L+Cu) 
 
 
5.6  Phosphite ligands 
 
5.6.1 Synthesis of (S)-2-(2-diphenylphosphinitbenzylideneamino)-N-tert-butyl-3-
methylbutanamide 49 
OPPh2
N
O
H
N
 
 
General Procedure. Under argon, the benzylacohol 48 (0.5 g, 1.8 mmol) was dissolved in 30 ml of 
dry tetrahydrofuran and cooled to -78 °C before slow addition of lithium diisopropylamine (2.7 
mmol) over 5 min. The reaction mixture was further stirred for 25 min at -78 °C (color turns from 
pale yellow to coulorless). Chlorodiphenylphosphine (0.43 ml, 2.35 mmol) was added dropwise 
over 3 min and the reaction mixture was allowed to warm to room temperature over 30 min. The 
reaction mixture was stripped to dryness and redissolved in degassed diethyl ether, filtered and 
immediately purified by silica-gel chromatography under inert atmosphere. (Diethyl ether/hexane 
9/1) to afford the diphenylphosphinite ligand  49 as a white solid. 75 % Yield. 
 
C28H33N2O2P     (460.55) 
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1H-NMR (400 MHz, CDCl3)  δ 0.9 (d, 3H, J = 7.0Hz), 0.96 (d, 3H, J = 7.0Hz), 1.34 (s, 9H), 
2.43 (m, 1H), 3.57 (d, 1H, J = 5.5Hz), 6.7-7.8 (m, 14H, Ar), 
8.25 (s, 1H) 
13C-NMR (100 MHz, CDCl3)   δ 18 (CH3), 19 (CH3), 29 (CH3), 33 (CH), 51 (C), 81 (CH), 
117-138 (CH, Ar), 161 (C), 168 (CH), 171 (C) 
31P-NMR (162 MHz, CDCl3)  δ 112.2 
Rf (diethyl ether/hexane 9/1)   0.25 
 
 
5.6.2 Copper-complex synthesis 
 
OPPh2
N
O
H
N
(L*)(Cu)IIOTf+ Cu(OTf)2
 
 
Synthesis following the general procedure (5.5.1.4) with phosphinite-imine ligand (0.3 g, 0.65 
mmol) and copper (II)-trifluormethanesulfonate (0.24 g, 0.65  mmol) 
 
C29H33CuF3N2O5PS  (673.16) 
ESI-MS   983.4 (36, 2L+Cu), 672.1 (48, L+Cu+OTf), 523.2 (100, L+Cu) 
 
5.6.3 Synthesis of (S)-2-(2-dicyclohexylphosphinitbenzylideneamino)-N-tert-butyl-3-
methylbutanamide 
N
O
H
N
O
P
 
 
Synthesis following the general procedure (5.6.1) with benzylacohol (0.5 g, 1.08 mmol) and 
chlorodicyclohexylphosphine (1.4  mmol). 55 % Yield. 
 
C28H45N2O2P     (472.64) 
1H-NMR (400 MHz, CDCl3)  δ 0.8 (d, 3H), 1.05 (d, 3H), 1.1-2.0 (m, 22H), 1.35 (s, 9H),  
2.61 (m, 1H), 3.5 (m, 1H), 6.65 (s, 1H), 8.55 (s, 1H) 
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 5.6.4 Copper-complex synthesis 
 
 
N
O
H
N
O
P (L*)(Cu)IIOTf+ Cu(OTf)2
 
 
Synthesis following the general procedure (5.5.1.4) with phosphinite-imine ligand (0.3 g, 0.63 
mmol) and copper (II)-trifluormethanesulfonate (0.23 g, 0.63  mmol) 
 
C29H45CuF3N2O5PS  (685.26) 
ESI-MS   1007.6 (44, 2L+Cu), 684.2 (49, L+Cu+OTf), 535.3 (100, L+Cu) 
 
 
5.7 Synthesis of Amide Ligands 
 
5.7.1  Synthesis of N-((S)-1-(tert-butylcarbamoyl)-2-methylpropyl)-2-
(diphenylphosphino)benzamide 51 
PPh2
N
H O
H
N
O
 
 
Coupling following the general procedure (5.4.1) with (diphenylphosphino)benzoic acid (1.9 g, 6.2 
mmol) and tert-butylvaline-amide (1.07 g, 6.2 mmol ) in 70 ml of degassed dichloromethane for 8 
hours. Solvents for extraction were also degassed. Yield 93 %. 
 
C28H33N2O2P    (460.55) 
1H-NMR (400 MHz, CDCl3)  δ = 0.45-0.60 (dd, 6H, J = 7.0, 74.0), 1.42 (s, 9H), 2.8 (m, 
1H), 4.6 (m, 1H), 6.98-7.9 (m, 14H) 
ESI-MS    525.3 (52, L+Cu), 524.4 (34), 523.5 (100) 
 
 
5.8    Synthesis of Ferrocene-imine ligands 
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 5.8.1 Synthesis of ferrocenecarbaldehyde 56 
 
Fe
O
H
 
 
In an argon-flushed flask was introduced ferrocene (10 g, 53.75 mmol) and dried under high 
vacuum for 12 h. Dry Potassium tert-butoxide (0.75 g, 6.7 mmol) was added under argon and the 
mixture was dissolved in 300 ml of dry tetrahydrofuran and cooled at -78°C in a dry ice/acetone 
bath. Over a period of 15 min, t-BuLi (0.1 mol) was added dropwise and the mixture stirred at -78 
°C for 2h before dropwise addition of DMF (0.12 mol, 9.7 ml). The cooling bath was removed and 
the solution allowed to warm to -30 °C. At this point the solution was hydrolysed with water (20 
ml), which turned the mixture deep red. Solvents were removed under vacuum and the aldehyde 
extracted with dichloromethane (3 x 100 ml). Extracts were combined and the solvent removed 
under vacuum. Products were separated by flash chromatography on silica-gel using first hexane 
(first fraction: unreacted ferrocene) then dichloromethane (second fraction: ferrocene 
monoaldehyde). Yield 90 %. 
 
C11H10FeO     (214.04) 
1H-NMR (400 MHz, CDCl3)   δ = 4.20 (s, 5H), 4.6 (s, 2H), 4.8 (s, 2H), 9.95 (s, 1H) 
13C-NMR (100 MHz, CDCl3)   δ = 70.0, 72.3 
Rf (CH2Cl2)    0.6 
 
 
5.8.2 Synthesis of (dimethoxymethyl)ferrocene 57 
 
Fe
OMe
OMe
 
 
Ferrocenecarbaldehyde 56 (5 g, 23.3 mmol) was dissolved in 50 ml of trimethyl orthoformate and a 
catalytic amount of p-toluenesulfonic acid monohydrate (0.2 g, 1.0 mmol) was added. The dark red 
solution was refluxed for 12h. The solution was filtered on Celite and further eluted with diethyl 
ether until the filtrate was colorless. After removal of the solvents and drying under vacuum 
overnight, crude acetal 57 was quantitatively isolated. 
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 C13H16FeO2     (260.11) 
1H-NMR (400 MHz, CDCl3)  δ = 3.29 (s, 6H), 4.13 (m, 2H), 4.15 (s, 5H), 4.3 (m, 2H), 5.41 
(s, 1H) 
13C-NMR (100 MHz, CDCl3)  δ = 52.5 (CH3), 67.5 (CH3), 68.2 (CH3), 69.2 (CH3), 85.5 (C), 
102.9 (CH) 
 
 
5.8.3 Synthesis of (2-ferrocenyl-1,3-dioxan-4-yl)methanol  
 
Fe
O
O
HO  
 
Butane-1,2,4-triol (2.5 g, 23.4 mmol) was introduced under argon in a 100 ml flask and dried by 
mixing with dry diethyl ether and removing the solvent under vacuum overnight. The triol was 
dissolved in 30 ml of dry dichloromethane, 15 g of activated 4A molecular sieves and a catalytic 
amount of camphorsulfonic acid (0.26 g, 1.1 mmol) were introduced. The crude ferrocene-acetal 57 
was dissolved in 10 ml of dry dichloromethane, added to the flask and stirred overnight at room 
temperature. The crude reaction mixture was directly filtered on Celite, eluted with dry 
dichloromethane and the solvent removed under vacuum. The obtained yellow triol acetal was 
placed in freezer for 3 days. The yellow crystals formed were washed with a minimum amount of 
cold toluene and filtered. Yield 75 %. 
 
C15H18FeO3     (302.15) 
1H-NMR (400 MHz, CDCl3)  δ 1.39 (m, 1H), 1.8 (m, 1H), 3.65 (m, 2H), 3.95 (m, 2H), 4.12 
(m, 2H), 4.20 (s, 5H), 4.22 (m, 1H), 4.4 (m, 2H), 5.41 (s, 1H) 
 
 
 
 
 
 
 
5.8.4 Synthesis of 2-ferrocenyl-4-(methoxymethyl)-1,3-dioxane 58 
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Fe
O
O
O  
 
Sodium hydride (20.0 mmol) was placed in a flask under inert atmosphere and 10 ml of dry 
tetrahydrofuran was added. The mixture was cooled at 0 °C and the triol-acetal (4 g, 13.2 mmol) in 
40 ml of dry tetrahydrofuran was added dropwise over one hour (caution. Hydrogen evolved). 
Iodomethane (1.3 ml, 20.0 mmol) was then added dropwise and the reaction mixture allowed to 
warm to room temperature overnight. The reaction mixture was cooled to 0 °C and methanol 
slowly added until bubbling ceased. Solvents were removed under vacuum and the crude brown oil 
was purified by flash chromatography on silica-gel (Hexane/diethyl ether 6/4) followed by 
crystalisation in freezer. Yellow crystals, 92 % yield. 
 
C16H20FeO3     (316.17) 
1H-NMR (400 MHz, CDCl3)   δ 1.47 (m, 1H), 1.8 (m, 2H), 3.45 (s, 3H), 3.55 (m, 2H), 3.9 
(m, 1H), 4.0 (m, 1H), 4.1-4.35 (m, 10H), 5.40 (s, 1H) 
13C-NMR (100 MHz, CDCl3)   δ 27.9 (CH2), 59.3, 66.5, 66.6, 67.7, 67.8, 68.7, 69.5, 75.5, 
75.9, 85.9, 100.0 
Rf (Hexane / diethyl ether 6/4) 0.5 
 
 
5.8.5  Synthesis of (2-(4-(methoxymethyl)-1,3-dioxan-2-yl)ferrocenyl)diphenylphosphine 59 
 
Fe O
O
PPh2
O
 
 
The triol-acetal 58 (2 g, 6.3 mmol) was placed under argon in a flask and dissolved in dry diethyl 
ether (30 ml). The solution was cooled to -78 °C and t-BuLi (1.1 equivalent) was added dropwise, 
giving a yellow precipitate. The cooling bath was removed and the reaction mixture stirred at room 
temperature for one hour, the solution turning to orange. The reaction mixture was cooled again at 
–30 °C and chlorodiphenylphosphine (1.2 eq., 1.4 ml) was added dropwise. The solution was 
allowed to warm to room temperature and further stirred for 3 hours before quenching with 
degassed water (1 ml), and the solvents were removed under vacuum. The crude reaction mixture 
was purified by flash chromatography on silica-gel (Hexane / diethyl ether 8/2). Yield 63 % 
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 C28H30FeO3P     (501.35) 
1H-NMR (400 MHz, CDCl3)  δ 1.35 (m, 1H), 1.75 (m, 1H), 2.91 (d, 2H), 3.1 (s, 3H), 3.5 
(m, 1H), 3.9 (m, 1H), 4.05 (s, 5H), 4.25 (m, 2H), 5.62 (d, 1H), 
7.1-7.6 (m, 10H) 
13C-NMR (100 MHz, CDCl3)  δ 23 (CH2), 59.8, 66.2, 66.4, 67.3, 68.7, 71.3, 76.5, 77.3, 
100.7, 128-137 
31P-NMR (162 MHz, CDCl3)  δ = -24.1 
Rf (Hexane / diethyl ether 8/2) 0.3 
 
 
5.8.6 Synthesis of 2-(diphenylphosphino)ferrocenecarbaldehyde 60 
 
Fe H
OPPh2
 
 
The phosphino acetal 59 (1 g, 2.0 mmol) was dissolved under argon in dry dichloromethane (25 
ml) and 7 ml of degassed water were added followed by p-toluenesulfonic acid monohydrate (0.6 
g, 3.0 mmol). The solution was stirred at room temperature for 12 h and extracted with diethyl 
ether. Solvents were removed under vacuum and the reaction product purified by flash 
chromatography on silica-gel (Hexane / diethyl ether 5/5). Yield 90 %. 
 
C23H20FeOP     (399.22) 
1H-NMR (400 MHz, CDCl3)  δ 4.07 (m, 1H), 4.21 (s, 5H), 4.69 (m, 1H), 5.1 (m, 1H), 7.1-
8.0 (m, 10H), 10.21 (d, 1H, J = 3.0Hz) 
13C-NMR (100 MHz, CDCl3)   δ 71.1, 74.2, 76.2, 80.3, 83.4, 128.3, 130.0, 132.2, 135.5, 
136.3, 193.3 
31P-NMR (162 MHz, CDCl3)             δ = -26.0 
 
 
 
 
 
5.8.7 Synthesis of (S, SFc) and (S, RFc)-2-((2-(diphenylphosphino)-
ferrocenyl)methyleneamino)-N-tert-butyl-3-methylbutanamide 62 
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Fe
N O
HN
PPh2 Fe
PPh2
N O
HN
 
(S, SFc)                                            (S, RFc) 
 
Synthesis following the general procedure (5.5.1.3) with tert-butylvaline-amide (0.43 g, 2.5 mmol) 
and racemic diphenylphosphino-ferrocenecarbaldehyde 60 (1 g, 2.5 mmol). A minimal amount of 
degassed dichloromethane was added to solubilise the diphenylphosphino-ferrocenaldehyde. The 
reaction mixture was left to stirr at room temperature for 24 hours.  The solution was stripped to 
dryness under vaccum to give an orange-red powder. The crude reaction mixture was directly 
purified by chromatography on silica-gel (SiO2) using degassed solvents (Hexane/Et2O 8/2). Single 
crystals of the (S, RFc)-diastereoisomer suitable for X-ray crystallography were obtained by 
recrystallisation from Et2O. Yield: 80 % 
 
Analytical Data of (S, SFc) 
C32H37FeN2OP    (552.47) 
1H-NMR (400 MHz, CDCl3)   δ 0.23 (d, 3H, J = 0.7Hz), 0.54 (d, 3H, ,J = 0.7Hz), 1.52 (s, 
9H), 1.95 (m, 1H), 3.35 (m, 1H), 3.74 (m, 1H), 4.16 (s, 5H), 
4.4 (m, 1H), 4.76 (m, 1H), 7.05-7.6 (m, 10H), 8.05 (s, 1H) 
31P-NMR (162 MHz, CDCl3)   δ = -21.3 
IR (KBr)  3311, 3069, 2960, 2869, 1669, 1513, 1452, 1433, 1360,1278, 
1224, 1106, 1025, 1001, 820, 742, 696, 619, 489, 457 
ESI-MS 613.4 (7), 614.5 (3), 615.3 (M+Cu, 100), 616.3 (37), 617.3 
(49), 618.3 (16), 619.3 (3) 
(α)D20                                                  -42.0 (c = 0.4, CHCl3) 
Rf   0.31 (hexane/Et2O 8/2) 
 
 
Analytical Data of (S, RFc) 
C32H37FeN2OP    (552.47) 
1H-NMR (400 MHz, CDCl3)  δ 0.80 (d, 3H, J = 0.7Hz), 0.90 (d, 3H, ,J = 0.7Hz), 1.19 (s, 
9H), 2.1 (m, 1H), 3.34 (d, 1H, J = 0.51Hz), 3.87 (m, 1H), 4.11 
(s, 5H), 4.48 (m, 1H), 4.94 (m, 1H), 7.1-7.55 (m, 10H), 8.18 
(s, 1H) 
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31P-NMR (162 MHz, CDCl3)  δ = -24.4 
IR (KBr)  3361, 3080, 2959, 2924, 2845, 1667, 1636, 1516, 1453, 1433, 
1364, 1318, 1280, 1280, 1224, 1106, 1002, 829, 746, 698, 
604, 589, 496, 483, 443 
(α)D20                                                  -84.8 (c = 0.65, CHCl3) 
Rf   0.40 (hexane/Et2O 8/2) 
 
 
5.9       Synthesis of Diethylpropylvaline-amide Ferrocenyl Ligand 
 
5.9.1       Synthesis of (S)-2-amino-N-(3-ethylpentan-3-yl)-3-methylbutanamide 
 
H2N
H
N
O  
 
Synthesis following the general procedure (5.4.1, 5.4.2) with Boc-valine (1 g, 4.6 mmol) and 1,1-
diethyl-propylamine (4.6 mmol). Yield 89%. 
 
C12H26N2O     (214.35) 
1H-NMR (400 MHz, CDCl3)  δ 0.70 (t, 9H, J =  0.76Hz), 0.75 (d, 3H, J =  0.68 Hz), 0.91 (d, 
3H, J =  0.68 Hz), 1.63 (m, 6H), 2.23 (m, 1H), 3.05 (d, 1H, J =  
0.40 Hz), 6.87 (s, 1H) 
 
 
5.9.2 Synthesis of (S, SFc)-2-((2-(diphenylphosphino)-ferrocenyl)methyleneamino)-N-(3-
ethylpentan-3-yl)-3-methylbutanamide 63 
 
Fe
N O
HN
PPh2
 
 
Synthesis following the general procedure (5.8.7) with diethylpropylvaline-amide (0.54 g, 2.5 
mmol) and racemic diphenylphosphino-ferrocenecarbaldehyde (1 g, 2.5 mmol). A minimal amount 
of degassed dichloromethane was added to solubilise the diphenylphosphino-ferrocenaldehyde. 
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The reaction mixture was left to stirr at room temperature for 24 hours.  The solution was stripped 
to dryness under vaccum to give an orange-red powder. The crude reaction mixture was directly 
purified by chromatography on silica-gel (SiO2) using degassed solvents (Hexane/Et2O 7/3). Yield 
30% 
 
C35H43FeN2OP    (594.55) 
1H-NMR (400 MHz, CDCl3)   δ 0.2 (d, 3H, J = 0.68Hz), 0.55 (d, 3H, J = 0.68Hz), 0.86 (t, 
9H,  d, 3H, J = 0.76Hz), 1.87 (m, 6H), 2.0 (m, 1H), 3.35 (m, 
1H), 3.7 (s, 1H), 4.15 (s, 5H), 4.41 (m, 1H), 4.76 (m, 1H), 
6.94-7.5 (m, 10H), 8.03 (s, 1H) 
13C-NMR (100 MHz, CDCl3)   δ 8.7, 18.5, 21.1, 28.7, 33.5, 61.0, 71.8, 72.0, 72.5, 75.0, 75.9, 
128-137, 185 
31P-NMR (162 MHz, CDCl3)  δ = -22.3 
(α)D20                                                  -39.0 (c = 0.5, CHCl3) 
Rf     0.5 (hexane /Et2O 7/3) 
 
 
5.10 Synthesis of Synthesis of (S,SFc) and (S,RFc)-2-((2-(diphenylphosphino)-
ferrocenyl)methyleneamino)-N-tert-butyl-2-cyclohexylacetamide 64 
 
Fe
N O
HN
PPh2
Fe
PPh2
N O
HN
 
      (S, SFc)                                      (S, RFc) 
 
Synthesis following the general procedure (5.8.7) with tert-butylcyclohexylglycine-amide (0.53 g, 
2.5 mmol) and racemic diphenylphosphino-ferrocenecarbaldehyde (1 g, 2.5 mmol). Yield 60% 
 
Analytical Data for (S, SFc) 
C35H41FeN2OP    (592.53) 
1H-NMR (400 MHz, CDCl3)  δ 0.5-1.80 (m, 6H), 1.53 (s, 9H), 3.35 (m, 1H), 3.7 (m, 1H), 
4.16 (s, 5H), 4.39 (t, 1H, J = 0.33Hz), 4.73 (m, 1H), 7.1-7.5 
(m, 10H), 8.0 (s, 1H ) 
31P-NMR (162 MHz, CDCl3)   δ = -21.4 
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(α)D20                                                  -45.0 (c = 0.5, CHCl3) 
Rf     0.33 (hexane/Et2O  8/2) 
 
 
Analytical Data for (S, RFc) 
C35H41FeN2OP    (592.53) 
1H-NMR (400 MHz, CDCl3)   δ 1.0-1.55 (m, 5H), 1.21 (s, 9H), 1.85 (m, 1H), 3.35 (d, 1H, J 
= 0.43Hz), 3.85 (m, 1H), 4.11 (s, 5H), 4.48 (t, 1H, J = 0.3Hz), 
4.93 (m, 1H), 6.28 (s, 1H), 7.1-7.55 (m, 10H), 8.15 (d, 1H, J = 
0.2Hz ) 
31P-NMR (162 MHz, CDCl3)  δ = -24.5 
(α)D20                                                  -90.0 (c = 0.6, CHCl3) 
Rf 0.41 (hexane/Et2O  8/2) 
 
 
5.11    Synthesis of Ferroceme-amide Ligands 
 
5.11.1  Synthesis of ferrocenecarboxylic acid 67 
 
Fe
COOH
 
 
In an argon-flushed two-neck flask was introduced ferrocene (10 g, 53.75 mmol) and dried under 
high vacuum for 12 h. Dry Potassium tert-butoxide (0.75 g, 6.7 mmol) was added under argon and 
the mixture was dissolved in 300 ml of dry tetrahydrofuran and cooled at -78°C in a dry ice/acetone 
bath. Over a period of 15 min, t-BuLi (0.1 mol) was added dropwise and the mixture stirred at that 
temperature for 2h. 5g of dry-ice were introduced in a flask and CO2 transferred to the reaction 
mixture by canula (caution: pressure must be released).The cooling bath was removed and the 
solution allowed to warm to -30 °C while CO2 was kept bubling. The colour turned deep red. At 
this point the solution was hydrolysed with water (20 ml) and the acid extracted with 
dichloromethane (3 x 100 ml). Extracts were combined and the solvent removed under vacuum. 
Products were separated by flash chromatography on silica-gel using first hexane (first fraction: 
unreacted ferrocene) then hexane/ethyl acetate (second fraction: ferrocenecarboxylic acid). Yield 
65 %. 
 
C11H10FeO2     (230.04) 
 
140 
1H-NMR (400 MHz, CDCl3)   δ 4.26 (s, 5H), 4.48 (s, 2H), 4.88 (s, 2H) 
13C-NMR (100 MHz, CDCl3)   δ 63.5, 70.5, 71, 72.3, 112 
Rf      0.45 (hexane/EtOAc 7/3) 
 
 
5.11.2  Synthesis of N-((S)-1-(tert-butylcarbamoyl)-2-methylpropyl)ferrocenecarboxamide 68 
 
Fe
N O
HNO
H
 
 
Synthesis following the general procedure (5.4.1) with ferrocenecarboxylic acid 67 (2 g, 8.7 mmol) 
and tert-butylvaline-amide (1.5g, 8.7 mmol) in dichloromethane for 12 hours. The crude reaction 
mixture was filtered over celite eluting with dichloromethane. Solvents were removed under 
vacuum and the filtrate purified by silica-gel chromatography eluting with EtOAc/Hexane 7/3. 
Yield 94 %. 
 
C20H28FeN2O2   (384.29) 
1H-NMR (400 MHz, CDCl3) : δ 1.0 (t, 6H, J = 0.43Hz), 1.37 (s, 9H), 2.1 (m, 1H), 4.2 (s, 
6H), 4.38 (s, 2H), 4.72 (s, 2H), 5.89 (s, 1H), 6.45 (s, 1H) 
13C-NMR (100 MHz, CDCl3)  δ 19.1, 20.1, 29.2, 32.2, 63.2, 69.2, 70.5, 71.2, 169, 172 
IR (KBr)    3309, 3086, 2966, 2873, 1629, 1540, 1457, 1389, 1363, 1308, 
1267, 1226, 1106, 1022, 1002, 920, 817, 771, 702, 638, 569, 
484 
 
 
 
 
 
 
 
5.11.3 Synthesis of N-((S,SFc)-1-(tert-butylcarbamoyl)-2-methylpropyl)-2- 
(diphenylphosphino)ferrocenecarboxamide 69 
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Fe
N O
HNO
H
PPh2
 
 
To a suspension of ferrocenecarboxamide 68 (0.5 g, 1.3 mmol) in 50 ml of dry tertrahydrofuran at -
78 °C was added dropwise under argon three equivalents of a 1.3M solution of sec-BuLi. The 
reaction mixture was left to stirr at -78 °C for two hours, the colour turning to deep red before 
addition of chlorodiphenylphosphine (0.83 ml, 4.5 mmol). The reaction mixture became yellow 
and was allowed to warm to room temperature over one hour. Solvents were evaporated and the 
residu stripped to dryness under high vacuum, redissolved in 5ml of dry diethyl ether, filtered and 
immediately purified by column chromatography on silica-gel eluting with hexane/EtOAc (5/5). 
Yield 70% 
 
C32H37FeN2O2P    (568.47) 
1H-NMR (400 MHz, CDCl3)  δ 0.65 (d, 3H, J = 0.75Hz), 0.77 (d, 3H, J = 0.75Hz), 1.4 (s, 
9H), 2.05 (m, 1H), 3.76 (m, 1H), 4.14 (m, 1H), 4.17 (s, 5H), 
4.45(t, 1H, J =  0.25Hz), 5.15 (m, 1H), 5.9 (m, 1H), 7.1-7.7 
(m, 10H) 
13C-NMR (100 MHz, CDCl3)  δ 19.0, 20.0, 23.3, 29.2, 31.2, 52.3, 60.2,63.3, 70.9, 71.2, 75.0, 
129-139, 170, 172 
31P-NMR (162 MHz, CDCl3)  δ = -23.69 
ESI-MS (MeOH)  629.4 (2), 631.3 (M+Cu, 100), 632.3 (27), 633.3 (44), 634.2 
(14), 635.2 (2), 1197.3 (5), 1198.1 (2), 1199.1 (2M+Cu, 44), 
1200.1 (34), 1201.1 (32), 1202.1 (17), 1203.1 (4) 
Rf 0.5 (hexane/EtOAc 5/5) 
 
 
 
 
 
 
5.11.4  Synthesis of N-((S,SFc)-1-(tert-butylcarbamoyl)-2-methylpropyl)-2- 
(trimethylsilyl)ferrocenecarboxamide 71 
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Fe
N O
HNO
H
Si
 
 
Synthesis following the procedure described in 5.11.3 with ferrocenecarboxamide 68 (0.5g, 1.3 
mmol) and chlorotrimethylsilane (4.5 mmol). Yield 10%. 
 
C23H36FeN2O2Si    (456.47) 
1H-NMR (400 MHz, CDCl3)  δ 0.31 (s, 9H), 1.04 (m, 6H) 1.34 (s, 9H), 2.15 (m, 1H), 4.14 
(m, 1H), 4.22 (s, 5H), 4.32 (m, 1H), 4.45(m, 1H), 4.74 (m, 
1H) 
13C-NMR (100 MHz, CDCl3)  0.5 (CH3), 19, 20, 29.3, 30.4, 53, 54, 70.5, 170 
ESI-MS (MeOH)      456.3 (12), 457.4 (100), 458.3 (32), 459.2 (10) 
 
 
5.12 Axially Chiral Ligands 
 
5.12.1 Synthesis of 1-1’-dibromoferrocene 75 
 
Fe
Br
Br 
 
In a argon-flushed flask was introduced ferrocene (10 g, 53.75 mmol) and dried under high vacuum 
for 12 h. The mixture was dissolved in 300 ml of dry tetrahydrofuran and cooled at -78 °C in a dry 
ice/acetone bath. Over a period of 15 min, n-BuLi (0.1 mol) was added dropwise and the mixture 
stirred at that temperature for 2h before dropwise addition over 12h of a solution of 
tetrabromoethane (0.12 mol) in 10 ml of dry terahydrofuran. The cooling bath was removed and the 
solution allowed warming to -30 °C. At this point the solution was hydrolysed with water (20 ml), 
which turned the mixture deep red. Solvents were removed under vacuum and the aldehyde 
extracted with dichloromethane (3 x 100 ml). Extracts were combined and the solvent removed 
under vacuum. Products were separated by flash chromatography on silica-gel using first hexane 
(first fraction: unreacted ferrocene) then dichloromethane (second fraction: dibromoferrocene). 
Yield 90 %. 
 
C10H8Br2Fe                  (343.82) 
 
143
1H-NMR (400 MHz, CDCl3)  δ 4.17 (s, 4H), 4.42 (s, 4H) 
MS  344 (100), 263 (3.5), 199 (2), 182 (2), 157 (2), 128 (91), 102 
(13.5), 78 (4.5), 56 (22) 
 
5.12.2 Synthesis of 2(bromo(1’-bromo)ferrocenyl)trimethylsilane 76 
 
Fe
Br
Br
Si
 
 
To a suspension of dibromoferrocene 75 (3g, 8.7 mmol) in 70 ml of dry tertrahydrofuran at -78° C 
was added dropwise under argon a solution of LDA prepared by addition of 5.6ml of a 2M solution 
of n-BuLi on a solution of 1.6 ml (11.3 mmol) of diisopropylamine in 10 ml of THF at -78 °C. The 
reaction mixture was left to stirr at -78 °C for two hours, the colour turning to deep red before 
addition of chlorotrimethylsilane (8.7 mmol). The reaction mixture became yellow and was 
allowed to warm to room temperature over one hour. The reaction was quenched with 10 ml of 
water, extracted with diethyl ether (3x 80 ml), the solvents evaporated and the residu purified by 
column chromatography on silica-gel eluting with hexane. Yield 70% 
 
C13H16Br2FeSi    (416.0) 
1H-NMR (400 MHz, CDCl3)  δ 0.34 (s, 9H), 4.02 (d, 1H, J = 0.1Hz), 4.07 (m, 1H), 4.16 (m, 
1H), 4.3 (t, 1H, J = 0.23Hz), 4.41 (m, 1H), 4.47 (m, 1H), 4.57 
(m, 1H) 
13C-NMR (100 MHz, CDCl3)  δ  0.2, 70.7, 70.8, 71.7, 72.9, 73.4, 74.1, 76.2, 78.8, 84.7 
Rf                                                       0.6 (hexane) 
 
 
 
 
 
 
 
5.12.3 2-(bromo(1’-diphenylphosphine)ferrocenyl)trimethylsilane 77 
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Fe
Br
PPh2
Si
 
 
To a solution of 76 (1.5g, 3.6 mmol) in 150 ml of dry tetrahydrofuran under argon at -78° C was 
added dropwise 2.25 ml (3.65 mmol) of a 1.6M solution of n-BuLi in hexane. After 20 min, 0.69 
ml of chlorodiphenylphosphine (3.7 mmol) were slowly added at -78° C over a period of 30 min. 
The resulting mixture was stirred for an additional 3h at -78°C, then slowly allowed to warm up to 
room temperature and stirred overnight under argon. The orange suspension was quenched with 10 
ml of water, extracted with diethyl ether (3x 100 ml) and the solvents evaporated before 
purification by column chromatography on silica-gel using hexane/EtOac as eluent. Yield 80% 
 
C25H26BrFePSi    (521.28) 
1H-NMR (400 MHz, CDCl3)   δ 0.28 (s, 9H), 3.94 (m, 1H), 4.14 (m, 1H), 4.18 (m, 1H), 4.3 
(m, 1H), 4.39 (m, 1H), 4.42 (m, 1H), 4.44 (m, 1H), 7.3-7.45 
(m, 10H) 
13C-NMR (100 MHz, CDCl3)  δ 0.1, 73.4, 75.1, 75.5, 75.6, 77.1, 128-134 
31P-NMR (162 MHz, CDCl3)   δ = -19.4 
Rf     0.4 (hexane/EtOAc 7/3) 
 
 
5.12.4 Synthesis of 2-(carbaldehyde(1’-diphenylphosphine)ferrocenyl)trimethylsilane 78 
 
Fe
PPh2
Si
O
H7
1
2
3
4
5
6
8
9
10
11 12
 
 
To a solution of 77 (1.0g, 1.9 mmol) in 70 ml of dry tetrahydrofuran under argon at -20° C was 
added dropwise 1.25 ml (2.0 mmol) of a 1.6M solution of n-BuLi in hexane. After one hour, 0.63 
ml of DMF (7.7 mmol) were slowly added at -20° C and the resulting mixture was stirred for an 
additional hour at -20°C, then slowly allowed to warm up to room temperature. The orange 
suspension was quenched with 5 ml of water, extracted with diethyl ether (3x 80 ml) and the 
solvents evaporated before purification by column chromatography on silica-gel using 
hexane/EtOAc as eluent. Yield 70%. The enantiomers were separated by semipreparative HPLC. 
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After separation, single crystals suitable for X-ray crystallography were obtained by 
recrystallisation from hexane/isopropanol. 
 
C26H27FeOPSi    (470.4) 
1H-NMR (400 MHz, CDCl3)  δ 0.25 (s, 9H, H1), 4.21 (s, 1H, 12), 4.23 (s, 1H, H9), 4.43 (s, 
1H, H6), 4.48 (s, 1H, H10), 4.52 (s, 1H, H11), 4.56 (s, 1H, 
H5), 4.82 (s, 1H, H4), 7.3-7.4 (m, 10H, Ar), 9.8 (s, 1H, H7) 
13C-NMR (100 MHz, CDCl3)  δ 0.3 (C1), 72.4 (C11), 72.7 (C10), 73.8 (C12), 74.7 (C9), 75.3 
(C2), 75.5 (C6), 76.4 (C5), 77.3 (C8), 81.2 (C4), 83.9 (C3), 
129-132 (C Ar), 194.3 (C7) 
31P-NMR (162 MHz, CDCl3)   δ = -20.47 
ESI-MS   (MeOH)     531.3 (7), 533.3 (100, M+Cu), 534.3 (35.2), 535.3 (55.3), 
536.3 (17.5), 493.4 (81.6, M+Na), 494.4 (27.7) 
Rf     0.4 (Hexane/EtOAc 9/1) 
HPLC    Daicel, Chiracel OD-H (250 mm x 4.6 mm), 
hexan/isopropanol 99/1, 0.9 mL/min; T = 20° C, Rt (SFc) = 
15.2 min , (RFc) = 16.3 min 
(α)D20                                                  SFc : +72.0 (c = 0.36, CHCl3) 
 
 
5.12.5 Synthesis of (S,SFc)-N-tert-butyl-3-methyl-2-((2-trimethylsilanyl-(1’-
diphenylphosphine)ferrocenylmethyleme)-amino)-butyramide 79 
 
Fe
N O
HN
SiMe3
PPh2  
 
Synthesis following the general procedure (5.8.7) with tert-butylvaline-amide (36 mg, 0.21 mmol) 
and (SFc)-2-(carbaldehyde(1’-diphenylphosphine)ferrocenyl)trimethylsilane 78 (0.1 g, 0.21 mmol). 
The reaction mixture was left to stirr at room temperature for 24 hours. The solution was stripped 
to dryness under vaccum to give an orange-red powder. The crude reaction mixture was directly 
purified by chromatography on silica-gel (SiO2) using degassed solvents (Hexane/Et2O 8/2). Yield 
90% 
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C35H45FeN2OPSi    (624.65) 
1H-NMR (400 MHz, CDCl3)  δ 0.26 (s, 9H), 1.05 (m, 6H), 1.39 (s, 9H), 2.5 (m, 1H), 3.85 
(m, 1H), 4.21 (s, 1H), 4.39 (s,1H), 4.42 (s, 1H), 4.45 (s, 1H), 
4.77 (m, 2H), 4.98 (s, 1H), 6.18 (s, 1H), 7.2-7.7 (m, 10H), 
8.59 (d, 1H, J = 1.46Hz) 
31P-NMR (162 MHz, CDCl3)  δ = -22.7 
ESI-MS  (MeOH)   685.4 (7), 686.5 (3), 687.5 (100), 688.4 (52), 689.4 (24) 
 
 
 
 
5.12.6 Synthesis of (S,RFc)-N-tert-butyl-3-methyl-2-((2-trimethylsilanyl-(1’-
diphenylphosphine)ferrocenylmethyleme)-amino)-butyramide 79 
 
Fe
N O
HN
PPh2
Me3Si
 
 
Synthesis following the procedure described in 5.12.5, with tert-butylvaline-amide (36 mg, 0.21 
mmol) and (RFc)-2-(carbaldehyde(1’-diphenylphosphine)ferrocenyl)trimethylsilane 78 (0.1 g, 0.21 
mmol). Yield 90% 
 
C35H45FeN2OPSi    (624.65) 
1H-NMR (400 MHz, CDCl3)  δ 0.25 (s, 9H), 0.88 (m, 6H), 1.40 (s, 9H), 2.6 (m, 1H), 3.6 (m, 
1H), 4.20 (s, 1H), 4.4 (s,1H), 4.41 (s, 1H), 4.47 (s, 1H), 4.78 
(m, 2H), 5.1 (s, 1H), 6.41 (s, 1H), 7.2-7.7 (m, 10H), 8.4 (d, 
1H, J = 1.38Hz) 
31P-NMR (162 MHz, CDCl3)  δ = -22.0 
 
 
 
 
 
5.12.7 Synthesis of bromo(1’-diphenylphosphino)ferrocene 
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 Fe
Br
PPh2 
 
Synthesis following the procedure decribed in 5.12.3 (1.0g, 2.9 mmol). The orange suspension was 
quenched with 10 ml of water, extracted with diethyl ether (3x 100 ml) and stored at -30 °Cduring 
24h for crystallisation. Yield 70% 
 
C22H18BrFeP     (449.1) 
1H-NMR (400 MHz, CDCl3)  δ 4.03 (m, 1H), 4.1 (s, 1H), 4.19 (m, 3H), 4.33 (m, 1H), 4.4 
(m, 2H), 7.4-7.55 (m, 10H) 
13C-NMR (100 MHz, CDCl3)  68, 69, 70, 72, 75, 78, 79, 128-135 
31P-NMR (162 MHz, CDCl3)  δ = -19.1 
MS  448 (100),  369 (94), 365 (2), 313 (20), 291 (8), 263 (4), 233 
(7), 183 (27), 141 (5), 115 (11), 77 (4), 56 (14) 
 
 
5.12.8 Synthesis of carbaldehyde(1’-diphenylphosphino)ferrocene 
 
Fe
PPh2
O
H
 
 
Synthesis following the procedure decribed in 5.12.4 (0.5g, 1.1 mmol). 
The orange suspension was quenched with 5 ml of water, extracted with diethyl ether (3x 80 ml)  
and the solvents evaporated before purification by column chromatography on silica-gel using 
hexane/EtOAc (8/2) as eluent. Yield 80% . 
 
C23H19BrFeOP     (398.22) 
1H-NMR (400 MHz, CDCl3)   δ 4.20 (s, 2H), 4.49 (s, 4H), 4.68 (s, 2H), 7.3-7.45 (m, 
10H), 9.66 (s, 1H) 
13C-NMR (100 MHz, CDCl3)   70.9, 72.8, 74.8, 128-134, 193.8 
31P-NMR (162 MHz, CDCl3)   δ = -20.9 
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5.12.9 Synthesis of (S)-N-tert-butyl-2-((1’-diphenylphosphine)ferrocenylmethylene-amino)-3-
methyl-butyramide 81 
 
Fe
N O
HN
PPh2  
 
Synthesis following the procedure described in 5.12.5, with tert-butylvaline-amide (0.22 g, 1.25 
mmol) and carbaldehyde(1’-diphenylphosphino)ferrocene (0.5 g, 1.25 mmol). 
 
C32H37FeN2OP    (552.47) 
1H-NMR (400 MHz, CDCl3)  δ 0.77 (d, 6H, J = 0.55Hz), 1.26 (s, 9H), 2.05 (m, 1H), 3.15 (d, 
1H, J = 0.55Hz), 4.06 (d, 2H, J = 0.88Hz), 4.27 (t, 2H, J = 
0.2Hz), 4.44 (m, 2H),4.54 (m, 1H), 4.63 (m, 1H), 6.7 (s, 1H),  
7.3-7.45 (m, 10H), 7.77 (s, 1H) 
31P-NMR (162 MHz, CDCl3)  δ = -22.4 
ESI-MS (MeOH)      614.3 (14), 615.4 (100), 616.3 (58), 617.4 (10) 
 
 
5.13. Copper-catalysed 1,4-Addition of Diethylzinc to Enones 
 
5.13.1     1,4 addition to cyclopentenone, Synthesis of 3-ethyl-cyclopentanone 
 
O
 
 
General procedure 5.13.1.1 for catalysis with Non-ferrocene ligands. 
The adamantylvaline-amide ligand 39 copper-complex described in paragraph 5.5.5.4 (15 mg, 0.02 
mmol, 5 mol%) was placed under argon in an ampoule equipped with a magnetic stirring bar and a 
Young® valve, dissolved with 3 ml of degassed toluene. The ampoule was sealed under argon and 
the mixture stirred at room temperature for 30 min. To this green solution were added dropwise 
under argon stream two equivalents of 1.0M diethyl zinc solution (0.8 mmol, 0.8 ml), turning the 
colour to yellow, followed by one equivalent of cyclopentenone (0.4 mmol). The reaction mixture 
was stirred at room temperature for 12 h before quenching with 0.5 ml of saturated NH4Cl solution 
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and extraction with 5 ml of diethyl ether.  The organic layer was filtrated and submitted to G.C. and 
G.C-M.S analysis. The solvents were evaporated and the reaction mixture purified by column 
chromatography on silica-gel (pentan/diethyl ether 8/2) 
 
General procedure 5.13.1.2 for catalysis with Ferrocene ligands 
The ferrocenyl ligand (S, RFc)-62 (10 mg, 0.018 mmol, 5 mol%) was introduced under argon (glove 
box) in an ampoule equipped with a magnetic stirring bar and a Young® valve together with  3.8 mg 
(0.018 mmol) of CuI(OTf), and dissolved with 3ml of degassed toluene. The reaction mixture was 
stirred at room temperature for 30 min. and two equivalents of diethyl zinc (0.72 mmol, 0.72 ml, 
1M solution) were added dropwise, turning the colour to yellow. One equivalent of cyclopentenone 
(0.36 mmol) was added, and the reaction mixture stirred at room temperature for 12 hours. 
Treatement and analysis following the procedure 5.13.1.1. 
 
 
Analytical Data of : C7H12O  (112.17) 
1H-NMR (400 MHz, CDCl3) δ 0.91 (t, 3H,  J = 7.2 Hz), 1.4-3.45 (m, 9H) 
13C-NMR (100 MHz, CDCl3) δ  12.0, 28.3, 29.0, 38.0, 38.6 (CH), 44.5, 219.5 (C) 
MS  112 (43),  97 (3),  94 (0.5), 83 (100), 79 (3), 70 (16), 55 (67),  
51 (3), 41 (31) 
GC tR = 10.1 min (Restek Rtx1701, 30 m x 0.25 mm x 0.25 μm, 60 
kPa He or H2, Temp: 60 °C, 1°/min, 80 °C, 30°/min, 250 °C) 
tR = 11.7 min (+, R), 12.1 min (-, S), (Ivadex 7, 60 kPa He, 
Temp : 60 °C, 3°/min, 120 °C, 10°/min, 160 °C) 
 
 
5.13.2 1,4-addition to cyclohexenone, Synthesis of 3-ethyl-cyclohexanone 
 
O
 
 
Catalysis following the procedure described in 5.13.1.1 or 5.13.1.2. 
 
Analytical Data of : C8H14O   (126.20) 
1H-NMR (400 MHz, CDCl3) δ 0.92 (t, 3H, J = 7.4 Hz), 1.0-2.45 (m, 11H) 
13C-NMR (75 MHz, CDCl3) δ  11.0, 25.5, 29.4, 31.0, 40.6 (CH), 41.5, 48.0, 212.0 (C) 
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MS  126 (25), 111 (3), 108 (1), 97 (53), 83 (78), 70 (27), 55 (100), 
41 (93) 
GC tR = 18.1 min (Restek Rtx1701, 30 m x 0.25 mm x 0.25 μm, 60 
kPa He or H2, Temp: 60 °C, 1°/min, 80 °C, 30 °C /min, 250 
°C) 
tR = 10.5 min (R), 10.8 min (S), (Lipodex A, 60 kPa He, Temp : 
60 °C, 0.8°C/min, 70 °C, 30°C/min, 180 °C) 
 
5.14   Muscone Synthesis 
 
5.14.1   Synthesis of (E)-2-Methyl-cyclopentadec-2-enone 115 
 
O
 
 
To a solution of enyne 109 (0.4 g, 1.83 mmol) in 10 ml of dichloromethane at room temperature 
was added 475 µl of acetic acid (8 mmol). The reaction was left to stirr for 45 min. and 0.78 ml of 
trifluoromethane sulfonic acid (9 mmol) were added dropwise. The reaction was left at room 
temperature for 12h and neutralised by dropwise addition at 0° C of 15 ml of saturated Na2CO3. 
The reaction mixture was extracted with dichloromethane (2x 50 ml) and the solvents evaporated 
before purification by column chromatography on silica-gel using hexane/EtOAc (9.5/0.5) as 
eluent. Yield 75%. 
 
C16H28O     (236.39) 
1H-NMR (400 MHz, CDCl3)  δ 1.1-1.5 (m, 20H), 1.78 (s, 3H), 2.21 (m, 2H), 2.61 (t, 2H, J = 
0.88 Hz), 6.61 (td, 1H, J = 0.7, 0.14 Hz) 
13C-NMR (100 MHz, CDCl3)  δ  11.7 (CH3), 23.0, 25.5, 28.7, 29.4, 29.5, 29.8, 31.9, 32.1, 
37.6 (12x CH2), 137.5 (C), 142.8 (CH), 202.8 (C) 
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5.14.2      Synthesis of 2-Methylenecyclopentadecanone 116 
 
O
 
 
To a solution of enyne 109 (0.4 g, 1.83 mmol) in 10 ml of dichloromethane at room temperature 
were added 80 μl of nitric acid (8 mmol), folowed by 50 mg of  HgSO4 and 3 ml of water. The 
reaction was stirred at 40° C for 3 hours, at room temperature for 12 hours and neutralised by 
dropwise addition at 0° C of 15 ml of saturated Na2CO3. The reaction mixture was extracted with 
diethyl ether (2x 50 ml)  and the solvents evaporated before purification by column 
chromatography on silica-gel using hexane/EtOAc (9.5/0.5) as eluent. Yield 60%. 
 
C16H28O     (236.39) 
1H-NMR (400 MHz, CDCl3)  δ 1.2-1.31 (m, 16H), 1.5-1.7 (m, 4H), 2.6 (t, 2H), 5.15 (d, 2H, 
J = 8 Hz) 
13C-NMR (100 MHz, CDCl3)  δ  22.8, 25.2, 28.9, 29.0, 29.3, 29.8, 31.3, 39.8, 124.6 (CH2), 
145.0 (C), 202.6 (C) 
 
 
5.14.3 Synthesis of 1-Oxa-spiro[2.14]heptadec-4-yne 117 
 
O
 
 
To a solution of enyne 109 (0.15 g, 0.69 mmol) in 15 ml of dichloromethane at 0 °C were added 
200 mg of mCPBA (1.16 mmol) and 500 mg of NaHCO3 (5.9 mmol).The reaction mixture was 
allowed to warm to room temperature and stirred for 12 h. The reaction mixture was extracted with 
diethyl ether (2x 50 ml) and the solvents evaporated before purification by column chromatography 
on silica-gel using hexane/EtOAc (9.5/0.5) as eluent. Yield 70%  
 
C16H26O     (234.38) 
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1H-NMR (400 MHz, CDCl3)  δ 1.2-1.6 (m, H), 2.16 (t, 2H, J = 0.64Hz), 2.68 (d, 1H, J = 
0.53Hz), 2.90 (d, 1H, J = 0.53Hz) 
13C-NMR (100 MHz, CDCl3)  δ  22.9, 24.5, 25.9, 28.8, 29.0, 29.3, 31.6, 31.9, 32.1, 37.1, 
45.9, 51.5 (C), 55.1 (CH2), 78.9 (C), 84.3 (C) 
 
 
5.14.4 Synthesis of 1-Methyl-cyclopentadec-2-ynol 114 
 
OH
 
 
The 1-Oxa-spiro[2.14]heptadec-4-yne 117 (0.2 g, 0.85 mmol) was dissolved in 10 ml of dry THF 
and the reaction mixture cooled to 0° C before addition of LiBH(Et)3 (100 µl, 0.85 mmol). The 
reaction was further stirred 15 min. at 0°c before quenching with 5 ml of water and extraction with 
diethyl ether. Solvents were removed under vacuum and the residu purified by column 
chromatography on silica-gel using hexane/EtOAc as eluent.Yield 70% 
 
C16H28O     (236.39) 
1H-NMR (400 MHz, CDCl3)  δ 1.2-1.4 (m, 18H), 1.42 (s, 3H), 1.43-1.62 (m, 4H), 2.0 (1H, 
OH), 2.16 (t, 2H, J = 0.71 Hz) 
13C-NMR (100 MHz, CDCl3)  δ  22.9, 25.1, 28.8, 29.0, 29.8, 30.5 (CH3) , 31.7, 32.1, 38.4, 
44.4, 68.7 (C), 84.0 (C), 85.8 (C) 
Rf     0.6 (hexane/EtOAc 8/2) 
 
 
5.14.5 Synthesis of (E)-3-Methyl-cyclopentadec-2-enone 112 
 
O
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5.14.5.1   Synthesis by isomerisation 
 
To a solution of carbinol 114 (35 mg, 0.15 mmol) in 15 ml of dichloromethane at room temperature 
were added 9 mg of MoO2(acac)2 (0.027 mmol).The reaction mixture was further stirred for 6 
hours then refluxed for 12 hours. 5 ml of water were added and the reaction mixture extracted with 
diethyl ether (2x 50 ml). The solvent was evaporated before purification by column 
chromatography on silica-gel using hexane/EtOAc (8/2) as eluent. Yield 30%. 
 
 
5.14.5.2    Synthesis by oxidative-hydroboration 
 
The enyne 109 (0.5 g, 2.3 mmol) was dissolved in 40 ml of dry dichloromethane and 3.45 ml of a 
1M solution of Br2BH.SMe2 (3.45 mmol) was added dropwise. The reaction mixture was strirred at 
room temperature for 12 hours before addition of 2 ml of a 30% H2O2 solution and 15 ml of a 1 M 
solution of NaOH. The reaction mixture was refluxed for one hour before filtration on celite and 
extraction with diethyl ether (3x 50 ml). The solvent was evaporated before purification by column 
chromatography on silica-gel using hexane/Et2O (100/1) as eluent. Yield 30%. 
 
C16H28O     (236.39) 
1H-NMR (400 MHz, CDCl3)  δ = 1.1-1.4 (m, 18H), 2.11 (s, 3H), 2.31 (m, 2H), 2.62 (t, 2H, J 
= 0.75 Hz), 6.2 (s, 1H) 
13C-NMR (100 MHz, CDCl3)  δ = 19.1 (CH3), 25.8, 26.0, 26.9, 27.1, 27.2, 27.5, 40.4, 44.8 
(12x CH2), 124.1 (CH), 158.9 (C), 202.7 (C) 
Rf     0.8 (hexane/EtOAc 8/2) 
 
 
5.14.6 Synthesis of 2-Methyl-cyclopentadec-1-en-3-yne 118 
 
 
 
The enyne product was obtained as a side product under the reaction conditions described in 
5.14.5. Yield 30% 
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C16H26      (218.38) 
1H-NMR (400 MHz, CDCl3)  δ = 1.15-1.70 (m, 20H), 1.8 (s, 3H), 2.15 (m, 2H), 2.36 (t, J = 
5.3, 2H), 5.55 (t, J = 0.55 Hz, 1H) 
13C-NMR ( MHz, CDCl3)  δ = 19.25, 24,5 (CH3), 26.8, 26.9, 27.1, 27.3, 27.4, 27.8, 30.5, 
80.58 (C), 93.8 (C), 118.7 (C), 136.9 (CH) 
Rf 0.9 (hexane/EtOAc 8/2) 
 
 
 
 
 
 
 
5.14.7 Synthesis of (Z)-3-Methyl-cyclopentadec-2-enone 112 
 
O
 
 
The enone product 112 was obtained as a side product under the reaction conditions described in 
5.14.5.2 (yield 6%). 
 
C16H28O     (236.39) 
1H-NMR (400 MHz, CDCl3)  δ = 1.1-1.4 (m, 18H), 1.86 (s, 3H), 2.33 (m, 2H), 2.75 (t, 2H, J 
= 0.73 Hz), 6.13 (s, 1H) 
13C-NMR (100 MHz, CDCl3)   δ = 25.5 (CH3), 25.9, 26.8, 26.9, 27.0, 27.1, 27.2,32.1, 44.0 
(12x CH2), 125.4 (CH), 159.3 (C), 198.3 (C) 
Rf     0.65 (hexane/EtOAc 95/5) 
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5.14.8 Synthesis of (E)-3-Methyl-cyclopentadec-3-enone 120 
 
O
 
 
The product 120 was obtained as a side product under the reaction conditions described in 5.14.5.2 
(yield 18%) 
 
C16H28O     (236.39) 
1H-NMR (400 MHz, CDCl3)  δ = 1.1-1.4 (m, 18H), 1.6 (s, 3H), 2.06 (m, 2H), 2.38 (t, 2H, J 
= 0.77), 2.97 (s, 2H), 5.3 (t, 1H, J = 0.7 Hz) 
13C-NMR (100 MHz, CDCl3)  δ = 16.9 (CH3), 22.8, 23.0, 25.7, 26.9, 27.0, 27.1, 27.2, 29.1, 
31.9, 40.6, 55.4, 129.8 (C), 130.7 (CH), 210.9 (C) 
Rf     0.58 (hexane/EtOAc 95/5) 
 
 
5.14.9 Synthesis of (Z)-3-Methyl-cyclopentadec-3-enone 120 
 
O
 
 
The product 120 was obtained as a side product under the reaction conditions described in 5.14.5.2  
(6%). 
 
C16H28O     (236.39) 
1H-NMR (400 MHz, CDCl3)  δ = 1.1-1.4 (m, 18H), 1.65 (s, 3H), 2.05 (m, 2H), 2.37 (m, 2H), 
3.11 (s, 2H), 5.39 (t, 1H, J = 0.7 Hz) 
Rf     0.58 (hexane/EtOAc 95/5) 
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5.14.10  Synthesis of 2-hydroxymethylene-cyclopentadecanone 122 
 
O OH
H
 
 
To a suspension of sodium ethanolate (2.27 g, 33.4 mmol) and formic acid ethyl ester (2.68 ml, 
33,5 mmol) in 50 ml of diethyl ether at 0 °C was added dropwise a solution of cyclopentacanone (5 
g, 22.3 mmol) dissolved in 5 ml of diethyl ether. The reaction mixture was stirred two hours at 
room temperature and quenched with 20 ml of ice-cold water. After acidification with acetic acid, 
the product was extracted with diethyl ether (2x 50 ml). The solvent was evaporated before 
crystalisation in Et2O (5 ml). Yield 60% 
 
C16H28O2     (252.39) 
1H-NMR (400 MHz, CDCl3)  δ 1.2-1.5 (m, 20H), 1.69 (m, 2H), 2.15 (t, 2H, J = 0.83Hz), 2.4 
(t, 2H, J = 0.70Hz), 8.05 (d, 1H, J = 0.64Hz), 15.1 (d, 1H, J = 
0.63Hz) 
13C-NMR (100 MHz, CDCl3)  δ 24-28.5 (11x CH2), 30.5 (CH2), 37 (CH2), 113 (C), 180 
(CH), 197 (C) 
 
 
5.14.11  Synthesis of 2-diazo-cyclopentadecanone 123 
 
O
N
N
 
 
To a solution of 122 (2g, 7.9 mmol) and triethylamine (15.8 mmol) in dichloromethane (50 ml) at -
10 °C was added dropwise a solution of p-toluenesulfonyl azide (1.55 g, 7.9 mmol) keeping the 
temperature below 5 °C. After stirring for two hours at -10 °C, the reaction mixture was quenched 
with 10 ml of sat. aq. NaOH solution, and extracted with diethyl ether (2 x 50 ml). The solvent was 
evaporated before crystalisation in Et2O (5 ml). Yield 70% 
 
C15H26N2O     (250.38) 
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1H-NMR (400 MHz, CDCl3)  δ 1.15-1.4 (m, 20H), 1.52 (m, 2H), 1.70 (m, 2H), 2.4 (t, 2H, J 
= 0.6Hz) 
13C-NMR (100 MHz, CDCl3)  δ 24-28.5 (11x CH2), 38 (CH2), 135 (C), 148(C) 
Rf     0.45 (hexane/EtOAc  8/2) 
 
 
5.14.12   Synthesis of (Z)-cyclopentadec-2-enone 124 
 
O
 
 
The diazo compound 123 (1g, 4 mmol) was dissolved in THF (20 ml) and treated with Ag2O (458 
mg, 2 mmol) dissolved in 5 ml water at room temperature for 36 hours (Caution, nitrogen 
degagement). After filtration of the silver oxyde, the reaction mixture was quenched with 10 ml of 
sat. aq. Potassium carbonate, and extracted with diethyl ether (2 x 70 ml). The solvent was 
evaporated before crystalisation in toluene (5 ml). Yield 30% 
 
C15H26O     (222.37) 
1H-NMR (400 MHz, CDCl3)  δ = 1.2-1.31 (m, 16H), 1.48 (m, 2H), 1.65 (m, 2H), 2.43 (m, 
2H), 2.68 (m, 2H), 5.97-6.05 (dt, 1H, J = 7.3, 11.5 Hz), 6.21 
(dt, 1H, J = 1.1, 11.5 Hz) 
13C-NMR (100 MHz, CDCl3)  δ = 24, 26-28.5 (10x H2C), 44 , 128, 150, 203 
MS  222 (14), 207 (1), 193 (3.5), 179 (5), 165 (5), 137 (5), 123 (6), 
111 (13), 98 (36.5), 81 (34), 55 (81), 41 (100) 
Rf 0.65 (hexane/Et2O  9/1) 
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5.14.13   Synthesis of cyclopentadeca-2,14-dienone 128 
 
O
 
 
Cyclopentadecanone (1.8 g, 8.0 mmol) was dissolved in 30 ml of DMSO and 10 ml of 
fluorobenzene. IBX (6.7 g, 24.0 mmol) was added and the reaction mixture stirred at 80 °C for 24 
hours, forming a white precipitate. The reaction was quenched by slow addition of NaHCO3 at 0 °C 
followed by filtration over celite® eluting with dichloromethane. The filtrate was extracted with 
dichloromethane (2 x 150 ml), Et2O (150 ml), the solvent was removed under vacuum and the 
residu purified by column chromatography over silica-gel, eluting with hexane/EtOAc 9/1 to give 
the product as a colorless oil (1.1 g, 4.8 mmol, 60% yield).  
 
C15H24O     (220.35) 
1H-NMR (400 MHz, CDCl3)  δ 1.18-1.35 (m, 12H), 1.51 (m, 4H), 2.23 (m, 4H), 6.20 (dt, 
2H, J = 1.6, 15.6 Hz), 6.63 (dt, 2H, J = 8.0, 15.6 Hz) 
13C-NMR (100 MHz, CDCl3)  δ 26.7, 27.3, 27.6, 27.8, 32.2, 130.2 , 148.7, 193.4 
MS 220 (7.5), 205 (1), 191 (2), 179 (11), 163 (7), 149 (13), 135 
(14), 109 (19), 95 (55), 81 (67), 67 (54), 55 (81), 41 (100) 
Rf 0.45 (hexane/EtOAc 9/1) 
 
 
5.14.14     Synthesis of (S)-(E)-14-Methyl-cyclopentadec-2-enone 129 
 
O
 
 
The adamantylvaline-amide ligand 39 copper-complex  (17.6 mg, 0.02 mmol, 5 mol%) was 
placed under argon in an ampoule equipped with a magnetic stirring bar and a Young® valve, 
dissolved with 3 ml of degassed toluene. The ampoule was sealed under argon and the mixture 
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stirred for 30 min at -30 °C. To this green solution were added dropwise under argon stream two 
equivalents of 1.0 M dimethyl zinc solution in heptane (0.8 mmol, 0.8 ml), turning the colour to 
yellow, followed by cyclopentadeca-2,14-dienone (88 mg, 0.4 mmol). The reaction mixture was 
stirred at -30 °C for 48 h before quenching with 3 ml of saturated NH4Cl solution, addition of 5 
μl of n-tridecane as internal standard and extraction with 5 ml of diethyl ether.  The organic layer 
was filtered and submitted to GC and GC-MS analysis. The solvents were evaporated and the 
reaction mixture purified by column chromatography on silica gel eluting with hexane/EtOAc 9/1 
to give the product as a colorless oil (93.7 mg, 0.39 mmol, 98%).  
 
 
C16H28O     (236.39) 
1H-NMR (400 MHz, CDCl3)  δ 0.89 (d, J = 6.8, 3H), 1.10-1.30 (m, 18H), 2.0-2.15 (m, 1H), 
2.2-2.35 (m, 2H), 2.35 (d, 2H, J = 10.0 Hz), 6.11 (dt, 1H, 1.6, 
15.6 Hz), 6.74 (m, 1H). 
13C NMR (100 MHz, CDCl3) δ 20.5, 24.5, 26.9, 27.0, 27.1, 27.2, 27.3, 27.5, 30.6, 31.7, 
34.3, 49.2, 131.4, 148.2, 201.3. 
MS (EI, m/z, %) 236 (M+, 22), 221 (6.5), 178 (6), 151 (4), 135 (8), 123 (14), 
109 (29), 81 (57), 67 (41), 55 (100), 41 (98).  
HPLC  (250 mm x 4.6 mm Daicel, Chiracel AS , 223 nm, 
hexan/isopropanol 98.5/1.5, 0.5 mL/min, 293K): 21.1 min (R), 
24.1 min (S). 
Rf  0.55 (hexane/EtOAc 9/1);). 
 
 
5.14.15   Synthesis of 3-Methyl-cyclopentadecanone 90 
 
O
 
 
5.14.15.1   Synthesis by copper-hydride conjugate addition 
 
The (S)-BINAP ligand (31 mg, 0.05 mmol) together with 10 mg of CuI(OTf) (0.047 mmol, 5 
mol%) and 5 mg of tBuONa (0.05 mmol)  were introduced under argon (glove box) in an ampoule 
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equipped with a magnetic stirring bar and a Young® valve and dissolved in 2 ml of degassed 
toluene. The reaction mixture was cooled to 0° C and stirred for 30 min. before addition of 1 ml of 
PMHS (50%, dimethysilyl copolymere) and 0.23 g of the (E)-3-Methyl-cyclopentadec-2-enone 112 
(1.0 mmol). The reaction mixture was stirred at 0° C for 24 hours. Treatement and analysis 
following the procedure 8.1.1. Yield 55% 
 
 
5.14.15.2   Synthesis by copper-catalysed dimethyl zinc conjugate addition 
 
Catalysis following the procedure described in 5.13.1.1, with enone 113 or 124 (0.5 mmol, 111 mg) 
and dimethyl zinc (1.0 mmol, 0.5 ml) at room temperature for 24 hours. 
 
 
5.14.15.3   Synthesis by hydrogenation of the enone 129 
 
The enone 129 (0.1 g, 0.42 mmol) was dissolved in 5 ml of ethanol together with 5 mg of Pd/C. 
The reaction mixture was stirred for one hour at room temperature with slow bubbling of hydrogen 
gas (ambient pressure) trough the solution, introduced through a stainless-steel needle. The reaction 
mixture was quenched with 0.5 ml of water, filtrated an extracted with diethyl ether (10 ml). The 
purification was obtained by column chromatography on silica-gel (hexan / Diethylether 9/1). 
Yield 97% 
 
C16H30O     (238.41) 
1H-NMR (400 MHz, CDCl3)  δ = 0.94 (d, J = 6.7, 3H), 1.10-1.49 (m, 20H), 1.50-1.58 (m, 
2H), 1.95-2.12 (m, 1H), 2.18 (dd, J = 15.0, 5.1, 1H), 2.35-2.50 
(m, 3H) 
13C-NMR (100 MHz, CDCl3)  δ = 21.1 (), 23.1, 25.1, 26.2, 26.3, 26.5, 26.6, 26.7, 26.8, 27.2, 
27.6  (10x CH2), 29.0 (), 35.6, 42.1, 50.8 (3x CH2), 212.0 (C) 
MS  238 (16), 223 ( 7), 209 (12), 180 (5), 163 (3), 149 (4.5), 135 
(5), 125 (18), 97 (25), 85 (47), 69 (45), 41 (100) 
Rf      0.59 (hexan / Diethylether 9/1) 
GC tR = 10.5 min (Restek Rtx1701, 30 m x 0.25 mm x 0.25 μm, 60 
kPa He or H2, Temp: 60° C, 1° C /min, 80°C, 30°C/min, 250 
°C) 
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tR =  11.7 min (+, R), 12.1 min (-, S), (M.N. Hydrodex β-3P, 75 
kPa He, Temp : 60°C, 15° C/min, 120° C, 0.7° C/min, 150° C, 
15° C/min, 180°C 
 
 
5.15.  Kinetic resolution of  Enones 
 
5.15.1 Synthesis of 5-methyl-cyclohex-2-enone 133 
 
O
 
 
General Procedure. To a solution of ethylester butyric acid (0.038 mol, 4.4 g) and butenal (0.038 
mol, 2.6 g) in t-BuOH (50 ml) was added 9.12 g of t-BuONa (0.095 mol, 2.5 eq.) at 0 °C. The 
reaction mixture was stirred at 80° C for 12 hours. Upon cooling to room temperature, the mixture 
was quenched with an 1M HCl solution (15 ml), diluted with a 1/1 mixture of ether and benzene 
(70 ml) and washed with 1M NaOH solution (25 ml x 2). The collected organic phase was dried 
over Na2SO4, filtered and concentrated under reduced pressure. The purification was obtained by 
column chromatography on silica-gel. (2/8  EtOAc/hexane). 
 
Analytical Data of : C7H10O   (110.15) 
1H-NMR (400 MHz, CDCl3) δ 1.05 (d, 3H, J = 0.65Hz), 2.03 (m, 1H), 2.1 (m, 1H), 2.2 (m, 
1H), 2.4 (m, 1H), 2.5 (m, 1H), 6.0 (m, 1H), 7.0 (m, 1H) 
MS   110 (23), 95 (3), 81 (0.3), 79 (0.3), 68 (100), 65 (2), 55 (4), 51 
(2), 41 (6) 
GC (Ivadex 7, 60 kPa H2, Temp : 60°C for 45min, 15° C /min, 
180) tR = 34.06 min and 40.29 min. For the reduced enone 
131 : tR = 23.3 min and 26.2 min 
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5.15.2 Synthesis of 5-Phenyl-cyclohex-2-enone 134 
 
O
 
 
Synthesis following the general procedure 5.15.1 with ethylester butyric acid (0.038 mol) and 3-
Phenyl-propenal (0.038 mol). The product was purified first by Kugelrohr destillation (150 °C, 26 
mbar) followed by column chromatography on silica-gel (2/8  EtOAc/hexane). 
 
Analytical Data of : C12H12O  (172.22) 
1H-NMR (400 MHz, CDCl3) δ 2.5-2.75 (m, 4H), 3.35 (m, 1H), 6.14 (dd, 1H, J = 0.25, 
0.73Hz), 7.05 (m, 1H), 7.23-7.36 (m, 5H) 
13C-NMR (100 MHz, CDCl3) δ 34.1, 41.4, 45.3, 127-130, 143.6, 149.9, 199.6 
GC (Ivadex 7, 70 kPa H2, Temp : 65° C, 4° C /min, 170°C) tR = 
25.76 min and 26.14 min. For the reduced enone 131 : tR = 
24.43 min and 24.53 min 
 
 
5.15.3 Synthesis of 5-Isopropyl-cyclohex-2-enone 135 
 
O
 
 
Synthesis following the general procedure 5.15.1 with ethylester butyric acid (0.038 mol) and 4-
Methyl-pent-2-enal (0.038 mol). 
 
Analytical Data of : C9H14O   (138.21) 
1H-NMR (400 MHz, CDCl3) δ 0.9 (d, 6H), 1.5-1.95 (m, 5H), 2.6 (m, 1H), 6.09 (m, 1H), 6.8 
(dd, 1H, J = 1.1, 1.7Hz) 
13C-NMR (100 MHz, CDCl3) δ  20, 30.5, 32, 42.2, 42.5, 130.2, 151.5, 201.1 
MS  138 (10), 123 (1), 110 (0.5), 95 (13), 91 (1), 81 (2.5), 68 (100), 
67 (24), 55 (7), 41 (18) 
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GC (Lipodex A, 60 kPa H2, Temp : 80°C, 1°C/min, 120°C, 15°C 
/min, 170°C) tR = 28.00 min and 28.97 min. For the reduced 
enone 131 : tR = 18.67 min and 20.27 min. 
 
 
5.15.4 Kinetic resolution : hydrogenation of enones 
 
General Procedure : A solution of 5-Isopropyl-cyclohexenone 135 (0.05 g, 0.36 mmol) and 17.5 
mg of iridium catalyst X68 (0.011 mmol, 3 mol%) in 1 ml of dry toluene was stirred in a 2 ml 
screw-cap vial placed in a high-pressure autoclave under 25 bar H2 for one hour at room 
temperature. The reaction was set up in glove-box under inert atmosphere. The reaction was 
quenched with 0.5 ml of water, the organic phase extracted. After filtration through a syringe filter, 
the solution was directly used for GC and GC-MS analysis. For retention times, see 5.14.15.3 and 
5.15.1-5.15.3. 
 
 
5.16.  Multicomponent Reaction 
 
5.16.1 Synthesis of  4-(1-Cyclohex-1-enyl-hexyl)-morpholine 141 
 
N
O
 
 
General Procedure: The PHOX ligand 106 (8.4 mg, 0.021 mmol) and 5 mg of Pd2(dba)3 (0.0054 
mmol, 5 mol%) were introduced under argon in an ampoule equipped with a magnetic stirring bar 
and a Young® valve and dissolved in 4 ml of degassed DMA. The mixture was stirred for 30 min. 
before addition of 38 μl of cyclohexenyltriflate 138 (0.21 mmol), 87 μl of morpholine (1.0 mmol) 
and 133 μl of 1-hexene (1.0 mmol). The reaction mixture was heated to 80° C and stirred for 72 
hours, the colour turning to yellow. The reaction was quenched with 1 ml of water and extracted 
with diethyl ether (2 x 10 ml). After filtration through a syringe filter, the solution was directly 
used for GC and GC-MS analysis. Purification was realized by column chromatography on silica-
gel (hexane/EtOAc 9/1). 
 
Analytical Data of : C16H29NO  (251.41) 
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1H-NMR (400 MHz, CDCl3) δ 0.89 (t, J = 0.75 Hz, 3H, CH3), 1.2-1.35 (m, 8H), 1.5-1.65 
(m, 4H), 1.89 (m, 2H), 2.02 (m, 2H), 2.3-2.5 (m, 4H), 3.68 (t, 
4H, J = 0.43 Hz), 5.5 (m, 1H) 
13C-NMR (100 MHz, CDCl3) δ 15.1 (CH3), 23.6 (CH2), 23.9 (CH2), 25.3 (CH2), 26.3 (CH2), 
26.4 (CH2), 27.3 (CH2), 29.9 (CH2), 33.1 (CH2), 52.7 (CH2), 
68.0, 73.5, 126.6 (CH), 140.6 (C) 
MS  251 (1.5), 180 (100), 170 (9), 152 (1.5), 121 (1), 107 (1.5), 95 
(5), 67 (7),  55 (7), 41 (11) 
GC (SE 54, 60 kPa H2, Temp : 130°C, 30 min, 1°C/min, 160°C, 
15°C /min, 175°C) tR = 26.00 min and 27.2 min. 
Rf     0.15 (hexane/EtOAc 9/1) 
 
 
5.16.2    4-(2-Hexylidene-cyclohexyl)-morpholine 142 
 
N
O
 
 
Synthesis following the general procedure 5.16.1. 
 
Analytical Data of : C16H29NO  (251.41) 
1H-NMR (400 MHz, CDCl3) δ 0.89 (t, J = 0.8 Hz, 3H, CH3), 1.19-1.42 (m, 11H), 1.68-1.80 
(m, 1H), 1.9-2.1 (m, 4H), 2.2-2.5 (m, 4H), 3.68 (t, 4H, J = 
0.47 Hz), 4.2-4.4 (m, 1H), 5.2 (t, 1H, J = 0.56 Hz) 
MS  251 (4), 208 (3.5), 194 (2), 180 (100), 164 (10), 152 (2), 126 
(9), 109 (5), 95 (15), 67 (12), 55 (9), 41 (9) 
Rf     0.45 (hexane/EtOAc 9/1) 
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5.16.3    1-Hex-1-enyl-cyclohexene 143 
 
 
 
Synthesis following the general procedure 5.16.1. 
 
Analytical Data of : C12H20   (164.29) 
1H-NMR (400 MHz, CDCl3) δ 0.9 (t, 3H), 1.32 (m, 4H), 1.55-1.70 (m, 4H), 2.1 (m, 6H),  
5.55 (m, 1H), 5.63 (m, 1H), 6.0 (d, 1H, J = 1.56 Hz) 
MS   165 (4), 164 (33), 149 (2), 135 (23), 121 (25), 117 (2.5),  107 
(30), 93 (47), 79 (100), 67 (45), 55 (19), 53 (13), 41 (40) 
Rf     0.93 (hexane/EtOAc 9/1) 
 
 
5.16.4    1-(1-Methylene-pentyl)-cyclohexene 144 
 
 
 
Synthesis following the general procedure 5.16.1. 
 
Analytical Data of : C12H20   (164.29) 
1H-NMR (400 MHz, CDCl3) δ 0.9 (t, 3H), 1.32 (m, 4H), 1.55-1.70 (m, 4H), 2.1 (m, 6H), 
4.8 (s, 1H), 4.9 (s, 1H), 5.9 (t, 1H, J = 0.4 Hz) 
MS  164 (13), 149 (5), 135 (3), 122 (77), 109 (2), 107 (81), 93 (48), 
79 (100), 67 (21), 53 (21.5), 41 (43) 
Rf     0.93 (hexane/EtOAc 9/1) 
 
 
 
 
 
166 
5.16.5  Synthesis of 4-[1-(2-Cyclohex-1-enyl-vinyl)-hexyl]-morpholine 155 
 
N
O
 
 
Synthesis following the general procedure 5.16.1 with β-bromostyrene (0.21 mmol, 27 μl). 
 
Analytical Data of : C18H27NO  (273.41) 
1H-NMR (400 MHz, CDCl3) δ 0.86 (m, 3H), 1.28 (m, 8H), 2.45-2.68 (m, 4H), 2.82 (m, 
1H), 3.7 (t, 4H, J = 0.44 Hz), 6.1 (qd, 1H, J = 1.0, 1.9 Hz), 
6.43 (d, 1H, J = 1.9 Hz), 7.1-7.5 (m, 5H) 
GC (SE 54, 60 kPa H2, Temp : 130°C, 30 min, 1°C /min, 160°C, 
15°C /min, 175°C) tR = 26.50 min and 27.40 min. 
 
 
5.16.6  Synthesis of [2-(2-Butoxy-cyclohexylidene)-ethyl]-bis-(2-methoxy-ethyl)-amine 148 
 
O
N
O
O
11
1
2
3
4
5 6
789
10
12
13
14
 
 
Synthesis following the general procedure 5.16.1 with butylvinyl ether (1.0 mmol, 100 μl) and Bis-
(2-methoxy-ethyl)-amine (1.0 mmol, 110 μl). Yield 50% 
 
Analytical Data of : C18H35NO3  (313.48) 
 
1H-NMR (400 MHz, CDCl3) δ 0.90 (t, 3H, J = 0.7, C1), 1.25-1.85 (m, 10H, 1.35 C8, 1.36 
C2, 1.47 C7, 1.53 C3, 1.62 C8, 1.63 C6, 1.80 C6C7 ), 2.16 (m, 
2H, C9), 2.71 (t, 4H, J = 0.6 Hz, C12), 3.24 (m, 3H, C4C11), 
3.34 (m, 7H, C4C14), 3.47 (t, 4H, J = 0.6 Hz, C13), 3.63 (t, 
1H, J = 0.35 Hz, C5), 5.41 (t, 1H, J = 0.69Hz, C10) 
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13C-NMR (100 MHz, CDCl3) δ 14.0 (C1), 19.5 (C2), 22.0 (C7), 25.5 (C9), 27.4 (C8), 32.1 
(C3), 34.2 (C6), 51.5 (C11), 53.6 (C12), 58.8 (C14), 67.6 
(C4), 71.1 (C13), 81.0 (C5), 120.2 (C10), 142.1 (C);  NOE 
C10-C5 
Rf     0.19 (hexane/EtOAc 8/2) 
 
 
5.16.7   Synthesis of (E)-4-[2-(2-Butoxy-cyclohexylidene)-ethyl]-morpholine 
 
O
N
O
 
 
Synthesis following the general procedure 5.16.1 with butylvinyl ether (1.0 mmol, 100 μl) and  
morpholine (1.0 mmol, 87 μl). 
 
Analytical Data of : C16H29NO2  (267.41) 
1H-NMR (400 MHz, CDCl3) δ 0.9 (t, 3H), 1.25-1.55 (m, 6H), 1.55-1.65 (m, 2H), 1.72-1.81 
(m, 2H), 2.17 (t, 2H), 2.43 (m, 4H), 3.03 (d, 2H), 3.20-3.35 
(m, 2H), 3.67 (m, 1H), 3.72 (t, 4H), 5.35 (t, 1H) 
13C-NMR (100 MHz, CDCl3) δ 14.3 (CH3), 19.9, 22.5, 26.1, 27.7, 32.5, 33.1, 34.6, 54.0, 
55.7, 67.4, 68.1, 81.3,  119.0, 140.4 
ESI-MS    268.2 (M+H, 100), 269.2 (22), 270.5 (5) 
Rf     0.20 (hexane/EtOAc 8/2) 
GC (SE 54, 60 kPa H2, Temp : 120°C, 0.5°C /min, 150°C, 1°C 
/min, 160, 15°C) tR = 28.50 min and 29.30min. 
 
 
5.16.8   Synthesis of 4-[2-(2-Ethoxy-cyclohexylidene)-ethyl]-morpholine 
 
 
O
N
O
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Synthesis following the general procedure 5.16.1 with ethylvinyl ether (1.0 mmol, 80 μl) and  
morpholine (1.0 mmol, 87 μl). 
 
Analytical Data of : C14H25NO2  (239.35) 
1H-NMR (400 MHz, CDCl3) δ 1.18 (t, 3H, J = 0.8 Hz), 1.25-1.60 (m, 2H), 1.70-1.82 (m, 
2H), 1.92-2.00 (m, 2H), 2.43 (m, 4H), 3.03 (d, 2H, J = 0.70 
Hz), 3.25-3.4 (m, 2H), 3.68 (m, 2H), 3.72 (t, 4H, J = 0.52 Hz), 
4.31 (t, 1H, J = 0.17 Hz), 5.41 (t, 1H, J = 0.70 Hz) 
13C-NMR (100 MHz, CDCl3) δ 15.9 (CH3), 21.25 , 28.8, 33.1, 33.2, 54.0, 55.6, 62.9, 67.4, 
72.4 (CH), 122.1, 143.3 
ESI-MS    240.2 (100, M+H), 241.2 (14), 242.2 (3) 
GC (SE 54, 60 kPa H2, Temp : 130°C, 30 min, 1°C /min, 160°C, 
15°C /min, 175°C) tR = 28.10 min and 28.87 min 
 
 
5.16.9   Synthesis of 4-[2-(2-Isobutoxy-cyclohexylidene)-ethyl]-morpholine 
 
O
N
O
 
 
Synthesis following the general procedure 5.16.1 with 2-Methyl-1-vinyloxy-propane (1.0 mmol, 
105 μl) and  morpholine (1.0 mmol, 87 μl). 
 
Analytical Data of : C16H29NO2  (267.41) 
1H-NMR (400 MHz, CDCl3) δ 0.9 (dt, 6H), 1.25-1.68 (m, 2H), 1.70-1.86 (m, 2H), 1.92-
2.05 (m, 2H), 2.45 (m, 4H), 3.03 (d, 2H), 3.20-3.35 (m, 2H), 
3.68 (m, 2H), 3.72 (t, 4H), 4.25 (t, 1H), 5.41 (t, 1H, J = 0.70 
Hz) 
GC (SE 54, 60 kPa H2, Temp : 130°C, 30 min, 1°C /min, 160°C, 
15°C /min, 175°C) tR = 27.30 min and 28.15 min 
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5.16.10   Synthesis of Trifluoromethanesulfonic acid 1-methylene-butyl ester 149 
 
OTf
 
 
To a solution of 1-pentyne (5 g, 0.073 mol) in 10 ml of pentane at -30 °C was added dropwise 11 g 
of Trifluoromethanesulfonic acid  (0.073 mol) over 15 min. turning the colour to deep red. The 
reaction mixture was left to warm to room temperature over 45 min. and quenched with dropwise 
addition of NaHCO3 (10 ml). After extraction with diethyl ether (2 x 50 ml) and evaporation of the 
solvents, the product was purified by distillation. Yield 60% 
 
Analytical Data of : C6H9F3O3S  (218.19) 
1H-NMR (400 MHz, CDCl3) δ 0.95 (t, 3H), 1.58 (m, 2H), 2.31 (t, 2H), 4.92 (dt, 1H, J = 
0.37, 0.1 Hz), 5.08 (d, 1H, J = 0.37 Hz) 
13C-NMR (75 MHz, CDCl3) δ 13.5 (CH3), 19.7 (CH2), 36.1 (CH2), 104.5 (CH2), 120.5 
(CF3), 157.2 (C) 
MS   218 (0.5), 190 (23), 139 (1.5), 126 (35.5), 87 (13), 73 (8), 69 
(100), 53 (16) 
 
 
5.16.10   Synthesis of 4-(2-Propyl-oct-2-enyl)-morpholine 151 
 
N
O
 
 
Synthesis following the general procedure 5.16.1 with vinyltriflate (0.2 mmol, 35 μl) and 
morpholine (1.0 mmol, 87 μl). 
 
Analytical Data of : C15H29NO  (239.4) 
1H-NMR (400 MHz, CDCl3)  δ 0.89 (m, 6H), 1.2-1.4 (m, 8H), 1.96-2.1 (m, 4H), 2.35 (m, 
4H), 2.81 (s, 2H), 3.7 (m, 4H), 5.32 (t, 1H) 
13C-NMR (75 MHz, CDCl3)  δ 14.4, 14.5, 21.9, 22.9, 28.0, 29.9, 31.3, 32.0, 53.9, 66.0, 
67.5, 129.0 (CH), 141.3 (C) 
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6. X-Ray structures 
 
6.1 Structure of (S,RFc)-2-((2-(diphenylphosphino)-ferrocenyl)methyleneamino)-N-tert-butyl-3-
methylbutanamide 62 
 
Summenformel C32H37FeN2OP  Volumen [Å3]  2882.32  
Molmasse  552.47    Z   4 
Strahlung  MoKα (λ= 071023)  Temp. [K]  173 
Raumgruppe  P 21 21 21   Dcalc [g/cm3]  1.273 
Kristallklasse  Orthorombic   R-Wert [%]  0.041 
a [Å]   10.2689 (2)   Farbe    Orange 
b [Å]   10.2829 (3) 
c [Å]   27.2962 (4) 
α [°]   90 
β [°]   90 
γ [°]   90 
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6.2    Structure of (SFc)-2-(carbaldehyde(1’-diphenylphosphino)ferrocenyl)trimethylsilane 78 
 
 
 
Summenformel C26H27FeOPSi  Volumen [Å3]  1175.79 
Molmasse  470.40    Z   2 
Strahlung  MoKα (λ= 071023)  Temp. [K]  173 
Raumgruppe  P-1    Dcalc [g/cm3]  1.329 
Kristallklasse  Triclinic   R-Wert [%]  0.0567 
a [Å]   8.3914 (2)   Farbe    Orange 
b [Å]   11.4523 
c [Å]   12.5228 (4) 
α [°]   87.6705 (14) 
β [°]   83.0527 (15) 
γ [°]   79.8767 (17) 
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